data_1wt8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wt8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 N--CA 1.457 -0.671 0 N-CA-C 110.272 -0.703 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.54 111.61 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.311 1.053 . . . . 0.0 109.281 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -130.11 175.08 9.19 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.027 -163.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p 174.46 144.09 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.763 1.625 . . . . 0.0 112.721 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -70.87 -39.81 72.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.358 162.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -166.5 -170.66 1.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.409 1.084 . . . . 0.0 109.073 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -55.86 -47.54 77.14 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.496 1.518 . . . . 0.0 111.824 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -40.96 23.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 122.179 -0.325 . . . . 0.0 110.828 172.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.69 -0.91 16.95 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 120.951 -1.093 . . . . 0.0 111.588 -168.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.99 9.39 2.13 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -31.72 -47.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 159.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -55.32 -26.56 41.38 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.216 1.806 . . . . 0.0 112.015 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -70.17 -17.85 63.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 112.416 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.32 -91.66 0.09 OUTLIER Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.377 0.989 . . . . 0.0 111.466 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 tp -99.53 -100.48 0.23 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.91 -42.86 4.29 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 mm 52.87 65.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 123.117 1.437 . . . . 0.0 109.261 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -60.22 145.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.742 1.617 . . . . 0.0 112.012 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.03 132.57 38.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.862 -141.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -74.65 166.51 23.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -66.12 69.38 0.06 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.11 1.764 . . . . 0.0 111.278 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.55 -34.08 2.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 126.946 2.212 . . . . 0.0 112.455 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.45 118.8 26.61 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.073 0.937 . . . . 0.0 113.067 -153.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.04 58.95 5.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.67 1.588 . . . . 0.0 109.418 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 67.04 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.225 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.66 -52.7 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 128.358 2.663 . . . . 0.0 115.091 -172.048 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.448 -1.148 0 N-CA-C 109.162 -1.13 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.5 93.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 121.937 0.875 . . . . 0.0 109.308 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.12 160.43 17.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.949 -150.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.1 p -147.42 122.67 10.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.132 -1.849 . . . . 0.0 114.955 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -69.58 -31.81 70.19 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.932 150.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -171.14 -178.92 2.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.471 1.508 . . . . 0.0 107.784 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.97 -47.23 81.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.634 1.574 . . . . 0.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -33.76 16.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.506 173.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.98 -6.75 35.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 119.847 1.203 . . . . 0.0 112.112 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.296 21.1 m -133.68 5.09 3.66 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.157 0.983 . . . . 0.0 113.412 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -39.08 -40.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 122.226 1.013 . . . . 0.0 113.53 163.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ptm -56.28 -24.95 46.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.953 1.701 . . . . 0.0 112.135 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.1 m -65.05 -23.91 67.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.345 0.658 . . . . 0.0 111.864 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.13 -84.91 0.08 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -116.87 -99.67 0.44 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.6 1.16 . . . . 0.0 109.016 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.47 -73.43 1.06 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.3 mm 49.47 73.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.095 1.358 . . . . 0.0 109.93 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.9 p -82.45 160.36 22.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.711 1.205 . . . . 0.0 112.85 -167.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.2 t -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.335 2.254 . . . . 0.0 113.55 -166.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -92.89 139.38 30.59 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 156.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -39.79 70.68 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.759 2.823 . . . . 0.0 115.969 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.73 0.46 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.62 1.581 . . . . 0.0 112.466 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -123.42 136.7 54.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.786 1.634 . . . . 0.0 109.327 -166.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.2 m -82.2 166.96 19.16 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.283 0.947 . . . . 0.0 112.055 164.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -121.89 118.38 28.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.33 1.052 . . . . 0.0 109.393 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 0.75 37.2 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.991 -0.894 . . . . 0.0 114.077 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.465 0.3 0 CA-C-N 119.003 1.402 . . . . 0.0 111.557 175.755 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.9 115.26 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.12 162.89 22.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 124.776 1.23 . . . . 0.0 109.966 -148.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -175.85 142.32 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -166.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -79.38 -32.15 43.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.597 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -165.27 -179.85 5.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.328 1.051 . . . . 0.0 108.583 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -56.72 -43.97 81.15 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.178 1.391 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -36.85 41.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.141 172.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -74.5 -5.59 43.55 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.995 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 1.83 6.38 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.501 1.12 . . . . 0.0 114.013 174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -41.47 -34.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.9 ptp -52.33 -31.53 33.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 111.47 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.6 m -65.04 -25.87 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 112.716 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.25 -92.47 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 118.937 0.789 . . . . 0.0 111.319 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 tp -133.01 -106.03 0.25 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.744 1.218 . . . . 0.0 109.167 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.8 45.52 2.89 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.2 mm -65.92 97.75 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -88.18 127.87 35.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.835 0.854 . . . . 0.0 111.796 -164.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.99 115.95 20.71 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.882 0.873 . . . . 0.0 112.272 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -88.36 88.48 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 39.83 38.13 0.42 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.017 2.527 . . . . 0.0 114.72 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.02 -49.56 0.44 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.334 -0.703 . . . . 0.0 111.387 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -127.31 147.92 50.24 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.31 -161.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.257 1.0 OUTLIER -105.56 160.35 15.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 111.152 170.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -131.63 141.39 49.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.323 1.449 . . . . 0.0 108.164 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.95 40.57 93.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.41 0.55 . . . . 0.0 112.195 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.8 t . . . . . 0 N--CA 1.439 -0.98 0 C-N-CA 127.008 2.123 . . . . 0.0 110.889 -175.317 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.557 -0.594 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.22 110.77 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.139 0.971 . . . . 0.0 108.948 173.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -130.03 176.2 8.27 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.962 -161.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.9 p -171.57 152.59 3.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.195 -1.821 . . . . 0.0 109.624 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -24.47 17.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.94 160.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -168.27 -177.43 3.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 106.966 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -43.81 98.31 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.38 1.072 . . . . 0.0 110.821 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -35.11 14.83 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.971 170.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.69 -3.55 28.92 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.562 -1.336 . . . . 0.0 111.992 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 m -135.42 8.36 3.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 124.429 1.092 . . . . 0.0 113.802 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.9 p -37.6 -42.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 161.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.2 ptm -56.16 -26.07 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.574 1.55 . . . . 0.0 111.957 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.7 m -69.81 -18.79 63.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.233 1.013 . . . . 0.0 111.489 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.53 -88.08 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.154 0.888 . . . . 0.0 111.473 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -105.6 -140.07 0.37 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.638 1.575 . . . . 0.0 108.017 -177.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.562 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -80.24 49.84 3.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 128.054 2.74 . . . . 0.0 109.08 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.37 103.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.718 1.607 . . . . 0.0 108.798 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -72.33 141.87 48.82 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.8 0.84 . . . . 0.0 112.201 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.3 t -107.66 110.6 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.177 1.791 . . . . 0.0 111.47 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -76.25 169.8 17.52 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 164.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -1.38 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.389 2.676 . . . . 0.0 115.414 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.42 21.93 2.05 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.682 164.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.27 119.22 27.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.299 1.84 . . . . 0.0 108.392 -170.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 151.19 23.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.105 1.362 . . . . 0.0 110.924 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -127.87 126.33 41.39 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.856 -0.528 . . . . 0.0 111.107 -154.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.34 45.24 31.11 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.317 0.398 . . . . 0.0 112.385 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.441 -0.918 0 C-N-CA 125.82 1.648 . . . . 0.0 112.258 -175.74 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.7 113.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 C-N-CA 124.318 1.047 . . . . 0.0 109.077 172.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -129.41 -179.92 5.43 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.005 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -178.28 156.96 1.02 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.333 -168.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -40.99 19.4 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.961 1.305 . . . . 0.0 108.904 166.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -165.54 -174.81 3.28 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.88 -46.9 64.68 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 127.037 2.135 . . . . 0.0 112.755 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -38.03 26.48 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.972 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.18 -12.38 60.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.101 -0.999 . . . . 0.0 111.503 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.03 12.9 3.95 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -36.62 -44.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 160.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.7 ptm -59.05 -22.75 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.439 1.895 . . . . 0.0 112.337 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -64.58 -21.47 66.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.629 0.772 . . . . 0.0 110.672 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.35 -68.97 0.2 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.559 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -129.54 -138.71 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.118 1.767 . . . . 0.0 108.383 -173.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.61 52.8 4.2 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 128.546 2.974 . . . . 0.0 109.199 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 mm -59.04 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 126.284 1.834 . . . . 0.0 108.38 168.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 p -81.51 144.11 31.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.462 0.705 . . . . 0.0 112.446 -162.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.18 118.48 33.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.722 0.772 . . . . 0.0 111.205 -149.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -79.37 -173.05 3.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.711 1.205 . . . . 0.0 108.633 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -58.49 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.443 1.897 . . . . 0.0 112.147 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.56 71.68 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 128.072 2.749 . . . . 0.0 113.468 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -122.07 121.58 37.3 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 1.389 . . . . 0.0 113.641 -155.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.77 68.85 2.43 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 126.738 2.015 . . . . 0.0 109.147 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -48.09 150.22 1.24 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.551 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.69 -40.64 2.91 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.502 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 114.3 -169.285 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 N-CA-C 110.564 -0.591 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.286 6.1 t -94.12 114.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 101.314 -3.587 . . . . 0.0 101.314 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -123.39 178.75 5.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 124.759 1.224 . . . . 0.0 108.68 -160.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p 179.67 145.08 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.336 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -39.73 53.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.515 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -166.71 -175.54 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.635 1.574 . . . . 0.0 107.083 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -45.2 -46.84 12.5 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 128.483 2.713 . . . . 0.0 113.865 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.24 -44.6 8.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.986 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -4.73 30.62 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.291 -0.88 . . . . 0.0 111.621 -168.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.79 6.26 3.17 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 p -34.76 -45.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 161.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -55.74 -25.86 42.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.916 1.686 . . . . 0.0 111.731 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB3' ' CA ' ' A' ' 30' ' ' CYS . 59.8 m -75.45 -6.84 52.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.167 0.987 . . . . 0.0 112.627 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.65 -95.86 0.11 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 tp -105.7 -99.17 0.33 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -47.11 6.03 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mm 47.53 63.79 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.036 1.334 . . . . 0.0 108.853 -168.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -67.18 136.49 55.12 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.464 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -105.51 164.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -148.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -117.04 171.82 7.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.15 71.95 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 126.465 1.906 . . . . 0.0 113.141 -166.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.56 -23.68 19.44 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.82 2.628 . . . . 0.0 112.447 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.8 140.22 49.99 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.758 1.223 . . . . 0.0 108.549 -160.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 2.5 t -108.69 149.05 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.4 111.77 7.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.906 0.483 . . . . 0.0 110.78 -155.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.54 55.26 6.16 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.457 ' CA ' ' HB3' ' A' ' 16' ' ' CYS . 2.0 m . . . . . 0 CA--C 1.538 0.519 0 C-N-CA 125.326 1.45 . . . . 0.0 110.548 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 N--CA 1.453 -0.896 0 N-CA-C 109.37 -1.05 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.37 106.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.509 1.147 . . . . 0.0 109.714 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -127.08 175.87 7.79 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.278 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.67 166.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.355 1.862 . . . . 0.0 111.103 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -43.46 9.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.184 1.393 . . . . 0.0 108.446 160.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -158.05 -170.95 3.32 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -41.56 67.55 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.996 2.118 . . . . 0.0 112.509 -171.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -42.33 32.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.739 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -7.25 47.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.749 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -137.41 12.73 3.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.138 1.375 . . . . 0.0 114.08 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -35.09 -45.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 159.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.6 ptp -54.79 -25.65 29.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.613 1.565 . . . . 0.0 112.273 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 m -67.5 -22.49 65.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 111.862 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.74 -95.16 0.11 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.659 1.118 . . . . 0.0 111.686 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.601 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -89.88 -140.26 0.14 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 170.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.601 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -56.91 -41.27 91.62 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.99 0.805 . . . . 0.0 111.306 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . 0.274 9.8 mm 50.19 64.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 123.008 1.385 . . . . 0.0 109.386 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.63 118.58 2.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.155 2.182 . . . . 0.0 111.378 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 127.54 43.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.64 0.776 . . . . 0.0 110.826 -160.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.17 -167.54 0.52 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.001 0.92 . . . . 0.0 109.653 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -39.14 70.03 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 130.811 3.644 . . . . 0.0 114.028 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.34 31.93 13.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.75 2.119 . . . . 0.0 113.445 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 120.19 24.12 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.317 1.047 . . . . 0.0 111.954 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -90.8 68.32 6.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.503 1.521 . . . . 0.0 110.391 -170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.83 156.45 0.97 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.284 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.86 -30.48 3.87 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.998 -0.89 . . . . 0.0 113.377 164.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.34 0.194 0 C-N-CA 125.518 1.527 . . . . 0.0 113.855 -172.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.251 2.9 t -96.66 105.25 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 -166.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -121.77 163.8 18.5 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.495 -156.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.79 126.26 16.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.233 -169.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.67 -33.54 75.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 161.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -168.82 -177.88 3.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.577 2.351 . . . . 0.0 104.971 164.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.69 -49.41 65.39 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.525 -169.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -22.09 13.62 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.05 -20.68 66.6 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.476 -1.39 . . . . 0.0 110.943 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.99 9.35 11.85 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.0 p -44.02 -35.1 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 162.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -53.72 -29.8 41.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.492 1.117 . . . . 0.0 111.493 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.96 -29.67 66.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.192 0.997 . . . . 0.0 111.472 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.79 168.49 24.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.8 tp -8.79 -84.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.083 2.953 . . . . 0.0 114.287 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.42 -64.95 1.01 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.5 mm 40.25 61.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 110.839 -163.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.42 142.8 42.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.502 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -104.12 140.55 37.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -164.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -85.92 -159.4 0.46 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 0.0 109.165 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -60.62 77.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.817 1.647 . . . . 0.0 112.477 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.32 8.35 62.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.044 2.735 . . . . 0.0 113.165 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -137.15 120.89 17.39 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.449 1.1 . . . . 0.0 108.837 -162.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.284 31.2 p -98.66 68.42 1.8 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.837 1.653 . . . . 0.0 110.669 -165.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -60.41 76.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.25 0 C-N-CA 127.968 2.507 . . . . 0.0 110.74 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.21 -41.35 0.07 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 125.09 1.356 . . . . 0.0 112.634 176.183 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 0 N--CA 1.457 -0.662 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.26 5.3 t -124.25 111.46 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -163.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -130.72 172.37 12.05 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-O 122.038 0.923 . . . . 0.0 111.746 -153.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -175.18 152.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.2 -171.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.83 -48.17 15.25 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 159.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -142.87 170.93 14.78 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.084 1.754 . . . . 0.0 110.135 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -46.53 -45.26 18.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 126.89 2.076 . . . . 0.0 113.911 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -45.56 -38.45 6.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.245 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -6.23 48.91 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.564 1.146 . . . . 0.0 108.425 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 61.1 m -140.38 13.25 2.37 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 p -42.4 -39.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 164.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -55.68 -25.7 41.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.896 1.678 . . . . 0.0 112.019 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.07 -24.82 64.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.759 0.824 . . . . 0.0 111.397 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.87 -73.95 0.17 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.579 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -113.81 -144.88 0.39 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.889 1.676 . . . . 0.0 108.134 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.579 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -80.91 53.87 4.64 Favored Glycine 0 C--N 1.318 -0.43 0 C-N-CA 128.241 2.829 . . . . 0.0 108.383 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mm -59.74 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 109.284 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -68.52 141.2 55.62 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.548 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.3 m -95.47 117.31 30.15 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.583 1.553 . . . . 0.0 110.795 -160.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLY . 11.8 mptt -80.02 -171.68 3.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -49.25 71.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.386 2.675 . . . . 0.0 114.87 -171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.77 12.87 83.74 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.717 3.056 . . . . 0.0 114.302 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -144.54 129.66 18.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.024 1.412 . . . . 0.0 111.34 -160.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 28.7 p -103.57 59.35 0.75 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.429 1.468 . . . . 0.0 112.277 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -55.35 117.07 3.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.438 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.6 1.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.34 0.171 0 CA-C-O 122.487 1.137 . . . . 0.0 109.61 169.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.453 -0.899 0 N-CA-C 108.707 -1.305 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 116.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-O 122.726 1.25 . . . . 0.0 108.361 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.09 -176.14 2.97 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 112.83 -1.986 . . . . 0.0 108.761 -167.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.86 142.31 0.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.75 1.62 . . . . 0.0 112.574 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -49.99 75.71 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 160.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -164.88 -164.5 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.62 -48.57 19.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 129.696 3.198 . . . . 0.0 114.836 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -44.98 -40.66 6.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.592 174.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -69.81 -9.24 53.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.316 -0.865 . . . . 0.0 111.507 -172.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.17 4.34 4.06 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -36.51 -45.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 163.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ptm -58.27 -22.67 53.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.606 1.962 . . . . 0.0 112.215 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.0 m -73.71 -10.16 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.04 0.936 . . . . 0.0 111.946 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.31 -91.5 0.08 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 165.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.9 tp -101.04 -84.85 0.43 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.097 0.959 . . . . 0.0 109.036 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -138.7 60.91 0.58 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -54.95 101.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 109.389 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -78.54 162.94 25.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.601 0.76 . . . . 0.0 111.392 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.11 121.9 27.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.87 0.868 . . . . 0.0 110.314 -158.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -70.02 -169.37 0.27 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 164.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -40.77 70.35 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 130.148 3.379 . . . . 0.0 114.4 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 57.05 26.0 54.84 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 127.628 2.537 . . . . 0.0 113.724 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -128.57 131.23 48.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.079 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.12 110.06 21.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.075 1.75 . . . . 0.0 108.042 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -76.31 73.79 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.996 0.519 . . . . 0.0 112.289 -161.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.82 57.02 5.56 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.269 0.462 . . . . 0.0 112.076 166.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 129.493 3.117 . . . . 0.0 114.255 174.89 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 N--CA 1.454 -0.829 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.266 1.3 t -132.03 125.33 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 -171.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.39 175.56 5.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 124.949 1.299 . . . . 0.0 109.61 -167.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 p -175.27 143.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.478 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -28.13 25.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.587 1.155 . . . . 0.0 109.626 168.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -170.5 176.74 4.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.96 -43.63 70.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 126.381 1.873 . . . . 0.0 111.758 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.1 -36.47 18.8 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.142 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.51 -9.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.855 -1.153 . . . . 0.0 112.564 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 m -136.13 12.89 3.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -35.59 -44.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 158.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -56.59 -25.36 52.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.117 1.767 . . . . 0.0 112.001 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -67.22 -19.9 65.61 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.517 0.727 . . . . 0.0 111.072 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.91 -80.01 0.15 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 168.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -112.11 -139.79 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.88 1.672 . . . . 0.0 108.359 -175.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.57 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.81 51.45 4.04 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 128.382 2.896 . . . . 0.0 108.951 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 mm -57.87 82.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 108.819 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.9 p -72.37 142.15 48.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -164.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -89.03 113.42 24.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.418 1.087 . . . . 0.0 109.971 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.86 -177.93 6.6 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -4.59 -70.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.374 2.27 . . . . 0.0 115.872 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.24 1.2 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 161.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.36 118.45 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.772 2.029 . . . . 0.0 109.09 -157.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -96.89 62.6 1.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 124.807 2.242 . . . . 0.0 110.32 -160.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -69.35 112.24 5.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.117 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.27 -47.56 0.58 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.341 0.205 0 C-N-CA 126.537 1.935 . . . . 0.0 114.965 -167.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.9 99.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 122.912 1.339 . . . . 0.0 111.704 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -124.38 173.07 8.65 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.138 -159.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 p -163.78 133.92 4.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.181 -159.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -73.1 -30.75 63.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.231 1.012 . . . . 0.0 110.125 160.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -170.16 176.22 4.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.907 1.683 . . . . 0.0 106.817 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.0 -38.46 79.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 110.227 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -36.21 53.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.296 173.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.07 -15.45 63.08 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.372 -1.455 . . . . 0.0 111.558 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.1 m -125.26 6.55 7.78 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 124.449 1.099 . . . . 0.0 113.298 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.6 p -41.29 -39.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 164.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.1 ptm -56.0 -26.4 48.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.84 1.656 . . . . 0.0 111.963 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 m -68.56 -27.73 66.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.102 0.961 . . . . 0.0 111.483 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.74 -89.67 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -129.49 -101.48 0.32 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.761 1.224 . . . . 0.0 110.097 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.58 50.83 0.83 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.79 85.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.75 122.49 18.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -154.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.1 t -74.56 107.67 6.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.75 0.42 . . . . 0.0 111.615 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 25' ' ' GLY . 6.8 mtmp? -83.35 -167.66 1.78 Allowed 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 166.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -34.31 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 129.78 3.232 . . . . 0.0 114.701 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 58.92 13.69 20.26 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 127.295 2.379 . . . . 0.0 114.557 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.71 113.89 8.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.076 1.438 . . . . 0.0 111.619 -167.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 p -98.11 136.8 37.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.227 -0.921 . . . . 0.0 113.141 -166.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -90.83 132.07 36.1 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.619 0.767 . . . . 0.0 112.481 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.57 41.07 11.63 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 123.39 0.519 . . . . 0.0 113.286 160.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.441 -0.877 0 C-N-CA 125.684 1.594 . . . . 0.0 112.865 -174.157 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 N-CA-C 110.817 -0.493 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 102.26 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.697 1.237 . . . . 0.0 110.69 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -124.67 175.61 7.1 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.596 -160.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -178.97 157.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.32 1.848 . . . . 0.0 110.663 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -76.16 -61.89 1.79 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -140.81 -178.16 5.41 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.105 1.762 . . . . 0.0 109.283 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -51.4 -48.23 62.68 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.285 1.834 . . . . 0.0 113.354 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -50.81 -33.42 23.48 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.485 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.72 -10.55 57.11 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 121.079 -1.013 . . . . 0.0 110.981 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.1 m -136.67 13.23 3.18 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -31.82 -48.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 157.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.5 ptp -58.97 -21.85 59.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.207 2.203 . . . . 0.0 112.665 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -66.67 -25.3 66.5 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.302 0.641 . . . . 0.0 110.429 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.74 -78.85 0.05 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.61 -91.36 0.16 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 109.199 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.18 49.08 0.88 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -65.51 78.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.1 p -68.85 153.17 44.27 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -116.28 114.04 23.82 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.527 0.68 . . . . 0.0 109.297 -163.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -160.22 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -47.98 75.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.755 2.422 . . . . 0.0 114.183 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.15 33.56 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 127.8 2.619 . . . . 0.0 113.247 -169.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.23 121.35 26.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.127 0.971 . . . . 0.0 112.438 -166.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.17 63.27 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.163 2.185 . . . . 0.0 109.197 -172.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -56.77 119.92 6.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.158 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.52 6.6 67.96 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.135 -1.369 . . . . 0.0 114.678 165.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.343 0.323 0 C-N-CA 127.997 2.519 . . . . 0.0 115.242 179.591 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.457 -0.639 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.294 3.0 t -117.77 107.67 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -143.73 170.83 15.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.349 1.071 . . . . 0.0 110.103 -144.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.85 144.56 4.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.823 -157.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -88.12 -39.36 14.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.412 1.485 . . . . 0.0 108.534 159.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.93 -179.05 7.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -44.64 -42.03 7.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.631 3.172 . . . . 0.0 113.43 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -41.44 41.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.663 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -7.32 49.25 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.062 -169.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.7 m -134.27 10.64 3.82 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 113.264 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 p -39.58 -41.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.534 1.159 . . . . 0.0 113.655 161.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ptm -55.93 -24.43 37.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.778 1.631 . . . . 0.0 111.834 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.9 m -66.18 -22.61 66.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.527 0.731 . . . . 0.0 111.88 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.51 -87.4 0.1 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.028 0.831 . . . . 0.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.579 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -96.97 -146.03 0.3 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.291 1.436 . . . . 0.0 107.159 178.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.579 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -81.38 49.57 4.04 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 127.167 2.317 . . . . 0.0 108.829 172.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mm -46.85 127.52 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.13 1.372 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -68.69 125.76 27.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.87 1.268 . . . . 0.0 112.186 -172.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -87.08 113.67 23.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 165.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -90.1 -170.96 2.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.112 1.365 . . . . 0.0 108.105 167.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -44.57 74.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.559 2.744 . . . . 0.0 114.314 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.91 -5.39 32.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 127.903 2.668 . . . . 0.0 114.166 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -133.11 132.93 42.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.093 1.757 . . . . 0.0 107.785 -162.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 p -114.66 82.29 1.7 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.996 1.725 . . . . 0.0 113.427 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -49.22 142.13 7.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.406 166.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.1 5.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 167.543 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 N-CA-C 109.608 -0.959 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.37 104.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.561 1.172 . . . . 0.0 110.858 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -132.3 175.32 9.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.866 -158.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -172.61 146.31 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.019 -1.9 . . . . 0.0 110.767 -161.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -55.96 4.82 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 158.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.7 p -136.48 176.1 9.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.507 1.923 . . . . 0.0 108.036 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.8 -44.66 39.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 112.405 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -38.85 18.72 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.214 174.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.25 -10.93 58.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.016 -1.052 . . . . 0.0 112.527 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -129.53 7.09 5.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 p -40.17 -41.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 163.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.7 ptm -57.75 -24.72 58.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.311 1.845 . . . . 0.0 112.347 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.82 -26.87 65.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.959 0.904 . . . . 0.0 110.516 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.2 -82.16 0.06 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 tp -142.97 -97.02 0.12 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.695 1.198 . . . . 0.0 109.501 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.43 40.92 2.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.319 1.438 . . . . 0.0 110.24 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.11 76.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.423 1.089 . . . . 0.0 108.595 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 t -71.8 152.82 42.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.668 1.187 . . . . 0.0 111.855 -166.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.6 t -114.78 136.68 52.81 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.379 1.472 . . . . 0.0 111.58 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.06 129.69 30.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 39.38 53.22 2.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.548 1.539 . . . . 0.0 113.373 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 -19.19 52.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 124.557 1.075 . . . . 0.0 113.644 171.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -115.69 131.54 56.9 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.026 1.331 . . . . 0.0 111.696 -169.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.51 131.81 55.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.151 1.38 . . . . 0.0 111.927 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -100.19 115.92 30.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.481 -153.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.25 53.61 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.584 -0.564 . . . . 0.0 114.382 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.451 -0.395 0 C-N-CA 125.581 1.552 . . . . 0.0 114.04 -178.45 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 108.447 -1.405 . . . . 0.0 108.447 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.256 3.8 t -125.07 115.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -163.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -130.35 174.58 9.71 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 125.514 1.525 . . . . 0.0 108.432 -164.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -176.45 138.88 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.171 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -27.11 33.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.401 0.281 . . . . 0.0 111.272 161.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.42 168.44 26.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.263 1.825 . . . . 0.0 106.943 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -54.98 -39.06 68.59 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 126.352 1.861 . . . . 0.0 110.93 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -41.61 9.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.627 168.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.04 -2.55 24.77 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 121.068 -1.02 . . . . 0.0 111.085 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -137.11 7.43 2.9 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 125.492 1.517 . . . . 0.0 113.97 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 p -38.17 -41.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 162.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -54.18 -27.3 33.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.646 1.578 . . . . 0.0 111.826 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.61 -26.47 67.85 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.271 1.029 . . . . 0.0 111.797 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.58 -90.22 0.1 Allowed Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -91.94 -139.6 0.18 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.606 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -58.76 -51.68 57.58 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.598 1.094 . . . . 0.0 111.009 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.8 mm 49.79 71.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.316 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.84 146.96 4.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.786 2.035 . . . . 0.0 114.001 -172.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -111.59 118.2 35.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.715 1.206 . . . . 0.0 110.661 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -89.39 -175.45 4.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -40.44 79.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.932 2.493 . . . . 0.0 114.133 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.34 76.01 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.614 2.53 . . . . 0.0 114.551 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.9 129.93 40.95 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.868 1.334 . . . . 0.0 110.576 -163.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 145.99 33.37 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.102 0.864 . . . . 0.0 111.044 -163.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -131.97 126.69 34.63 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.152 -0.343 . . . . 0.0 110.194 -154.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 -29.1 10.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.313 0.958 . . . . 0.0 111.889 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.341 0.223 0 C-N-CA 125.243 1.417 . . . . 0.0 113.312 -169.497 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.456 -0.684 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.265 5.4 t -124.42 114.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -162.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -143.13 169.25 17.96 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.004 -155.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.8 p -154.52 156.38 36.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.543 -1.662 . . . . 0.0 109.206 -167.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -53.66 5.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 155.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -140.35 168.96 18.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.592 1.957 . . . . 0.0 107.269 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -42.1 -48.21 4.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 127.195 2.198 . . . . 0.0 114.964 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -60.11 -24.73 64.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.655 -176.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.37 -23.77 67.55 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.954 -1.091 . . . . 0.0 111.313 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.07 11.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.532 1.133 . . . . 0.0 113.19 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -42.48 -39.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.719 1.247 . . . . 0.0 113.413 163.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.0 ptp -54.25 -25.16 21.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.066 1.346 . . . . 0.0 111.718 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.2 -29.46 68.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.961 0.904 . . . . 0.0 112.377 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.42 -91.73 0.09 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.585 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -95.61 -138.73 0.24 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -54.36 -48.33 64.91 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.28 0.943 . . . . 0.0 111.565 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 mm 41.44 66.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.361 1.464 . . . . 0.0 109.634 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.52 100.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.547 1.139 . . . . 0.0 111.008 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.4 142.22 58.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.017 -168.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -158.97 0.59 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.74 1.216 . . . . 0.0 108.254 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -53.35 73.88 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 128.001 2.52 . . . . 0.0 113.767 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.99 66.57 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.342 2.401 . . . . 0.0 112.949 -175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.65 119.3 13.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.859 -162.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.291 27.4 p -107.46 66.24 0.66 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 121.236 1.835 . . . . 0.0 111.314 -164.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -16.32 111.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.914 2.885 . . . . 0.0 115.592 165.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.87 28.66 73.42 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.321 159.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.457 -0.094 0 C-N-CA 127.9 2.48 . . . . 0.0 113.98 174.204 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 N--CA 1.457 -0.621 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -110.87 107.2 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -160.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -132.73 170.08 15.77 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.843 -154.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -160.2 147.7 16.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.739 -164.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -33.97 57.73 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.775 -0.578 . . . . 0.0 110.009 155.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 t -170.7 -168.57 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 126.586 1.954 . . . . 0.0 106.122 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.84 -46.44 87.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 127.856 2.463 . . . . 0.0 113.221 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.421 ' CG ' ' N ' ' A' ' 12' ' ' ASP . 23.0 ptt180 -39.68 -41.28 1.05 Allowed 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.332 167.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' N ' ' CG ' ' A' ' 11' ' ' ARG . 0.4 OUTLIER -79.68 -0.26 33.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -159.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -139.94 8.38 2.31 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 p -36.89 -44.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 161.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -58.35 -22.34 53.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 126.727 2.011 . . . . 0.0 111.812 -175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -60.45 -28.77 68.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.801 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.42 -89.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -102.61 -90.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.898 0.879 . . . . 0.0 109.872 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.69 57.64 0.7 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.36 92.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.777 0.831 . . . . 0.0 109.469 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -60.81 150.38 32.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.212 1.005 . . . . 0.0 110.894 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 38.2 t -119.53 136.95 54.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.875 0.87 . . . . 0.0 112.528 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -85.37 -154.15 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.112 0.965 . . . . 0.0 110.473 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.53 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.835 2.054 . . . . 0.0 112.87 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.03 16.35 66.35 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 127.427 2.441 . . . . 0.0 112.961 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -141.94 124.4 15.75 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.257 1.029 . . . . 0.0 111.789 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.6 p -118.57 86.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.622 1.556 . . . . 0.0 112.669 -160.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -48.83 155.73 0.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.25 1.42 . . . . 0.0 112.925 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.59 69.12 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.245 -0.753 . . . . 0.0 114.914 159.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 118.317 1.058 . . . . 0.0 111.118 173.942 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.271 6.6 t -124.47 109.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 -165.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -135.46 166.14 23.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.623 -150.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 p -166.57 155.84 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.966 -162.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 -50.43 4.17 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.813 1.645 . . . . 0.0 107.447 161.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -132.59 170.67 14.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.698 1.999 . . . . 0.0 107.673 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -57.61 -40.03 78.2 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.569 1.548 . . . . 0.0 111.425 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -22.45 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.624 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.11 -23.26 67.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.742 1.155 . . . . 0.0 109.797 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -120.23 13.82 12.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.824 1.65 . . . . 0.0 113.372 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -36.36 -43.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 159.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.0 ptp -54.39 -26.28 29.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.479 1.511 . . . . 0.0 111.656 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.96 -32.45 72.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.168 0.587 . . . . 0.0 111.31 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.47 -80.83 0.08 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.574 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -104.9 -142.53 0.37 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.768 1.627 . . . . 0.0 108.412 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.574 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -81.6 52.79 4.62 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 128.11 2.767 . . . . 0.0 108.276 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.4 mm -58.68 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.092 1.357 . . . . 0.0 110.624 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 t -36.52 136.54 0.34 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.388 2.275 . . . . 0.0 113.389 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.6 t -102.25 122.5 44.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.425 1.49 . . . . 0.0 109.847 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -96.65 -172.13 2.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.943 1.297 . . . . 0.0 108.2 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.37 77.47 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.73 2.412 . . . . 0.0 113.156 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.26 -2.28 66.81 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 127.998 2.713 . . . . 0.0 114.26 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -133.12 135.07 45.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.651 1.58 . . . . 0.0 107.771 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.2 p -111.82 138.47 48.37 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 121.113 1.778 . . . . 0.0 111.709 -169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -102.85 125.36 49.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.235 -156.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.67 56.15 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.645 168.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.157 0 C-N-CA 124.178 0.991 . . . . 0.0 111.06 173.905 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 N-CA-C 108.566 -1.359 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.255 2.1 t -119.82 114.93 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 -175.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -119.75 164.17 16.35 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 -144.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.81 156.81 33.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.636 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.28 -28.87 20.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 152.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -170.7 -178.33 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.358 1.863 . . . . 0.0 107.391 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.26 -49.29 34.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.753 2.021 . . . . 0.0 113.931 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.93 -38.58 10.78 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.06 174.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.28 -6.61 44.29 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 121.43 -0.794 . . . . 0.0 110.578 -170.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.0 m -131.25 6.44 4.52 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.696 1.198 . . . . 0.0 114.113 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 p -41.2 -38.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 122.394 1.093 . . . . 0.0 113.838 163.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.2 ptp -54.18 -27.12 31.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.435 1.494 . . . . 0.0 111.812 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -62.14 -27.6 69.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.217 0.607 . . . . 0.0 112.075 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.38 -86.85 0.1 OUTLIER Glycine 0 C--N 1.338 0.682 0 CA-C-N 119.21 0.913 . . . . 0.0 111.549 174.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.602 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -92.88 -138.88 0.19 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.602 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -59.83 -52.16 54.61 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.432 1.015 . . . . 0.0 110.998 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.9 mm 46.79 69.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.633 1.573 . . . . 0.0 110.546 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 153.69 17.0 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.072 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -120.84 136.79 54.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -95.0 -173.29 2.92 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.145 1.378 . . . . 0.0 108.16 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.57 69.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.605 2.362 . . . . 0.0 113.464 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.6 -35.81 2.7 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.864 3.126 . . . . 0.0 113.31 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -141.59 133.5 27.43 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -141.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.1 p -109.24 128.46 55.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.968 1.258 . . . . 0.0 113.456 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.43 86.35 2.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.988 -148.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.31 -25.91 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 C--N 1.341 0.217 0 C-N-CA 125.893 1.677 . . . . 0.0 113.413 -173.878 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 45.7 m . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.25 21.4 Cg_exo -73.22 40.81 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.789 3.659 . . . . 0.0 116.033 -167.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -67.8 118.32 56.7 Favored Pre-proline 0 N--CA 1.435 -1.184 0 O-C-N 120.98 -1.075 . . . . 0.0 108.437 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 50.82 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.76 2.307 . . . . 0.0 110.272 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.54 111.61 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.311 1.053 . . . . 0.0 109.281 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -130.11 175.08 9.19 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.027 -163.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p 174.46 144.09 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.763 1.625 . . . . 0.0 112.721 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -70.87 -39.81 72.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.358 162.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -166.5 -170.66 1.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.409 1.084 . . . . 0.0 109.073 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -55.86 -47.54 77.14 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.496 1.518 . . . . 0.0 111.824 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -40.96 23.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 122.179 -0.325 . . . . 0.0 110.828 172.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.69 -0.91 16.95 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 120.951 -1.093 . . . . 0.0 111.588 -168.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.99 9.39 2.13 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -31.72 -47.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 159.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -55.32 -26.56 41.38 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.216 1.806 . . . . 0.0 112.015 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -70.17 -17.85 63.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 112.416 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.32 -91.66 0.09 OUTLIER Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.377 0.989 . . . . 0.0 111.466 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 tp -99.53 -100.48 0.23 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.91 -42.86 4.29 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 mm 52.87 65.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 123.117 1.437 . . . . 0.0 109.261 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -60.22 145.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.742 1.617 . . . . 0.0 112.012 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.03 132.57 38.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.862 -141.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -74.65 166.51 23.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -66.12 69.38 0.06 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.11 1.764 . . . . 0.0 111.278 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.55 -34.08 2.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 126.946 2.212 . . . . 0.0 112.455 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.45 118.8 26.61 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.073 0.937 . . . . 0.0 113.067 -153.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.04 58.95 5.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.67 1.588 . . . . 0.0 109.418 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 67.04 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.225 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.66 -52.7 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.5 t -20.25 -57.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.358 2.663 . . . . 0.0 115.091 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 162.198 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 118.602 -0.713 . . . . 0.0 112.04 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.83 65.62 1.28 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 1 C-N-CA 125.395 4.063 . . . . 0.0 113.33 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 16.36 77.21 0.13 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 128.869 2.867 . . . . 0.0 114.143 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.16 69.44 3.19 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.243 1.962 . . . . 0.0 109.162 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.5 93.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 121.937 0.875 . . . . 0.0 109.308 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.12 160.43 17.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.949 -150.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.1 p -147.42 122.67 10.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.132 -1.849 . . . . 0.0 114.955 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -69.58 -31.81 70.19 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.932 150.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -171.14 -178.92 2.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.471 1.508 . . . . 0.0 107.784 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.97 -47.23 81.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.634 1.574 . . . . 0.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.63 -33.76 16.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.506 173.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.98 -6.75 35.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 119.847 1.203 . . . . 0.0 112.112 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . 0.296 21.1 m -133.68 5.09 3.66 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.157 0.983 . . . . 0.0 113.412 -177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 p -39.08 -40.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 122.226 1.013 . . . . 0.0 113.53 163.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ptm -56.28 -24.95 46.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.953 1.701 . . . . 0.0 112.135 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.1 m -65.05 -23.91 67.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.345 0.658 . . . . 0.0 111.864 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.13 -84.91 0.08 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -116.87 -99.67 0.44 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.6 1.16 . . . . 0.0 109.016 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.47 -73.43 1.06 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.3 mm 49.47 73.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.095 1.358 . . . . 0.0 109.93 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.9 p -82.45 160.36 22.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.711 1.205 . . . . 0.0 112.85 -167.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.2 t -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.335 2.254 . . . . 0.0 113.55 -166.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -92.89 139.38 30.59 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 156.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -39.79 70.68 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.759 2.823 . . . . 0.0 115.969 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.73 0.46 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.62 1.581 . . . . 0.0 112.466 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -123.42 136.7 54.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.786 1.634 . . . . 0.0 109.327 -166.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 95.2 m -82.2 166.96 19.16 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.283 0.947 . . . . 0.0 112.055 164.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -121.89 118.38 28.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.33 1.052 . . . . 0.0 109.393 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 0.75 37.2 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.991 -0.894 . . . . 0.0 114.077 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.1 t -51.72 -35.69 44.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 1.402 . . . . 0.0 111.557 175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.397 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -75.01 51.78 2.88 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.773 3.649 . . . . 0.0 114.158 -171.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -64.0 119.25 53.58 Favored Pre-proline 0 N--CA 1.435 -1.21 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.38 52.3 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.235 1.957 . . . . 0.0 108.762 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.9 115.26 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.12 162.89 22.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 124.776 1.23 . . . . 0.0 109.966 -148.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -175.85 142.32 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -166.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -79.38 -32.15 43.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.597 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -165.27 -179.85 5.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.328 1.051 . . . . 0.0 108.583 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -56.72 -43.97 81.15 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.178 1.391 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -36.85 41.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.141 172.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -74.5 -5.59 43.55 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.995 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 1.83 6.38 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.501 1.12 . . . . 0.0 114.013 174.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -41.47 -34.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.9 ptp -52.33 -31.53 33.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 111.47 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.6 m -65.04 -25.87 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 112.716 177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.25 -92.47 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 118.937 0.789 . . . . 0.0 111.319 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 tp -133.01 -106.03 0.25 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.744 1.218 . . . . 0.0 109.167 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.8 45.52 2.89 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.2 mm -65.92 97.75 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -88.18 127.87 35.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.835 0.854 . . . . 0.0 111.796 -164.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.99 115.95 20.71 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.882 0.873 . . . . 0.0 112.272 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -88.36 88.48 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 39.83 38.13 0.42 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.017 2.527 . . . . 0.0 114.72 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.02 -49.56 0.44 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.334 -0.703 . . . . 0.0 111.387 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -127.31 147.92 50.24 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.31 -161.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.257 1.0 OUTLIER -105.56 160.35 15.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 111.152 170.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -131.63 141.39 49.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.323 1.449 . . . . 0.0 108.164 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.95 40.57 93.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.41 0.55 . . . . 0.0 112.195 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.8 t -68.39 74.17 0.24 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.008 2.123 . . . . 0.0 110.889 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 125.591 1.556 . . . . 0.0 111.739 176.63 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.15 -175.45 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.72 3.613 . . . . 0.0 113.492 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -55.05 145.72 42.8 Favored Pre-proline 0 N--CA 1.436 -1.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.228 165.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.31 55.14 4.52 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.186 2.591 . . . . 0.0 110.557 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.22 110.77 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.139 0.971 . . . . 0.0 108.948 173.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -130.03 176.2 8.27 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.962 -161.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.9 p -171.57 152.59 3.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.195 -1.821 . . . . 0.0 109.624 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -24.47 17.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.94 160.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -168.27 -177.43 3.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 106.966 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -43.81 98.31 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.38 1.072 . . . . 0.0 110.821 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -35.11 14.83 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.971 170.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.69 -3.55 28.92 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.562 -1.336 . . . . 0.0 111.992 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 m -135.42 8.36 3.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 124.429 1.092 . . . . 0.0 113.802 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.9 p -37.6 -42.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 161.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.2 ptm -56.16 -26.07 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.574 1.55 . . . . 0.0 111.957 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.7 m -69.81 -18.79 63.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.233 1.013 . . . . 0.0 111.489 178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.53 -88.08 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.154 0.888 . . . . 0.0 111.473 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -105.6 -140.07 0.37 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.638 1.575 . . . . 0.0 108.017 -177.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.562 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -80.24 49.84 3.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 128.054 2.74 . . . . 0.0 109.08 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.37 103.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.718 1.607 . . . . 0.0 108.798 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -72.33 141.87 48.82 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.8 0.84 . . . . 0.0 112.201 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.3 t -107.66 110.6 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.177 1.791 . . . . 0.0 111.47 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -76.25 169.8 17.52 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 164.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -1.38 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.389 2.676 . . . . 0.0 115.414 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.42 21.93 2.05 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.682 164.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.27 119.22 27.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.299 1.84 . . . . 0.0 108.392 -170.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 151.19 23.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.105 1.362 . . . . 0.0 110.924 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -127.87 126.33 41.39 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.856 -0.528 . . . . 0.0 111.107 -154.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.34 45.24 31.11 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.317 0.398 . . . . 0.0 112.385 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.41 75.15 0.16 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.82 1.648 . . . . 0.0 112.258 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.331 -0.217 0 C-N-CA 124.672 1.189 . . . . 0.0 109.292 174.612 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.77 167.39 5.38 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.401 3.401 . . . . 0.0 113.609 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -57.36 141.18 78.32 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 167.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.64 63.71 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.784 2.322 . . . . 0.0 109.65 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.7 113.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 C-N-CA 124.318 1.047 . . . . 0.0 109.077 172.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -129.41 -179.92 5.43 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.005 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -178.28 156.96 1.02 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.333 -168.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -40.99 19.4 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.961 1.305 . . . . 0.0 108.904 166.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -165.54 -174.81 3.28 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.88 -46.9 64.68 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 127.037 2.135 . . . . 0.0 112.755 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.33 -38.03 26.48 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.972 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.18 -12.38 60.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.101 -0.999 . . . . 0.0 111.503 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.03 12.9 3.95 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -36.62 -44.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 160.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.7 ptm -59.05 -22.75 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.439 1.895 . . . . 0.0 112.337 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -64.58 -21.47 66.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.629 0.772 . . . . 0.0 110.672 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.35 -68.97 0.2 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.559 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -129.54 -138.71 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.118 1.767 . . . . 0.0 108.383 -173.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.61 52.8 4.2 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 128.546 2.974 . . . . 0.0 109.199 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 mm -59.04 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 126.284 1.834 . . . . 0.0 108.38 168.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 p -81.51 144.11 31.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.462 0.705 . . . . 0.0 112.446 -162.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.18 118.48 33.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.722 0.772 . . . . 0.0 111.205 -149.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -79.37 -173.05 3.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.711 1.205 . . . . 0.0 108.633 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -58.49 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.443 1.897 . . . . 0.0 112.147 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.56 71.68 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 128.072 2.749 . . . . 0.0 113.468 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -122.07 121.58 37.3 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 1.389 . . . . 0.0 113.641 -155.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.77 68.85 2.43 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 126.738 2.015 . . . . 0.0 109.147 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -48.09 150.22 1.24 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.551 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.69 -40.64 2.91 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.502 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -29.13 -56.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 114.3 -169.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 123.799 0.84 . . . . 0.0 110.783 169.169 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.252 35.3 Cg_exo -61.67 77.23 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 124.803 3.669 . . . . 0.0 113.663 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -50.18 118.95 9.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.809 1.243 . . . . 0.0 109.905 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.49 24.43 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.856 1.704 . . . . 0.0 110.564 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.286 6.1 t -94.12 114.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 101.314 -3.587 . . . . 0.0 101.314 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -123.39 178.75 5.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 124.759 1.224 . . . . 0.0 108.68 -160.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p 179.67 145.08 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.336 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -39.73 53.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.515 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -166.71 -175.54 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.635 1.574 . . . . 0.0 107.083 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -45.2 -46.84 12.5 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 128.483 2.713 . . . . 0.0 113.865 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.24 -44.6 8.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.986 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -4.73 30.62 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.291 -0.88 . . . . 0.0 111.621 -168.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.79 6.26 3.17 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 p -34.76 -45.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 161.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -55.74 -25.86 42.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.916 1.686 . . . . 0.0 111.731 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB3' ' CA ' ' A' ' 30' ' ' CYS . 59.8 m -75.45 -6.84 52.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.167 0.987 . . . . 0.0 112.627 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.65 -95.86 0.11 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 tp -105.7 -99.17 0.33 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -47.11 6.03 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mm 47.53 63.79 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.036 1.334 . . . . 0.0 108.853 -168.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -67.18 136.49 55.12 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.464 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -105.51 164.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -148.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -117.04 171.82 7.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.15 71.95 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 126.465 1.906 . . . . 0.0 113.141 -166.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.56 -23.68 19.44 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.82 2.628 . . . . 0.0 112.447 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.8 140.22 49.99 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.758 1.223 . . . . 0.0 108.549 -160.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 2.5 t -108.69 149.05 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.4 111.77 7.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.906 0.483 . . . . 0.0 110.78 -155.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.54 55.26 6.16 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.457 ' CA ' ' HB3' ' A' ' 16' ' ' CYS . 2.0 m -67.79 66.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.326 1.45 . . . . 0.0 110.548 176.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 CA--C 1.532 0.268 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.772 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.77 65.69 1.8 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 124.873 3.715 . . . . 0.0 113.296 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.02 115.83 9.94 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 124.345 1.058 . . . . 0.0 109.514 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.56 60.58 7.87 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.149 1.899 . . . . 0.0 109.37 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.37 106.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.509 1.147 . . . . 0.0 109.714 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -127.08 175.87 7.79 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.278 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.67 166.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.355 1.862 . . . . 0.0 111.103 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -43.46 9.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.184 1.393 . . . . 0.0 108.446 160.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -158.05 -170.95 3.32 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -41.56 67.55 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.996 2.118 . . . . 0.0 112.509 -171.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 -42.33 32.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.739 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -7.25 47.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.749 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -137.41 12.73 3.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.138 1.375 . . . . 0.0 114.08 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -35.09 -45.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 159.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.6 ptp -54.79 -25.65 29.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.613 1.565 . . . . 0.0 112.273 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 m -67.5 -22.49 65.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 111.862 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.74 -95.16 0.11 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.659 1.118 . . . . 0.0 111.686 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.601 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -89.88 -140.26 0.14 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 170.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.601 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -56.91 -41.27 91.62 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.99 0.805 . . . . 0.0 111.306 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . 0.274 9.8 mm 50.19 64.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 123.008 1.385 . . . . 0.0 109.386 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.63 118.58 2.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.155 2.182 . . . . 0.0 111.378 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 127.54 43.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.64 0.776 . . . . 0.0 110.826 -160.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.17 -167.54 0.52 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.001 0.92 . . . . 0.0 109.653 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -39.14 70.03 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 130.811 3.644 . . . . 0.0 114.028 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.34 31.93 13.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.75 2.119 . . . . 0.0 113.445 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 120.19 24.12 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.317 1.047 . . . . 0.0 111.954 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -90.8 68.32 6.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.503 1.521 . . . . 0.0 110.391 -170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.83 156.45 0.97 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.284 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.86 -30.48 3.87 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.998 -0.89 . . . . 0.0 113.377 164.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.4 t -34.83 -55.21 0.57 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.518 1.527 . . . . 0.0 113.855 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.237 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.31 168.22 4.02 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.562 2.842 . . . . 0.0 111.532 162.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -47.64 115.73 3.99 Favored Pre-proline 0 N--CA 1.438 -1.059 0 C-N-CA 124.385 1.074 . . . . 0.0 110.288 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 40.53 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.581 2.188 . . . . 0.0 109.373 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.251 2.9 t -96.66 105.25 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 -166.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -121.77 163.8 18.5 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.495 -156.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.79 126.26 16.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.233 -169.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.67 -33.54 75.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 161.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -168.82 -177.88 3.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.577 2.351 . . . . 0.0 104.971 164.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.69 -49.41 65.39 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.525 -169.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.89 -22.09 13.62 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 176.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.05 -20.68 66.6 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.476 -1.39 . . . . 0.0 110.943 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.99 9.35 11.85 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.0 p -44.02 -35.1 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 162.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -53.72 -29.8 41.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.492 1.117 . . . . 0.0 111.493 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.96 -29.67 66.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.192 0.997 . . . . 0.0 111.472 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.79 168.49 24.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.8 tp -8.79 -84.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.083 2.953 . . . . 0.0 114.287 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.42 -64.95 1.01 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.5 mm 40.25 61.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 110.839 -163.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.42 142.8 42.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.502 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -104.12 140.55 37.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -164.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -85.92 -159.4 0.46 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 0.0 109.165 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -60.62 77.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.817 1.647 . . . . 0.0 112.477 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.32 8.35 62.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.044 2.735 . . . . 0.0 113.165 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -137.15 120.89 17.39 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.449 1.1 . . . . 0.0 108.837 -162.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.284 31.2 p -98.66 68.42 1.8 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.837 1.653 . . . . 0.0 110.669 -165.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -60.41 76.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.25 0 C-N-CA 127.968 2.507 . . . . 0.0 110.74 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.21 -41.35 0.07 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -44.11 -46.56 8.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.09 1.356 . . . . 0.0 112.634 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.451 -0.421 0 C-N-CA 125.308 1.443 . . . . 0.0 107.769 171.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.252 82.7 Cg_exo -41.01 -41.04 4.05 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.187 3.258 . . . . 0.0 113.119 165.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -95.17 104.01 13.82 Favored Pre-proline 0 N--CA 1.428 -1.54 0 C-N-CA 125.619 1.568 . . . . 0.0 108.132 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.06 61.65 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 108.241 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.26 5.3 t -124.25 111.46 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -163.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -130.72 172.37 12.05 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-O 122.038 0.923 . . . . 0.0 111.746 -153.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -175.18 152.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.2 -171.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.83 -48.17 15.25 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 159.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -142.87 170.93 14.78 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.084 1.754 . . . . 0.0 110.135 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -46.53 -45.26 18.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 126.89 2.076 . . . . 0.0 113.911 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -45.56 -38.45 6.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.245 177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -6.23 48.91 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.564 1.146 . . . . 0.0 108.425 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 61.1 m -140.38 13.25 2.37 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 p -42.4 -39.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 164.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -55.68 -25.7 41.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.896 1.678 . . . . 0.0 112.019 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.07 -24.82 64.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.759 0.824 . . . . 0.0 111.397 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.87 -73.95 0.17 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.579 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -113.81 -144.88 0.39 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.889 1.676 . . . . 0.0 108.134 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.579 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -80.91 53.87 4.64 Favored Glycine 0 C--N 1.318 -0.43 0 C-N-CA 128.241 2.829 . . . . 0.0 108.383 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mm -59.74 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 109.284 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -68.52 141.2 55.62 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.548 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.3 m -95.47 117.31 30.15 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.583 1.553 . . . . 0.0 110.795 -160.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLY . 11.8 mptt -80.02 -171.68 3.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -49.25 71.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.386 2.675 . . . . 0.0 114.87 -171.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.77 12.87 83.74 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.717 3.056 . . . . 0.0 114.302 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -144.54 129.66 18.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.024 1.412 . . . . 0.0 111.34 -160.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 28.7 p -103.57 59.35 0.75 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.429 1.468 . . . . 0.0 112.277 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -55.35 117.07 3.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.438 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.6 1.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.7 t -49.08 -44.59 42.16 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 122.487 1.137 . . . . 0.0 109.61 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.444 -0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 106.346 161.455 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -51.01 151.47 11.67 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.676 2.25 . . . . 0.0 110.473 152.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 19.17 74.31 0.21 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 127.296 2.238 . . . . 0.0 114.349 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.76 66.78 6.64 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.398 2.065 . . . . 0.0 108.707 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 116.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-O 122.726 1.25 . . . . 0.0 108.361 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.09 -176.14 2.97 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 112.83 -1.986 . . . . 0.0 108.761 -167.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.86 142.31 0.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.75 1.62 . . . . 0.0 112.574 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -49.99 75.71 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 160.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -164.88 -164.5 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.62 -48.57 19.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 129.696 3.198 . . . . 0.0 114.836 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -44.98 -40.66 6.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.592 174.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -69.81 -9.24 53.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.316 -0.865 . . . . 0.0 111.507 -172.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.17 4.34 4.06 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -36.51 -45.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 163.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ptm -58.27 -22.67 53.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.606 1.962 . . . . 0.0 112.215 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.0 m -73.71 -10.16 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.04 0.936 . . . . 0.0 111.946 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.31 -91.5 0.08 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 165.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.9 tp -101.04 -84.85 0.43 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.097 0.959 . . . . 0.0 109.036 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -138.7 60.91 0.58 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -54.95 101.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 109.389 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -78.54 162.94 25.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.601 0.76 . . . . 0.0 111.392 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.11 121.9 27.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.87 0.868 . . . . 0.0 110.314 -158.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -70.02 -169.37 0.27 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 164.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -40.77 70.35 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 130.148 3.379 . . . . 0.0 114.4 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 57.05 26.0 54.84 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 127.628 2.537 . . . . 0.0 113.724 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -128.57 131.23 48.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.079 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.12 110.06 21.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.075 1.75 . . . . 0.0 108.042 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -76.31 73.79 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.996 0.519 . . . . 0.0 112.289 -161.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.82 57.02 5.56 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.269 0.462 . . . . 0.0 112.076 166.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.3 m -2.54 -75.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 129.493 3.117 . . . . 0.0 114.255 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.849 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.539 0.549 0 CA-C-O 119.402 -0.332 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.32 100.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 125.055 3.837 . . . . 0.0 112.329 170.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -62.25 135.09 94.94 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.55 -162.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.06 65.83 3.37 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.157 3.238 . . . . 0.0 109.033 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.266 1.3 t -132.03 125.33 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 -171.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.39 175.56 5.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 124.949 1.299 . . . . 0.0 109.61 -167.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 p -175.27 143.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.478 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -28.13 25.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.587 1.155 . . . . 0.0 109.626 168.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -170.5 176.74 4.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.96 -43.63 70.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 126.381 1.873 . . . . 0.0 111.758 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.1 -36.47 18.8 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.142 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.51 -9.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.855 -1.153 . . . . 0.0 112.564 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 m -136.13 12.89 3.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -35.59 -44.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 158.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -56.59 -25.36 52.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.117 1.767 . . . . 0.0 112.001 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -67.22 -19.9 65.61 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.517 0.727 . . . . 0.0 111.072 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.91 -80.01 0.15 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 168.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -112.11 -139.79 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.88 1.672 . . . . 0.0 108.359 -175.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.57 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.81 51.45 4.04 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 128.382 2.896 . . . . 0.0 108.951 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 mm -57.87 82.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 108.819 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.9 p -72.37 142.15 48.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -164.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -89.03 113.42 24.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.418 1.087 . . . . 0.0 109.971 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.86 -177.93 6.6 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -4.59 -70.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.374 2.27 . . . . 0.0 115.872 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.24 1.2 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 161.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.36 118.45 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.772 2.029 . . . . 0.0 109.09 -157.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -96.89 62.6 1.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 124.807 2.242 . . . . 0.0 110.32 -160.215 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -69.35 112.24 5.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.117 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.27 -47.56 0.58 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.4 t -31.4 -64.24 0.15 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.537 1.935 . . . . 0.0 114.965 -167.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.412 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -75.25 54.48 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.157 1 C-N-CA 125.395 4.063 . . . . 0.0 114.605 -166.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -63.6 118.91 49.21 Favored Pre-proline 0 N--CA 1.434 -1.266 0 O-C-N 121.124 -0.985 . . . . 0.0 109.736 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.5 63.94 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.677 2.251 . . . . 0.0 109.211 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.9 99.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 122.912 1.339 . . . . 0.0 111.704 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -124.38 173.07 8.65 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.138 -159.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 p -163.78 133.92 4.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.181 -159.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -73.1 -30.75 63.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.231 1.012 . . . . 0.0 110.125 160.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -170.16 176.22 4.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.907 1.683 . . . . 0.0 106.817 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.0 -38.46 79.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 110.227 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -36.21 53.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.296 173.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.07 -15.45 63.08 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.372 -1.455 . . . . 0.0 111.558 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.1 m -125.26 6.55 7.78 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 124.449 1.099 . . . . 0.0 113.298 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.6 p -41.29 -39.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 164.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.1 ptm -56.0 -26.4 48.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.84 1.656 . . . . 0.0 111.963 -178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 m -68.56 -27.73 66.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.102 0.961 . . . . 0.0 111.483 177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.74 -89.67 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -129.49 -101.48 0.32 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.761 1.224 . . . . 0.0 110.097 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.58 50.83 0.83 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.79 85.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.75 122.49 18.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -154.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.1 t -74.56 107.67 6.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.75 0.42 . . . . 0.0 111.615 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 25' ' ' GLY . 6.8 mtmp? -83.35 -167.66 1.78 Allowed 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 166.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -34.31 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 129.78 3.232 . . . . 0.0 114.701 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 58.92 13.69 20.26 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 127.295 2.379 . . . . 0.0 114.557 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.71 113.89 8.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.076 1.438 . . . . 0.0 111.619 -167.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 p -98.11 136.8 37.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.227 -0.921 . . . . 0.0 113.141 -166.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -90.83 132.07 36.1 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.619 0.767 . . . . 0.0 112.481 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.57 41.07 11.63 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 123.39 0.519 . . . . 0.0 113.286 160.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 41.8 t -65.42 77.36 0.06 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.684 1.594 . . . . 0.0 112.865 -174.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 109.011 170.586 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.273 39.8 Cg_exo -66.7 35.39 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 1 C-N-CA 125.799 4.332 . . . . 0.0 116.976 -176.347 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -98.11 153.75 37.99 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.07 52.12 3.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.59 2.193 . . . . 0.0 110.817 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 102.26 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.697 1.237 . . . . 0.0 110.69 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -124.67 175.61 7.1 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.596 -160.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -178.97 157.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.32 1.848 . . . . 0.0 110.663 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -76.16 -61.89 1.79 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -140.81 -178.16 5.41 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.105 1.762 . . . . 0.0 109.283 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -51.4 -48.23 62.68 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.285 1.834 . . . . 0.0 113.354 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -50.81 -33.42 23.48 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.485 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.72 -10.55 57.11 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 121.079 -1.013 . . . . 0.0 110.981 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.1 m -136.67 13.23 3.18 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -31.82 -48.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 157.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.5 ptp -58.97 -21.85 59.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.207 2.203 . . . . 0.0 112.665 -176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -66.67 -25.3 66.5 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.302 0.641 . . . . 0.0 110.429 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.74 -78.85 0.05 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.61 -91.36 0.16 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 109.199 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.18 49.08 0.88 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -65.51 78.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.1 p -68.85 153.17 44.27 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -116.28 114.04 23.82 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.527 0.68 . . . . 0.0 109.297 -163.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -160.22 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -47.98 75.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.755 2.422 . . . . 0.0 114.183 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.15 33.56 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 127.8 2.619 . . . . 0.0 113.247 -169.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.23 121.35 26.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.127 0.971 . . . . 0.0 112.438 -166.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.17 63.27 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.163 2.185 . . . . 0.0 109.197 -172.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -56.77 119.92 6.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.158 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.52 6.6 67.96 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.135 -1.369 . . . . 0.0 114.678 165.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 t -10.76 -76.26 0.0 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 127.997 2.519 . . . . 0.0 115.242 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.636 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.244 0.545 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.78 87.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 1 C-N-CA 125.341 4.028 . . . . 0.0 112.726 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -39.54 111.29 0.68 Allowed Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.802 2.041 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.1 57.57 5.28 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.906 2.404 . . . . 0.0 108.208 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.294 3.0 t -117.77 107.67 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -143.73 170.83 15.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.349 1.071 . . . . 0.0 110.103 -144.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.85 144.56 4.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.823 -157.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -88.12 -39.36 14.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.412 1.485 . . . . 0.0 108.534 159.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.93 -179.05 7.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -44.64 -42.03 7.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.631 3.172 . . . . 0.0 113.43 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.56 -41.44 41.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.663 177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -7.32 49.25 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.062 -169.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.7 m -134.27 10.64 3.82 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 113.264 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.4 p -39.58 -41.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.534 1.159 . . . . 0.0 113.655 161.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ptm -55.93 -24.43 37.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.778 1.631 . . . . 0.0 111.834 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.9 m -66.18 -22.61 66.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.527 0.731 . . . . 0.0 111.88 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.51 -87.4 0.1 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.028 0.831 . . . . 0.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.579 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -96.97 -146.03 0.3 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.291 1.436 . . . . 0.0 107.159 178.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.579 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -81.38 49.57 4.04 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 127.167 2.317 . . . . 0.0 108.829 172.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mm -46.85 127.52 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.13 1.372 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -68.69 125.76 27.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.87 1.268 . . . . 0.0 112.186 -172.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -87.08 113.67 23.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 165.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -90.1 -170.96 2.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.112 1.365 . . . . 0.0 108.105 167.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -44.57 74.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.559 2.744 . . . . 0.0 114.314 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.91 -5.39 32.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 127.903 2.668 . . . . 0.0 114.166 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -133.11 132.93 42.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.093 1.757 . . . . 0.0 107.785 -162.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 p -114.66 82.29 1.7 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.996 1.725 . . . . 0.0 113.427 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -49.22 142.13 7.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.406 166.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.1 5.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 m -58.87 -40.06 83.21 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--O 1.238 0.455 0 C-N-CA 126.032 1.733 . . . . 0.0 107.223 165.436 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.256 29.9 Cg_exo -69.32 38.49 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 125.141 3.894 . . . . 0.0 116.667 -170.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.1 117.39 56.0 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.623 1.169 . . . . 0.0 108.589 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.23 61.97 8.34 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.17 1.913 . . . . 0.0 109.608 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.37 104.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.561 1.172 . . . . 0.0 110.858 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -132.3 175.32 9.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.866 -158.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -172.61 146.31 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.019 -1.9 . . . . 0.0 110.767 -161.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -55.96 4.82 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 158.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.7 p -136.48 176.1 9.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.507 1.923 . . . . 0.0 108.036 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.8 -44.66 39.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 112.405 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -38.85 18.72 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.214 174.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.25 -10.93 58.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.016 -1.052 . . . . 0.0 112.527 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -129.53 7.09 5.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 p -40.17 -41.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 163.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.7 ptm -57.75 -24.72 58.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.311 1.845 . . . . 0.0 112.347 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.82 -26.87 65.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.959 0.904 . . . . 0.0 110.516 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.2 -82.16 0.06 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 tp -142.97 -97.02 0.12 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.695 1.198 . . . . 0.0 109.501 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.43 40.92 2.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.319 1.438 . . . . 0.0 110.24 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.11 76.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.423 1.089 . . . . 0.0 108.595 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 t -71.8 152.82 42.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.668 1.187 . . . . 0.0 111.855 -166.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.6 t -114.78 136.68 52.81 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.379 1.472 . . . . 0.0 111.58 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.06 129.69 30.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 39.38 53.22 2.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.548 1.539 . . . . 0.0 113.373 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 -19.19 52.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 124.557 1.075 . . . . 0.0 113.644 171.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -115.69 131.54 56.9 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.026 1.331 . . . . 0.0 111.696 -169.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.51 131.81 55.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.151 1.38 . . . . 0.0 111.927 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -100.19 115.92 30.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.481 -153.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.25 53.61 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.584 -0.564 . . . . 0.0 114.382 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t -41.54 -53.17 3.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.581 1.552 . . . . 0.0 114.04 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 120.994 0.426 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.0 101.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 125.033 3.822 . . . . 0.0 112.666 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -52.01 119.74 14.96 Favored Pre-proline 0 N--CA 1.437 -1.091 0 C-N-CA 124.706 1.203 . . . . 0.0 109.038 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.41 61.88 6.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.436 2.091 . . . . 0.0 108.447 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.256 3.8 t -125.07 115.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -163.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -130.35 174.58 9.71 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 125.514 1.525 . . . . 0.0 108.432 -164.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -176.45 138.88 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.171 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -27.11 33.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.401 0.281 . . . . 0.0 111.272 161.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.42 168.44 26.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.263 1.825 . . . . 0.0 106.943 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -54.98 -39.06 68.59 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 126.352 1.861 . . . . 0.0 110.93 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -41.61 9.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.627 168.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.04 -2.55 24.77 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 121.068 -1.02 . . . . 0.0 111.085 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -137.11 7.43 2.9 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 125.492 1.517 . . . . 0.0 113.97 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.9 p -38.17 -41.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 162.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -54.18 -27.3 33.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.646 1.578 . . . . 0.0 111.826 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.61 -26.47 67.85 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.271 1.029 . . . . 0.0 111.797 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.58 -90.22 0.1 Allowed Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -91.94 -139.6 0.18 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.606 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -58.76 -51.68 57.58 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.598 1.094 . . . . 0.0 111.009 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.8 mm 49.79 71.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.316 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.84 146.96 4.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.786 2.035 . . . . 0.0 114.001 -172.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -111.59 118.2 35.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.715 1.206 . . . . 0.0 110.661 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -89.39 -175.45 4.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -40.44 79.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.932 2.493 . . . . 0.0 114.133 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.34 76.01 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.614 2.53 . . . . 0.0 114.551 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.9 129.93 40.95 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.868 1.334 . . . . 0.0 110.576 -163.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 145.99 33.37 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.102 0.864 . . . . 0.0 111.044 -163.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -131.97 126.69 34.63 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.152 -0.343 . . . . 0.0 110.194 -154.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 -29.1 10.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.313 0.958 . . . . 0.0 111.889 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.5 t -41.68 -56.89 2.48 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.243 1.417 . . . . 0.0 113.312 -169.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.094 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -54.29 161.95 4.85 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 125.079 3.852 . . . . 0.0 113.142 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -49.83 117.58 7.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 124.708 1.203 . . . . 0.0 109.43 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.58 64.82 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.583 2.188 . . . . 0.0 108.359 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.265 5.4 t -124.42 114.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -162.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -143.13 169.25 17.96 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.004 -155.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.8 p -154.52 156.38 36.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.543 -1.662 . . . . 0.0 109.206 -167.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -53.66 5.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 155.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -140.35 168.96 18.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.592 1.957 . . . . 0.0 107.269 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -42.1 -48.21 4.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 127.195 2.198 . . . . 0.0 114.964 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -60.11 -24.73 64.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.655 -176.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.37 -23.77 67.55 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.954 -1.091 . . . . 0.0 111.313 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.07 11.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.532 1.133 . . . . 0.0 113.19 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 p -42.48 -39.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.719 1.247 . . . . 0.0 113.413 163.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.0 ptp -54.25 -25.16 21.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.066 1.346 . . . . 0.0 111.718 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.2 -29.46 68.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.961 0.904 . . . . 0.0 112.377 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.42 -91.73 0.09 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.585 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -95.61 -138.73 0.24 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -54.36 -48.33 64.91 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.28 0.943 . . . . 0.0 111.565 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 mm 41.44 66.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.361 1.464 . . . . 0.0 109.634 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.52 100.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.547 1.139 . . . . 0.0 111.008 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.4 142.22 58.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.017 -168.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -158.97 0.59 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.74 1.216 . . . . 0.0 108.254 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -53.35 73.88 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 128.001 2.52 . . . . 0.0 113.767 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.99 66.57 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.342 2.401 . . . . 0.0 112.949 -175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.65 119.3 13.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.859 -162.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.291 27.4 p -107.46 66.24 0.66 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 121.236 1.835 . . . . 0.0 111.314 -164.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -16.32 111.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.914 2.885 . . . . 0.0 115.592 165.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.87 28.66 73.42 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.321 159.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 m -22.7 -58.64 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 127.9 2.48 . . . . 0.0 113.98 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 122.541 0.336 . . . . 0.0 110.934 169.336 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.34 0.2 OUTLIER -27.98 -66.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.905 1 C-N-CA 127.644 5.562 . . . . 0.0 118.134 -167.81 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -63.31 116.45 25.46 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.531 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.32 48.86 2.84 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.667 1.631 . . . . 0.0 109.012 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -110.87 107.2 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -160.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -132.73 170.08 15.77 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.843 -154.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -160.2 147.7 16.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.739 -164.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -33.97 57.73 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.775 -0.578 . . . . 0.0 110.009 155.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 t -170.7 -168.57 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 126.586 1.954 . . . . 0.0 106.122 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.84 -46.44 87.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 127.856 2.463 . . . . 0.0 113.221 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.421 ' CG ' ' N ' ' A' ' 12' ' ' ASP . 23.0 ptt180 -39.68 -41.28 1.05 Allowed 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.332 167.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' N ' ' CG ' ' A' ' 11' ' ' ARG . 0.4 OUTLIER -79.68 -0.26 33.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -159.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -139.94 8.38 2.31 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.6 p -36.89 -44.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 161.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -58.35 -22.34 53.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 126.727 2.011 . . . . 0.0 111.812 -175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -60.45 -28.77 68.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.801 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.42 -89.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -102.61 -90.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.898 0.879 . . . . 0.0 109.872 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.69 57.64 0.7 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.36 92.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.777 0.831 . . . . 0.0 109.469 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -60.81 150.38 32.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.212 1.005 . . . . 0.0 110.894 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 38.2 t -119.53 136.95 54.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.875 0.87 . . . . 0.0 112.528 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -85.37 -154.15 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.112 0.965 . . . . 0.0 110.473 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.53 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.835 2.054 . . . . 0.0 112.87 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.03 16.35 66.35 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 127.427 2.441 . . . . 0.0 112.961 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -141.94 124.4 15.75 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.257 1.029 . . . . 0.0 111.789 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.6 p -118.57 86.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.622 1.556 . . . . 0.0 112.669 -160.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -48.83 155.73 0.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.25 1.42 . . . . 0.0 112.925 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.59 69.12 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.245 -0.753 . . . . 0.0 114.914 159.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 56.7 m -52.38 -38.83 59.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.317 1.058 . . . . 0.0 111.118 173.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.763 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.267 85.9 Cg_exo -44.56 -50.91 7.69 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 124.811 3.674 . . . . 0.0 114.479 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -85.43 110.62 30.73 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 125.478 1.511 . . . . 0.0 108.312 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.07 64.38 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.365 2.043 . . . . 0.0 108.133 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.271 6.6 t -124.47 109.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 -165.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -135.46 166.14 23.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.623 -150.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 p -166.57 155.84 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.966 -162.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 -50.43 4.17 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.813 1.645 . . . . 0.0 107.447 161.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -132.59 170.67 14.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.698 1.999 . . . . 0.0 107.673 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -57.61 -40.03 78.2 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.569 1.548 . . . . 0.0 111.425 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -22.45 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.624 177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.11 -23.26 67.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.742 1.155 . . . . 0.0 109.797 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -120.23 13.82 12.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.824 1.65 . . . . 0.0 113.372 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.5 p -36.36 -43.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 159.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.0 ptp -54.39 -26.28 29.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.479 1.511 . . . . 0.0 111.656 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.96 -32.45 72.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.168 0.587 . . . . 0.0 111.31 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.47 -80.83 0.08 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.574 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -104.9 -142.53 0.37 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.768 1.627 . . . . 0.0 108.412 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.574 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -81.6 52.79 4.62 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 128.11 2.767 . . . . 0.0 108.276 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.4 mm -58.68 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.092 1.357 . . . . 0.0 110.624 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 t -36.52 136.54 0.34 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.388 2.275 . . . . 0.0 113.389 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.6 t -102.25 122.5 44.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.425 1.49 . . . . 0.0 109.847 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -96.65 -172.13 2.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.943 1.297 . . . . 0.0 108.2 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.37 77.47 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.73 2.412 . . . . 0.0 113.156 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.26 -2.28 66.81 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 127.998 2.713 . . . . 0.0 114.26 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -133.12 135.07 45.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.651 1.58 . . . . 0.0 107.771 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.2 p -111.82 138.47 48.37 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 121.113 1.778 . . . . 0.0 111.709 -169.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -102.85 125.36 49.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.235 -156.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.67 56.15 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.645 168.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.1 m -45.01 -44.87 10.32 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.178 0.991 . . . . 0.0 111.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 123.026 0.53 . . . . 0.0 109.585 164.045 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -59.95 172.89 2.02 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 124.308 3.339 . . . . 0.0 113.253 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -56.22 126.74 68.89 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.71 168.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.07 55.88 4.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.654 2.236 . . . . 0.0 108.566 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.255 2.1 t -119.82 114.93 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 -175.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -119.75 164.17 16.35 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 -144.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.81 156.81 33.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.636 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.28 -28.87 20.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 152.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -170.7 -178.33 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.358 1.863 . . . . 0.0 107.391 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.26 -49.29 34.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.753 2.021 . . . . 0.0 113.931 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.93 -38.58 10.78 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.06 174.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.28 -6.61 44.29 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 121.43 -0.794 . . . . 0.0 110.578 -170.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.0 m -131.25 6.44 4.52 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.696 1.198 . . . . 0.0 114.113 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 p -41.2 -38.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 122.394 1.093 . . . . 0.0 113.838 163.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.2 ptp -54.18 -27.12 31.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.435 1.494 . . . . 0.0 111.812 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -62.14 -27.6 69.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.217 0.607 . . . . 0.0 112.075 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.38 -86.85 0.1 OUTLIER Glycine 0 C--N 1.338 0.682 0 CA-C-N 119.21 0.913 . . . . 0.0 111.549 174.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.602 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -92.88 -138.88 0.19 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.602 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -59.83 -52.16 54.61 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.432 1.015 . . . . 0.0 110.998 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.9 mm 46.79 69.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.633 1.573 . . . . 0.0 110.546 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 153.69 17.0 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.072 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -120.84 136.79 54.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -95.0 -173.29 2.92 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.145 1.378 . . . . 0.0 108.16 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.57 69.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.605 2.362 . . . . 0.0 113.464 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.6 -35.81 2.7 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.864 3.126 . . . . 0.0 113.31 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -141.59 133.5 27.43 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -141.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.1 p -109.24 128.46 55.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.968 1.258 . . . . 0.0 113.456 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.43 86.35 2.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.988 -148.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.31 -25.91 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 32.3 t -40.53 -49.16 2.92 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.893 1.677 . . . . 0.0 113.413 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 124.574 1.15 . . . . 0.0 108.318 169.016 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 N--CA 1.457 -0.671 0 N-CA-C 110.272 -0.703 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.54 111.61 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.311 1.053 . . . . 0.0 109.281 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -130.11 175.08 9.19 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.027 -163.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p 174.46 144.09 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.763 1.625 . . . . 0.0 112.721 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -70.87 -39.81 72.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.358 162.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -166.5 -170.66 1.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.409 1.084 . . . . 0.0 109.073 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -55.86 -47.54 77.14 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.496 1.518 . . . . 0.0 111.824 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.696 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -47.91 -40.96 23.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 122.179 -0.325 . . . . 0.0 110.828 172.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.69 -0.91 16.95 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 120.951 -1.093 . . . . 0.0 111.588 -168.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.99 9.39 2.13 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.1 p -31.72 -47.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 159.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.575 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.1 ptt? -55.32 -26.56 41.38 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.216 1.806 . . . . 0.0 112.015 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -70.17 -17.85 63.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 112.416 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.32 -91.66 0.09 OUTLIER Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.377 0.989 . . . . 0.0 111.466 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 tp -99.53 -100.48 0.23 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.91 -42.86 4.29 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 mm 52.87 65.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 123.117 1.437 . . . . 0.0 109.261 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -60.22 145.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.742 1.617 . . . . 0.0 112.012 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.03 132.57 38.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.862 -141.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -74.65 166.51 23.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -66.12 69.38 0.06 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.11 1.764 . . . . 0.0 111.278 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.55 -34.08 2.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 126.946 2.212 . . . . 0.0 112.455 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.45 118.8 26.61 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.073 0.937 . . . . 0.0 113.067 -153.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.04 58.95 5.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.67 1.588 . . . . 0.0 109.418 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 67.04 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.225 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.66 -52.7 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 128.358 2.663 . . . . 0.0 115.091 -172.048 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.448 -1.148 0 N-CA-C 109.162 -1.13 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.5 93.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 121.937 0.875 . . . . 0.0 109.308 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.12 160.43 17.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.949 -150.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 32.1 p -147.42 122.67 10.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.132 -1.849 . . . . 0.0 114.955 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -69.58 -31.81 70.19 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.932 150.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -171.14 -178.92 2.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.471 1.508 . . . . 0.0 107.784 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.97 -47.23 81.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.634 1.574 . . . . 0.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.655 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.63 -33.76 16.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.506 173.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.98 -6.75 35.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 119.847 1.203 . . . . 0.0 112.112 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 7' ' ' CYS 0.296 21.1 m -133.68 5.09 3.66 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.157 0.983 . . . . 0.0 113.412 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.0 p -39.08 -40.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 122.226 1.013 . . . . 0.0 113.53 163.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.494 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -56.28 -24.95 46.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.953 1.701 . . . . 0.0 112.135 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.1 m -65.05 -23.91 67.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.345 0.658 . . . . 0.0 111.864 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.13 -84.91 0.08 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -116.87 -99.67 0.44 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.6 1.16 . . . . 0.0 109.016 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.47 -73.43 1.06 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' A' ' 27' ' ' CYS . 18.3 mm 49.47 73.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.095 1.358 . . . . 0.0 109.93 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.9 p -82.45 160.36 22.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.711 1.205 . . . . 0.0 112.85 -167.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.2 t -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.335 2.254 . . . . 0.0 113.55 -166.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -92.89 139.38 30.59 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 156.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -39.79 70.68 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.759 2.823 . . . . 0.0 115.969 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.73 0.46 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.62 1.581 . . . . 0.0 112.466 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -123.42 136.7 54.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.786 1.634 . . . . 0.0 109.327 -166.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.2 m -82.2 166.96 19.16 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.283 0.947 . . . . 0.0 112.055 164.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -121.89 118.38 28.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.33 1.052 . . . . 0.0 109.393 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 0.75 37.2 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.991 -0.894 . . . . 0.0 114.077 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.465 0.3 0 CA-C-N 119.003 1.402 . . . . 0.0 111.557 175.755 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.9 115.26 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.12 162.89 22.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 124.776 1.23 . . . . 0.0 109.966 -148.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 2.6 p -175.85 142.32 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -166.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -79.38 -32.15 43.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.597 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -165.27 -179.85 5.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.328 1.051 . . . . 0.0 108.583 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -56.72 -43.97 81.15 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.178 1.391 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.617 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.04 -36.85 41.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.141 172.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -74.5 -5.59 43.55 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.995 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -127.27 1.83 6.38 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.501 1.12 . . . . 0.0 114.013 174.357 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 11' ' ' ARG . 14.5 p -41.47 -34.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.474 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.9 ptp -52.33 -31.53 33.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 111.47 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 66.6 m -65.04 -25.87 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 112.716 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.25 -92.47 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 118.937 0.789 . . . . 0.0 111.319 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 tp -133.01 -106.03 0.25 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.744 1.218 . . . . 0.0 109.167 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.8 45.52 2.89 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.2 mm -65.92 97.75 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -88.18 127.87 35.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.835 0.854 . . . . 0.0 111.796 -164.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.99 115.95 20.71 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.882 0.873 . . . . 0.0 112.272 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -88.36 88.48 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 39.83 38.13 0.42 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.017 2.527 . . . . 0.0 114.72 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.02 -49.56 0.44 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.334 -0.703 . . . . 0.0 111.387 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -127.31 147.92 50.24 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.31 -161.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.257 1.0 OUTLIER -105.56 160.35 15.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 111.152 170.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -131.63 141.39 49.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.323 1.449 . . . . 0.0 108.164 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.95 40.57 93.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.41 0.55 . . . . 0.0 112.195 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 26.8 t . . . . . 0 N--CA 1.439 -0.98 0 C-N-CA 127.008 2.123 . . . . 0.0 110.889 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.557 -0.594 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.22 110.77 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.139 0.971 . . . . 0.0 108.948 173.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -130.03 176.2 8.27 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.962 -161.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.9 p -171.57 152.59 3.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.195 -1.821 . . . . 0.0 109.624 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -24.47 17.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.94 160.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -168.27 -177.43 3.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 106.966 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -43.81 98.31 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.38 1.072 . . . . 0.0 110.821 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.688 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.04 -35.11 14.83 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.971 170.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.69 -3.55 28.92 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.562 -1.336 . . . . 0.0 111.992 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 m -135.42 8.36 3.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 124.429 1.092 . . . . 0.0 113.802 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 11' ' ' ARG . 11.9 p -37.6 -42.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 161.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.2 ptm -56.16 -26.07 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.574 1.55 . . . . 0.0 111.957 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 64.7 m -69.81 -18.79 63.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.233 1.013 . . . . 0.0 111.489 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.53 -88.08 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.154 0.888 . . . . 0.0 111.473 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -105.6 -140.07 0.37 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.638 1.575 . . . . 0.0 108.017 -177.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.662 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -80.24 49.84 3.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 128.054 2.74 . . . . 0.0 109.08 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.37 103.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.718 1.607 . . . . 0.0 108.798 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -72.33 141.87 48.82 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.8 0.84 . . . . 0.0 112.201 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.3 t -107.66 110.6 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.177 1.791 . . . . 0.0 111.47 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -76.25 169.8 17.52 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 164.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -1.38 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.389 2.676 . . . . 0.0 115.414 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.42 21.93 2.05 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.682 164.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.27 119.22 27.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.299 1.84 . . . . 0.0 108.392 -170.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 151.19 23.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.105 1.362 . . . . 0.0 110.924 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -127.87 126.33 41.39 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.856 -0.528 . . . . 0.0 111.107 -154.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.34 45.24 31.11 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.317 0.398 . . . . 0.0 112.385 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 42.6 t . . . . . 0 N--CA 1.441 -0.918 0 C-N-CA 125.82 1.648 . . . . 0.0 112.258 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.7 113.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 C-N-CA 124.318 1.047 . . . . 0.0 109.077 172.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.41 -179.92 5.43 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.005 -168.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -178.28 156.96 1.02 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.333 -168.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -40.99 19.4 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.961 1.305 . . . . 0.0 108.904 166.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -165.54 -174.81 3.28 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.88 -46.9 64.68 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 127.037 2.135 . . . . 0.0 112.755 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.669 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.33 -38.03 26.48 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.972 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.18 -12.38 60.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.101 -0.999 . . . . 0.0 111.503 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.03 12.9 3.95 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.3 p -36.62 -44.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 160.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.55 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.7 ptm -59.05 -22.75 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.439 1.895 . . . . 0.0 112.337 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -64.58 -21.47 66.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.629 0.772 . . . . 0.0 110.672 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.35 -68.97 0.2 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.63 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -129.54 -138.71 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.118 1.767 . . . . 0.0 108.383 -173.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.63 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.61 52.8 4.2 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 128.546 2.974 . . . . 0.0 109.199 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 mm -59.04 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 126.284 1.834 . . . . 0.0 108.38 168.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 p -81.51 144.11 31.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.462 0.705 . . . . 0.0 112.446 -162.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.18 118.48 33.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.722 0.772 . . . . 0.0 111.205 -149.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -79.37 -173.05 3.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.711 1.205 . . . . 0.0 108.633 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -58.49 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.443 1.897 . . . . 0.0 112.147 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.56 71.68 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 128.072 2.749 . . . . 0.0 113.468 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -122.07 121.58 37.3 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 1.389 . . . . 0.0 113.641 -155.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.77 68.85 2.43 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 126.738 2.015 . . . . 0.0 109.147 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -48.09 150.22 1.24 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.551 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.69 -40.64 2.91 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.502 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 114.3 -169.285 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 N-CA-C 110.564 -0.591 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 27' ' ' CYS 0.286 6.1 t -94.12 114.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 101.314 -3.587 . . . . 0.0 101.314 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -123.39 178.75 5.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 124.759 1.224 . . . . 0.0 108.68 -160.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p 179.67 145.08 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.336 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -39.73 53.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.515 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -166.71 -175.54 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.635 1.574 . . . . 0.0 107.083 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -45.2 -46.84 12.5 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 128.483 2.713 . . . . 0.0 113.865 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.695 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -44.24 -44.6 8.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.986 176.066 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -4.73 30.62 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.291 -0.88 . . . . 0.0 111.621 -168.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.79 6.26 3.17 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.9 p -34.76 -45.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 161.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.572 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -55.74 -25.86 42.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.916 1.686 . . . . 0.0 111.731 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 59.8 m -75.45 -6.84 52.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.167 0.987 . . . . 0.0 112.627 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.65 -95.86 0.11 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 tp -105.7 -99.17 0.33 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -47.11 6.03 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mm 47.53 63.79 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.036 1.334 . . . . 0.0 108.853 -168.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -67.18 136.49 55.12 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.464 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.51 164.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -148.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -117.04 171.82 7.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.15 71.95 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 126.465 1.906 . . . . 0.0 113.141 -166.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.56 -23.68 19.44 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.82 2.628 . . . . 0.0 112.447 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.8 140.22 49.99 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.758 1.223 . . . . 0.0 108.549 -160.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' HG12 ' A' ' 5' ' ' VAL . 2.5 t -108.69 149.05 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.4 111.77 7.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.906 0.483 . . . . 0.0 110.78 -155.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.54 55.26 6.16 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 2.0 m . . . . . 0 CA--C 1.538 0.519 0 C-N-CA 125.326 1.45 . . . . 0.0 110.548 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 N--CA 1.453 -0.896 0 N-CA-C 109.37 -1.05 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.37 106.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.509 1.147 . . . . 0.0 109.714 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -127.08 175.87 7.79 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.278 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.67 166.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.355 1.862 . . . . 0.0 111.103 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -43.46 9.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.184 1.393 . . . . 0.0 108.446 160.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -158.05 -170.95 3.32 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -41.56 67.55 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.996 2.118 . . . . 0.0 112.509 -171.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.68 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.48 -42.33 32.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.739 176.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -7.25 47.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.749 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -137.41 12.73 3.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.138 1.375 . . . . 0.0 114.08 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.2 p -35.09 -45.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 159.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.527 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.6 ptp -54.79 -25.65 29.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.613 1.565 . . . . 0.0 112.273 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 m -67.5 -22.49 65.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 111.862 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.74 -95.16 0.11 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.659 1.118 . . . . 0.0 111.686 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -89.88 -140.26 0.14 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 170.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.584 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -56.91 -41.27 91.62 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.99 0.805 . . . . 0.0 111.306 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . 0.274 9.8 mm 50.19 64.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 123.008 1.385 . . . . 0.0 109.386 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.63 118.58 2.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.155 2.182 . . . . 0.0 111.378 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 127.54 43.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.64 0.776 . . . . 0.0 110.826 -160.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.17 -167.54 0.52 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.001 0.92 . . . . 0.0 109.653 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -39.14 70.03 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 130.811 3.644 . . . . 0.0 114.028 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.34 31.93 13.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.75 2.119 . . . . 0.0 113.445 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 120.19 24.12 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.317 1.047 . . . . 0.0 111.954 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -90.8 68.32 6.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.503 1.521 . . . . 0.0 110.391 -170.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.83 156.45 0.97 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.284 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.86 -30.48 3.87 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.998 -0.89 . . . . 0.0 113.377 164.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.34 0.194 0 C-N-CA 125.518 1.527 . . . . 0.0 113.855 -172.432 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.446 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.251 2.9 t -96.66 105.25 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 -166.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -121.77 163.8 18.5 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.495 -156.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.79 126.26 16.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.233 -169.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.67 -33.54 75.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 161.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -168.82 -177.88 3.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.577 2.351 . . . . 0.0 104.971 164.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.69 -49.41 65.39 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.525 -169.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -54.89 -22.09 13.62 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 176.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.05 -20.68 66.6 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.476 -1.39 . . . . 0.0 110.943 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.99 9.35 11.85 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 11' ' ' ARG . 15.0 p -44.02 -35.1 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 162.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.466 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.5 ptt? -53.72 -29.8 41.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.492 1.117 . . . . 0.0 111.493 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.96 -29.67 66.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.192 0.997 . . . . 0.0 111.472 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.79 168.49 24.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.8 tp -8.79 -84.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.083 2.953 . . . . 0.0 114.287 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.42 -64.95 1.01 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.5 mm 40.25 61.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 110.839 -163.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.42 142.8 42.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.502 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -104.12 140.55 37.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -164.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -85.92 -159.4 0.46 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 0.0 109.165 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -60.62 77.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.817 1.647 . . . . 0.0 112.477 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.32 8.35 62.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.044 2.735 . . . . 0.0 113.165 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -137.15 120.89 17.39 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.449 1.1 . . . . 0.0 108.837 -162.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 5' ' ' VAL 0.284 31.2 p -98.66 68.42 1.8 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.837 1.653 . . . . 0.0 110.669 -165.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -60.41 76.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.25 0 C-N-CA 127.968 2.507 . . . . 0.0 110.74 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.21 -41.35 0.07 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 125.09 1.356 . . . . 0.0 112.634 176.183 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 0 N--CA 1.457 -0.662 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.26 5.3 t -124.25 111.46 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -163.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -130.72 172.37 12.05 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-O 122.038 0.923 . . . . 0.0 111.746 -153.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -175.18 152.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.2 -171.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.83 -48.17 15.25 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 159.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -142.87 170.93 14.78 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.084 1.754 . . . . 0.0 110.135 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -46.53 -45.26 18.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 126.89 2.076 . . . . 0.0 113.911 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.654 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -45.56 -38.45 6.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.245 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -6.23 48.91 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.564 1.146 . . . . 0.0 108.425 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 61.1 m -140.38 13.25 2.37 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.2 p -42.4 -39.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 164.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.497 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -55.68 -25.7 41.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.896 1.678 . . . . 0.0 112.019 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.07 -24.82 64.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.759 0.824 . . . . 0.0 111.397 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.87 -73.95 0.17 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -113.81 -144.88 0.39 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.889 1.676 . . . . 0.0 108.134 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.691 ' H ' HD23 ' A' ' 18' ' ' LEU . . . -80.91 53.87 4.64 Favored Glycine 0 C--N 1.318 -0.43 0 C-N-CA 128.241 2.829 . . . . 0.0 108.383 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mm -59.74 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 109.284 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -68.52 141.2 55.62 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.548 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.3 m -95.47 117.31 30.15 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.583 1.553 . . . . 0.0 110.795 -160.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 11.8 mptt -80.02 -171.68 3.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -49.25 71.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.386 2.675 . . . . 0.0 114.87 -171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.77 12.87 83.74 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.717 3.056 . . . . 0.0 114.302 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -144.54 129.66 18.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.024 1.412 . . . . 0.0 111.34 -160.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 5' ' ' VAL . 28.7 p -103.57 59.35 0.75 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.429 1.468 . . . . 0.0 112.277 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -55.35 117.07 3.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.438 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.6 1.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.34 0.171 0 CA-C-O 122.487 1.137 . . . . 0.0 109.61 169.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.453 -0.899 0 N-CA-C 108.707 -1.305 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 116.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-O 122.726 1.25 . . . . 0.0 108.361 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.09 -176.14 2.97 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 112.83 -1.986 . . . . 0.0 108.761 -167.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.86 142.31 0.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.75 1.62 . . . . 0.0 112.574 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -49.99 75.71 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 160.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -164.88 -164.5 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.62 -48.57 19.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 129.696 3.198 . . . . 0.0 114.836 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.725 ' O ' HG12 ' A' ' 14' ' ' VAL . 33.8 ptt180 -44.98 -40.66 6.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.592 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -69.81 -9.24 53.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.316 -0.865 . . . . 0.0 111.507 -172.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.17 4.34 4.06 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 11' ' ' ARG . 11.5 p -36.51 -45.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 163.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.557 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -58.27 -22.67 53.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.606 1.962 . . . . 0.0 112.215 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.0 m -73.71 -10.16 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.04 0.936 . . . . 0.0 111.946 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.31 -91.5 0.08 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 165.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.9 tp -101.04 -84.85 0.43 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.097 0.959 . . . . 0.0 109.036 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -138.7 60.91 0.58 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -54.95 101.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 109.389 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -78.54 162.94 25.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.601 0.76 . . . . 0.0 111.392 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.11 121.9 27.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.87 0.868 . . . . 0.0 110.314 -158.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -70.02 -169.37 0.27 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 164.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -40.77 70.35 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 130.148 3.379 . . . . 0.0 114.4 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 57.05 26.0 54.84 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 127.628 2.537 . . . . 0.0 113.724 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -128.57 131.23 48.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.079 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.12 110.06 21.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.075 1.75 . . . . 0.0 108.042 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -76.31 73.79 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.996 0.519 . . . . 0.0 112.289 -161.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.82 57.02 5.56 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.269 0.462 . . . . 0.0 112.076 166.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 129.493 3.117 . . . . 0.0 114.255 174.89 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 N--CA 1.454 -0.829 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.266 1.3 t -132.03 125.33 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 -171.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.39 175.56 5.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 124.949 1.299 . . . . 0.0 109.61 -167.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 p -175.27 143.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.478 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -28.13 25.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.587 1.155 . . . . 0.0 109.626 168.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -170.5 176.74 4.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.96 -43.63 70.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 126.381 1.873 . . . . 0.0 111.758 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.668 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.1 -36.47 18.8 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.142 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.51 -9.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.855 -1.153 . . . . 0.0 112.564 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 m -136.13 12.89 3.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 11' ' ' ARG . 8.8 p -35.59 -44.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 158.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.556 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -56.59 -25.36 52.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.117 1.767 . . . . 0.0 112.001 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -67.22 -19.9 65.61 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.517 0.727 . . . . 0.0 111.072 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.91 -80.01 0.15 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 168.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -112.11 -139.79 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.88 1.672 . . . . 0.0 108.359 -175.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.658 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.81 51.45 4.04 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 128.382 2.896 . . . . 0.0 108.951 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 mm -57.87 82.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 108.819 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.9 p -72.37 142.15 48.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -164.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -89.03 113.42 24.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.418 1.087 . . . . 0.0 109.971 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.86 -177.93 6.6 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -4.59 -70.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.374 2.27 . . . . 0.0 115.872 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.24 1.2 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 161.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.36 118.45 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.772 2.029 . . . . 0.0 109.09 -157.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -96.89 62.6 1.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 124.807 2.242 . . . . 0.0 110.32 -160.215 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -69.35 112.24 5.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.117 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.27 -47.56 0.58 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.341 0.205 0 C-N-CA 126.537 1.935 . . . . 0.0 114.965 -167.956 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.9 99.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 122.912 1.339 . . . . 0.0 111.704 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -124.38 173.07 8.65 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.138 -159.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 p -163.78 133.92 4.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.181 -159.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -73.1 -30.75 63.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.231 1.012 . . . . 0.0 110.125 160.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -170.16 176.22 4.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.907 1.683 . . . . 0.0 106.817 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.0 -38.46 79.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 110.227 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.673 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -52.36 -36.21 53.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.296 173.015 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.07 -15.45 63.08 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.372 -1.455 . . . . 0.0 111.558 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.1 m -125.26 6.55 7.78 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 124.449 1.099 . . . . 0.0 113.298 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.6 p -41.29 -39.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 164.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.517 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.1 ptm -56.0 -26.4 48.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.84 1.656 . . . . 0.0 111.963 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 45.2 m -68.56 -27.73 66.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.102 0.961 . . . . 0.0 111.483 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.74 -89.67 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -129.49 -101.48 0.32 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.761 1.224 . . . . 0.0 110.097 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.58 50.83 0.83 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.79 85.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.75 122.49 18.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -154.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.1 t -74.56 107.67 6.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.75 0.42 . . . . 0.0 111.615 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 25' ' ' GLY . 6.8 mtmp? -83.35 -167.66 1.78 Allowed 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 166.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -34.31 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 129.78 3.232 . . . . 0.0 114.701 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 58.92 13.69 20.26 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 127.295 2.379 . . . . 0.0 114.557 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.71 113.89 8.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.076 1.438 . . . . 0.0 111.619 -167.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 p -98.11 136.8 37.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.227 -0.921 . . . . 0.0 113.141 -166.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -90.83 132.07 36.1 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.619 0.767 . . . . 0.0 112.481 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.57 41.07 11.63 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 123.39 0.519 . . . . 0.0 113.286 160.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 41.8 t . . . . . 0 N--CA 1.441 -0.877 0 C-N-CA 125.684 1.594 . . . . 0.0 112.865 -174.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 N-CA-C 110.817 -0.493 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 102.26 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.697 1.237 . . . . 0.0 110.69 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -124.67 175.61 7.1 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.596 -160.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -178.97 157.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.32 1.848 . . . . 0.0 110.663 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -76.16 -61.89 1.79 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -140.81 -178.16 5.41 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.105 1.762 . . . . 0.0 109.283 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -51.4 -48.23 62.68 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.285 1.834 . . . . 0.0 113.354 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -50.81 -33.42 23.48 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.485 176.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.72 -10.55 57.11 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 121.079 -1.013 . . . . 0.0 110.981 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.1 m -136.67 13.23 3.18 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.4 p -31.82 -48.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 157.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.583 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.5 ptp -58.97 -21.85 59.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.207 2.203 . . . . 0.0 112.665 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -66.67 -25.3 66.5 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.302 0.641 . . . . 0.0 110.429 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.74 -78.85 0.05 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.61 -91.36 0.16 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 109.199 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.18 49.08 0.88 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -65.51 78.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.1 p -68.85 153.17 44.27 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -116.28 114.04 23.82 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.527 0.68 . . . . 0.0 109.297 -163.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -160.22 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -47.98 75.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.755 2.422 . . . . 0.0 114.183 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.15 33.56 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 127.8 2.619 . . . . 0.0 113.247 -169.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.23 121.35 26.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.127 0.971 . . . . 0.0 112.438 -166.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.17 63.27 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.163 2.185 . . . . 0.0 109.197 -172.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -56.77 119.92 6.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.158 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.52 6.6 67.96 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.135 -1.369 . . . . 0.0 114.678 165.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.343 0.323 0 C-N-CA 127.997 2.519 . . . . 0.0 115.242 179.591 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.457 -0.639 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.294 3.0 t -117.77 107.67 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -143.73 170.83 15.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.349 1.071 . . . . 0.0 110.103 -144.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.85 144.56 4.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.823 -157.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -88.12 -39.36 14.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.412 1.485 . . . . 0.0 108.534 159.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.93 -179.05 7.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -44.64 -42.03 7.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.631 3.172 . . . . 0.0 113.43 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.68 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.56 -41.44 41.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.663 177.301 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -7.32 49.25 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.062 -169.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.7 m -134.27 10.64 3.82 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 113.264 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.4 p -39.58 -41.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.534 1.159 . . . . 0.0 113.655 161.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.512 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -55.93 -24.43 37.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.778 1.631 . . . . 0.0 111.834 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.9 m -66.18 -22.61 66.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.527 0.731 . . . . 0.0 111.88 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.51 -87.4 0.1 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.028 0.831 . . . . 0.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.729 HD23 ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -96.97 -146.03 0.3 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.291 1.436 . . . . 0.0 107.159 178.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.729 ' H ' HD23 ' A' ' 18' ' ' LEU . . . -81.38 49.57 4.04 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 127.167 2.317 . . . . 0.0 108.829 172.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mm -46.85 127.52 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.13 1.372 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -68.69 125.76 27.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.87 1.268 . . . . 0.0 112.186 -172.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -87.08 113.67 23.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 165.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -90.1 -170.96 2.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.112 1.365 . . . . 0.0 108.105 167.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -44.57 74.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.559 2.744 . . . . 0.0 114.314 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.91 -5.39 32.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 127.903 2.668 . . . . 0.0 114.166 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -133.11 132.93 42.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.093 1.757 . . . . 0.0 107.785 -162.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 p -114.66 82.29 1.7 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.996 1.725 . . . . 0.0 113.427 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -49.22 142.13 7.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.406 166.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.1 5.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 167.543 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 N-CA-C 109.608 -0.959 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.37 104.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.561 1.172 . . . . 0.0 110.858 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -132.3 175.32 9.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.866 -158.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -172.61 146.31 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.019 -1.9 . . . . 0.0 110.767 -161.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -55.96 4.82 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 158.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.7 p -136.48 176.1 9.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.507 1.923 . . . . 0.0 108.036 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.8 -44.66 39.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 112.405 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.666 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.11 -38.85 18.72 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.214 174.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.25 -10.93 58.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.016 -1.052 . . . . 0.0 112.527 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -129.53 7.09 5.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.2 p -40.17 -41.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 163.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.513 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.7 ptm -57.75 -24.72 58.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.311 1.845 . . . . 0.0 112.347 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.82 -26.87 65.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.959 0.904 . . . . 0.0 110.516 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.2 -82.16 0.06 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 tp -142.97 -97.02 0.12 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.695 1.198 . . . . 0.0 109.501 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.43 40.92 2.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.319 1.438 . . . . 0.0 110.24 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.11 76.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.423 1.089 . . . . 0.0 108.595 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 t -71.8 152.82 42.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.668 1.187 . . . . 0.0 111.855 -166.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.6 t -114.78 136.68 52.81 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.379 1.472 . . . . 0.0 111.58 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.06 129.69 30.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 39.38 53.22 2.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.548 1.539 . . . . 0.0 113.373 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 -19.19 52.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 124.557 1.075 . . . . 0.0 113.644 171.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -115.69 131.54 56.9 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.026 1.331 . . . . 0.0 111.696 -169.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.51 131.81 55.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.151 1.38 . . . . 0.0 111.927 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -100.19 115.92 30.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.481 -153.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.25 53.61 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.584 -0.564 . . . . 0.0 114.382 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.451 -0.395 0 C-N-CA 125.581 1.552 . . . . 0.0 114.04 -178.45 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 108.447 -1.405 . . . . 0.0 108.447 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.256 3.8 t -125.07 115.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -163.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -130.35 174.58 9.71 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 125.514 1.525 . . . . 0.0 108.432 -164.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -176.45 138.88 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.171 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -27.11 33.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.401 0.281 . . . . 0.0 111.272 161.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.42 168.44 26.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.263 1.825 . . . . 0.0 106.943 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -54.98 -39.06 68.59 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 126.352 1.861 . . . . 0.0 110.93 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.702 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -45.36 -41.61 9.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.627 168.078 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.04 -2.55 24.77 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 121.068 -1.02 . . . . 0.0 111.085 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -137.11 7.43 2.9 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 125.492 1.517 . . . . 0.0 113.97 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.9 p -38.17 -41.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 162.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.512 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.2 ptt? -54.18 -27.3 33.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.646 1.578 . . . . 0.0 111.826 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.61 -26.47 67.85 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.271 1.029 . . . . 0.0 111.797 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.58 -90.22 0.1 Allowed Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -91.94 -139.6 0.18 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -58.76 -51.68 57.58 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.598 1.094 . . . . 0.0 111.009 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.8 mm 49.79 71.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.316 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.84 146.96 4.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.786 2.035 . . . . 0.0 114.001 -172.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -111.59 118.2 35.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.715 1.206 . . . . 0.0 110.661 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -89.39 -175.45 4.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -40.44 79.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.932 2.493 . . . . 0.0 114.133 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.34 76.01 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.614 2.53 . . . . 0.0 114.551 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.9 129.93 40.95 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.868 1.334 . . . . 0.0 110.576 -163.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 145.99 33.37 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.102 0.864 . . . . 0.0 111.044 -163.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -131.97 126.69 34.63 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.152 -0.343 . . . . 0.0 110.194 -154.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 -29.1 10.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.313 0.958 . . . . 0.0 111.889 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.341 0.223 0 C-N-CA 125.243 1.417 . . . . 0.0 113.312 -169.497 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.456 -0.684 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.265 5.4 t -124.42 114.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -162.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -143.13 169.25 17.96 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.004 -155.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.8 p -154.52 156.38 36.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.543 -1.662 . . . . 0.0 109.206 -167.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -53.66 5.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 155.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -140.35 168.96 18.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.592 1.957 . . . . 0.0 107.269 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -42.1 -48.21 4.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 127.195 2.198 . . . . 0.0 114.964 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.697 ' O ' HG12 ' A' ' 14' ' ' VAL 0.252 0.0 OUTLIER -60.11 -24.73 64.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.655 -176.887 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.37 -23.77 67.55 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.954 -1.091 . . . . 0.0 111.313 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.07 11.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.532 1.133 . . . . 0.0 113.19 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.3 p -42.48 -39.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.719 1.247 . . . . 0.0 113.413 163.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.508 ' N ' HG13 ' A' ' 14' ' ' VAL . 23.0 ptp -54.25 -25.16 21.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.066 1.346 . . . . 0.0 111.718 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.2 -29.46 68.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.961 0.904 . . . . 0.0 112.377 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.42 -91.73 0.09 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.554 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -95.61 -138.73 0.24 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.554 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -54.36 -48.33 64.91 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.28 0.943 . . . . 0.0 111.565 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 mm 41.44 66.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.361 1.464 . . . . 0.0 109.634 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.52 100.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.547 1.139 . . . . 0.0 111.008 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.4 142.22 58.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.017 -168.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -158.97 0.59 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.74 1.216 . . . . 0.0 108.254 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -53.35 73.88 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 128.001 2.52 . . . . 0.0 113.767 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.99 66.57 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.342 2.401 . . . . 0.0 112.949 -175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.65 119.3 13.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.859 -162.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.291 27.4 p -107.46 66.24 0.66 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 121.236 1.835 . . . . 0.0 111.314 -164.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -16.32 111.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.914 2.885 . . . . 0.0 115.592 165.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.87 28.66 73.42 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.321 159.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.457 -0.094 0 C-N-CA 127.9 2.48 . . . . 0.0 113.98 174.204 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 N--CA 1.457 -0.621 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -110.87 107.2 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -160.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -132.73 170.08 15.77 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.843 -154.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -160.2 147.7 16.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.739 -164.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -33.97 57.73 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.775 -0.578 . . . . 0.0 110.009 155.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 t -170.7 -168.57 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 126.586 1.954 . . . . 0.0 106.122 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.84 -46.44 87.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 127.856 2.463 . . . . 0.0 113.221 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.712 ' O ' HG12 ' A' ' 14' ' ' VAL . 23.0 ptt180 -39.68 -41.28 1.05 Allowed 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.332 167.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' N ' ' CG ' ' A' ' 11' ' ' ARG . 0.4 OUTLIER -79.68 -0.26 33.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -159.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -139.94 8.38 2.31 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 11' ' ' ARG . 13.6 p -36.89 -44.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 161.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.552 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptt? -58.35 -22.34 53.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 126.727 2.011 . . . . 0.0 111.812 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -60.45 -28.77 68.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.801 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.42 -89.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -102.61 -90.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.898 0.879 . . . . 0.0 109.872 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.69 57.64 0.7 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.36 92.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.777 0.831 . . . . 0.0 109.469 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -60.81 150.38 32.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.212 1.005 . . . . 0.0 110.894 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 38.2 t -119.53 136.95 54.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.875 0.87 . . . . 0.0 112.528 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -85.37 -154.15 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.112 0.965 . . . . 0.0 110.473 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.53 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.835 2.054 . . . . 0.0 112.87 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.03 16.35 66.35 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 127.427 2.441 . . . . 0.0 112.961 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -141.94 124.4 15.75 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.257 1.029 . . . . 0.0 111.789 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.6 p -118.57 86.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.622 1.556 . . . . 0.0 112.669 -160.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -48.83 155.73 0.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.25 1.42 . . . . 0.0 112.925 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.59 69.12 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.245 -0.753 . . . . 0.0 114.914 159.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 118.317 1.058 . . . . 0.0 111.118 173.942 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.271 6.6 t -124.47 109.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 -165.28 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -135.46 166.14 23.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.623 -150.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 p -166.57 155.84 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.966 -162.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 -50.43 4.17 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.813 1.645 . . . . 0.0 107.447 161.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -132.59 170.67 14.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.698 1.999 . . . . 0.0 107.673 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -57.61 -40.03 78.2 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.569 1.548 . . . . 0.0 111.425 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.685 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -60.3 -22.45 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.624 177.819 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.11 -23.26 67.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.742 1.155 . . . . 0.0 109.797 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -120.23 13.82 12.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.824 1.65 . . . . 0.0 113.372 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.5 p -36.36 -43.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 159.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.537 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.0 ptp -54.39 -26.28 29.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.479 1.511 . . . . 0.0 111.656 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.96 -32.45 72.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.168 0.587 . . . . 0.0 111.31 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.47 -80.83 0.08 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.681 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -104.9 -142.53 0.37 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.768 1.627 . . . . 0.0 108.412 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.681 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -81.6 52.79 4.62 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 128.11 2.767 . . . . 0.0 108.276 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.4 mm -58.68 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.092 1.357 . . . . 0.0 110.624 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 t -36.52 136.54 0.34 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.388 2.275 . . . . 0.0 113.389 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.6 t -102.25 122.5 44.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.425 1.49 . . . . 0.0 109.847 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -96.65 -172.13 2.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.943 1.297 . . . . 0.0 108.2 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.37 77.47 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.73 2.412 . . . . 0.0 113.156 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.26 -2.28 66.81 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 127.998 2.713 . . . . 0.0 114.26 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -133.12 135.07 45.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.651 1.58 . . . . 0.0 107.771 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 5' ' ' VAL . 30.2 p -111.82 138.47 48.37 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 121.113 1.778 . . . . 0.0 111.709 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -102.85 125.36 49.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.235 -156.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.67 56.15 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.645 168.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.157 0 C-N-CA 124.178 0.991 . . . . 0.0 111.06 173.905 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 N-CA-C 108.566 -1.359 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.255 2.1 t -119.82 114.93 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 -175.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -119.75 164.17 16.35 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 -144.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.81 156.81 33.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.636 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.28 -28.87 20.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 152.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -170.7 -178.33 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.358 1.863 . . . . 0.0 107.391 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.26 -49.29 34.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.753 2.021 . . . . 0.0 113.931 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.687 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -46.93 -38.58 10.78 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.06 174.529 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.28 -6.61 44.29 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 121.43 -0.794 . . . . 0.0 110.578 -170.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.0 m -131.25 6.44 4.52 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.696 1.198 . . . . 0.0 114.113 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 11' ' ' ARG . 13.2 p -41.2 -38.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 122.394 1.093 . . . . 0.0 113.838 163.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.473 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.2 ptp -54.18 -27.12 31.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.435 1.494 . . . . 0.0 111.812 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -62.14 -27.6 69.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.217 0.607 . . . . 0.0 112.075 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.38 -86.85 0.1 OUTLIER Glycine 0 C--N 1.338 0.682 0 CA-C-N 119.21 0.913 . . . . 0.0 111.549 174.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -92.88 -138.88 0.19 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.57 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -59.83 -52.16 54.61 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.432 1.015 . . . . 0.0 110.998 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.9 mm 46.79 69.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.633 1.573 . . . . 0.0 110.546 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 153.69 17.0 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.072 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -120.84 136.79 54.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -95.0 -173.29 2.92 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.145 1.378 . . . . 0.0 108.16 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.57 69.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.605 2.362 . . . . 0.0 113.464 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.6 -35.81 2.7 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.864 3.126 . . . . 0.0 113.31 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -141.59 133.5 27.43 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -141.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.1 p -109.24 128.46 55.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.968 1.258 . . . . 0.0 113.456 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.43 86.35 2.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.988 -148.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.31 -25.91 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 C--N 1.341 0.217 0 C-N-CA 125.893 1.677 . . . . 0.0 113.413 -173.878 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 45.7 m . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.25 21.4 Cg_exo -73.22 40.81 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.789 3.659 . . . . 0.0 116.033 -167.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -67.8 118.32 56.7 Favored Pre-proline 0 N--CA 1.435 -1.184 0 O-C-N 120.98 -1.075 . . . . 0.0 108.437 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 50.82 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.76 2.307 . . . . 0.0 110.272 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.54 111.61 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.311 1.053 . . . . 0.0 109.281 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -130.11 175.08 9.19 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.027 -163.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p 174.46 144.09 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.763 1.625 . . . . 0.0 112.721 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -70.87 -39.81 72.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.358 162.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -166.5 -170.66 1.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.409 1.084 . . . . 0.0 109.073 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -55.86 -47.54 77.14 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.496 1.518 . . . . 0.0 111.824 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.696 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -47.91 -40.96 23.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 122.179 -0.325 . . . . 0.0 110.828 172.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.69 -0.91 16.95 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 120.951 -1.093 . . . . 0.0 111.588 -168.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.99 9.39 2.13 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.1 p -31.72 -47.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 159.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.575 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.1 ptt? -55.32 -26.56 41.38 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.216 1.806 . . . . 0.0 112.015 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -70.17 -17.85 63.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 112.416 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.32 -91.66 0.09 OUTLIER Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.377 0.989 . . . . 0.0 111.466 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 tp -99.53 -100.48 0.23 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.91 -42.86 4.29 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 mm 52.87 65.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 123.117 1.437 . . . . 0.0 109.261 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -60.22 145.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.742 1.617 . . . . 0.0 112.012 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.03 132.57 38.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.862 -141.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -74.65 166.51 23.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -66.12 69.38 0.06 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.11 1.764 . . . . 0.0 111.278 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.55 -34.08 2.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 126.946 2.212 . . . . 0.0 112.455 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.45 118.8 26.61 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.073 0.937 . . . . 0.0 113.067 -153.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.04 58.95 5.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.67 1.588 . . . . 0.0 109.418 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 67.04 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.225 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.66 -52.7 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.5 t -20.25 -57.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.358 2.663 . . . . 0.0 115.091 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 162.198 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 118.602 -0.713 . . . . 0.0 112.04 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.83 65.62 1.28 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 1 C-N-CA 125.395 4.063 . . . . 0.0 113.33 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 16.36 77.21 0.13 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 128.869 2.867 . . . . 0.0 114.143 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.16 69.44 3.19 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.243 1.962 . . . . 0.0 109.162 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.5 93.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 121.937 0.875 . . . . 0.0 109.308 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.12 160.43 17.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.949 -150.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 32.1 p -147.42 122.67 10.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.132 -1.849 . . . . 0.0 114.955 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -69.58 -31.81 70.19 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.932 150.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -171.14 -178.92 2.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.471 1.508 . . . . 0.0 107.784 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.97 -47.23 81.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.634 1.574 . . . . 0.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.655 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.63 -33.76 16.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.506 173.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.98 -6.75 35.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 119.847 1.203 . . . . 0.0 112.112 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 7' ' ' CYS 0.296 21.1 m -133.68 5.09 3.66 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.157 0.983 . . . . 0.0 113.412 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.0 p -39.08 -40.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 122.226 1.013 . . . . 0.0 113.53 163.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.494 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -56.28 -24.95 46.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.953 1.701 . . . . 0.0 112.135 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.1 m -65.05 -23.91 67.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.345 0.658 . . . . 0.0 111.864 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.13 -84.91 0.08 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -116.87 -99.67 0.44 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.6 1.16 . . . . 0.0 109.016 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.47 -73.43 1.06 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' A' ' 27' ' ' CYS . 18.3 mm 49.47 73.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.095 1.358 . . . . 0.0 109.93 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.9 p -82.45 160.36 22.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.711 1.205 . . . . 0.0 112.85 -167.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.2 t -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.335 2.254 . . . . 0.0 113.55 -166.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -92.89 139.38 30.59 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 156.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -39.79 70.68 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.759 2.823 . . . . 0.0 115.969 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.73 0.46 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.62 1.581 . . . . 0.0 112.466 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -123.42 136.7 54.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.786 1.634 . . . . 0.0 109.327 -166.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.2 m -82.2 166.96 19.16 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.283 0.947 . . . . 0.0 112.055 164.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -121.89 118.38 28.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.33 1.052 . . . . 0.0 109.393 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 0.75 37.2 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.991 -0.894 . . . . 0.0 114.077 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.1 t -51.72 -35.69 44.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 1.402 . . . . 0.0 111.557 175.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.397 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -75.01 51.78 2.88 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.773 3.649 . . . . 0.0 114.158 -171.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -64.0 119.25 53.58 Favored Pre-proline 0 N--CA 1.435 -1.21 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.38 52.3 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.235 1.957 . . . . 0.0 108.762 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.9 115.26 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.12 162.89 22.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 124.776 1.23 . . . . 0.0 109.966 -148.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 2.6 p -175.85 142.32 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -166.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -79.38 -32.15 43.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.597 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -165.27 -179.85 5.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.328 1.051 . . . . 0.0 108.583 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -56.72 -43.97 81.15 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.178 1.391 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.617 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.04 -36.85 41.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.141 172.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -74.5 -5.59 43.55 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.995 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -127.27 1.83 6.38 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.501 1.12 . . . . 0.0 114.013 174.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 11' ' ' ARG . 14.5 p -41.47 -34.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.474 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.9 ptp -52.33 -31.53 33.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 111.47 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 66.6 m -65.04 -25.87 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 112.716 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.25 -92.47 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 118.937 0.789 . . . . 0.0 111.319 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 tp -133.01 -106.03 0.25 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.744 1.218 . . . . 0.0 109.167 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.8 45.52 2.89 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.2 mm -65.92 97.75 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -88.18 127.87 35.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.835 0.854 . . . . 0.0 111.796 -164.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.99 115.95 20.71 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.882 0.873 . . . . 0.0 112.272 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -88.36 88.48 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 39.83 38.13 0.42 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.017 2.527 . . . . 0.0 114.72 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.02 -49.56 0.44 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.334 -0.703 . . . . 0.0 111.387 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -127.31 147.92 50.24 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.31 -161.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.257 1.0 OUTLIER -105.56 160.35 15.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 111.152 170.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -131.63 141.39 49.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.323 1.449 . . . . 0.0 108.164 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.95 40.57 93.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.41 0.55 . . . . 0.0 112.195 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 26.8 t -68.39 74.17 0.24 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.008 2.123 . . . . 0.0 110.889 -175.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 125.591 1.556 . . . . 0.0 111.739 176.63 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.15 -175.45 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.72 3.613 . . . . 0.0 113.492 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -55.05 145.72 42.8 Favored Pre-proline 0 N--CA 1.436 -1.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.228 165.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.31 55.14 4.52 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.186 2.591 . . . . 0.0 110.557 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.22 110.77 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.139 0.971 . . . . 0.0 108.948 173.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -130.03 176.2 8.27 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.962 -161.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.9 p -171.57 152.59 3.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.195 -1.821 . . . . 0.0 109.624 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -24.47 17.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.94 160.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -168.27 -177.43 3.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 106.966 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -43.81 98.31 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.38 1.072 . . . . 0.0 110.821 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.688 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.04 -35.11 14.83 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.971 170.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.69 -3.55 28.92 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.562 -1.336 . . . . 0.0 111.992 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 m -135.42 8.36 3.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 124.429 1.092 . . . . 0.0 113.802 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 11' ' ' ARG . 11.9 p -37.6 -42.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 161.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.2 ptm -56.16 -26.07 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.574 1.55 . . . . 0.0 111.957 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 64.7 m -69.81 -18.79 63.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.233 1.013 . . . . 0.0 111.489 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.53 -88.08 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.154 0.888 . . . . 0.0 111.473 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -105.6 -140.07 0.37 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.638 1.575 . . . . 0.0 108.017 -177.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.662 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -80.24 49.84 3.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 128.054 2.74 . . . . 0.0 109.08 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.37 103.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.718 1.607 . . . . 0.0 108.798 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -72.33 141.87 48.82 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.8 0.84 . . . . 0.0 112.201 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.3 t -107.66 110.6 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.177 1.791 . . . . 0.0 111.47 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -76.25 169.8 17.52 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 164.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -1.38 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.389 2.676 . . . . 0.0 115.414 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.42 21.93 2.05 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.682 164.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.27 119.22 27.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.299 1.84 . . . . 0.0 108.392 -170.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 151.19 23.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.105 1.362 . . . . 0.0 110.924 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -127.87 126.33 41.39 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.856 -0.528 . . . . 0.0 111.107 -154.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.34 45.24 31.11 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.317 0.398 . . . . 0.0 112.385 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 42.6 t -67.41 75.15 0.16 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.82 1.648 . . . . 0.0 112.258 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.331 -0.217 0 C-N-CA 124.672 1.189 . . . . 0.0 109.292 174.612 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.77 167.39 5.38 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.401 3.401 . . . . 0.0 113.609 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -57.36 141.18 78.32 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 167.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.64 63.71 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.784 2.322 . . . . 0.0 109.65 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.7 113.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 C-N-CA 124.318 1.047 . . . . 0.0 109.077 172.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -129.41 -179.92 5.43 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.005 -168.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -178.28 156.96 1.02 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.333 -168.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -40.99 19.4 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.961 1.305 . . . . 0.0 108.904 166.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -165.54 -174.81 3.28 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.88 -46.9 64.68 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 127.037 2.135 . . . . 0.0 112.755 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.669 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.33 -38.03 26.48 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.972 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.18 -12.38 60.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.101 -0.999 . . . . 0.0 111.503 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.03 12.9 3.95 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.3 p -36.62 -44.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 160.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.55 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.7 ptm -59.05 -22.75 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.439 1.895 . . . . 0.0 112.337 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -64.58 -21.47 66.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.629 0.772 . . . . 0.0 110.672 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.35 -68.97 0.2 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.63 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -129.54 -138.71 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.118 1.767 . . . . 0.0 108.383 -173.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.63 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.61 52.8 4.2 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 128.546 2.974 . . . . 0.0 109.199 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 mm -59.04 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 126.284 1.834 . . . . 0.0 108.38 168.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 p -81.51 144.11 31.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.462 0.705 . . . . 0.0 112.446 -162.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.18 118.48 33.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.722 0.772 . . . . 0.0 111.205 -149.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -79.37 -173.05 3.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.711 1.205 . . . . 0.0 108.633 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -58.49 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.443 1.897 . . . . 0.0 112.147 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.56 71.68 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 128.072 2.749 . . . . 0.0 113.468 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -122.07 121.58 37.3 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 1.389 . . . . 0.0 113.641 -155.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.77 68.85 2.43 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 126.738 2.015 . . . . 0.0 109.147 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -48.09 150.22 1.24 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.551 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.69 -40.64 2.91 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.502 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -29.13 -56.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 114.3 -169.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 123.799 0.84 . . . . 0.0 110.783 169.169 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.252 35.3 Cg_exo -61.67 77.23 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 124.803 3.669 . . . . 0.0 113.663 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' C ' ' H ' ' A' ' 5' ' ' VAL . 19.0 m-85 -50.18 118.95 9.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.809 1.243 . . . . 0.0 109.905 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.49 24.43 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.856 1.704 . . . . 0.0 110.564 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 27' ' ' CYS 0.286 6.1 t -94.12 114.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 101.314 -3.587 . . . . 0.0 101.314 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -123.39 178.75 5.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 124.759 1.224 . . . . 0.0 108.68 -160.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p 179.67 145.08 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.336 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -39.73 53.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.515 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -166.71 -175.54 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.635 1.574 . . . . 0.0 107.083 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -45.2 -46.84 12.5 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 128.483 2.713 . . . . 0.0 113.865 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.695 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -44.24 -44.6 8.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.986 176.066 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -4.73 30.62 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.291 -0.88 . . . . 0.0 111.621 -168.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.79 6.26 3.17 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.9 p -34.76 -45.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 161.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.572 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -55.74 -25.86 42.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.916 1.686 . . . . 0.0 111.731 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 59.8 m -75.45 -6.84 52.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.167 0.987 . . . . 0.0 112.627 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.65 -95.86 0.11 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 tp -105.7 -99.17 0.33 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -47.11 6.03 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mm 47.53 63.79 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.036 1.334 . . . . 0.0 108.853 -168.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -67.18 136.49 55.12 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.464 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.51 164.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -148.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -117.04 171.82 7.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.15 71.95 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 126.465 1.906 . . . . 0.0 113.141 -166.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.56 -23.68 19.44 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.82 2.628 . . . . 0.0 112.447 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.8 140.22 49.99 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.758 1.223 . . . . 0.0 108.549 -160.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' HG12 ' A' ' 5' ' ' VAL . 2.5 t -108.69 149.05 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.4 111.77 7.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.906 0.483 . . . . 0.0 110.78 -155.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.54 55.26 6.16 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 2.0 m -67.79 66.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.326 1.45 . . . . 0.0 110.548 176.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 CA--C 1.532 0.268 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.772 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.77 65.69 1.8 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 124.873 3.715 . . . . 0.0 113.296 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.02 115.83 9.94 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 124.345 1.058 . . . . 0.0 109.514 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.56 60.58 7.87 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.149 1.899 . . . . 0.0 109.37 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.37 106.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.509 1.147 . . . . 0.0 109.714 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -127.08 175.87 7.79 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.278 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.67 166.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.355 1.862 . . . . 0.0 111.103 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -43.46 9.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.184 1.393 . . . . 0.0 108.446 160.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -158.05 -170.95 3.32 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -41.56 67.55 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.996 2.118 . . . . 0.0 112.509 -171.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.68 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.48 -42.33 32.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.739 176.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -7.25 47.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.749 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -137.41 12.73 3.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.138 1.375 . . . . 0.0 114.08 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.2 p -35.09 -45.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 159.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.527 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.6 ptp -54.79 -25.65 29.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.613 1.565 . . . . 0.0 112.273 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 m -67.5 -22.49 65.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 111.862 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.74 -95.16 0.11 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.659 1.118 . . . . 0.0 111.686 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -89.88 -140.26 0.14 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 170.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.584 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -56.91 -41.27 91.62 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.99 0.805 . . . . 0.0 111.306 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . 0.274 9.8 mm 50.19 64.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 123.008 1.385 . . . . 0.0 109.386 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.63 118.58 2.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.155 2.182 . . . . 0.0 111.378 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 127.54 43.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.64 0.776 . . . . 0.0 110.826 -160.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.17 -167.54 0.52 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.001 0.92 . . . . 0.0 109.653 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -39.14 70.03 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 130.811 3.644 . . . . 0.0 114.028 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.34 31.93 13.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.75 2.119 . . . . 0.0 113.445 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 120.19 24.12 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.317 1.047 . . . . 0.0 111.954 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -90.8 68.32 6.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.503 1.521 . . . . 0.0 110.391 -170.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.83 156.45 0.97 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.284 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.86 -30.48 3.87 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.998 -0.89 . . . . 0.0 113.377 164.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.4 t -34.83 -55.21 0.57 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.518 1.527 . . . . 0.0 113.855 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.237 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.31 168.22 4.02 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.562 2.842 . . . . 0.0 111.532 162.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -47.64 115.73 3.99 Favored Pre-proline 0 N--CA 1.438 -1.059 0 C-N-CA 124.385 1.074 . . . . 0.0 110.288 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 40.53 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.581 2.188 . . . . 0.0 109.373 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.446 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.251 2.9 t -96.66 105.25 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 -166.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -121.77 163.8 18.5 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.495 -156.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.79 126.26 16.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.233 -169.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.67 -33.54 75.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 161.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -168.82 -177.88 3.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.577 2.351 . . . . 0.0 104.971 164.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.69 -49.41 65.39 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.525 -169.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -54.89 -22.09 13.62 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 176.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.05 -20.68 66.6 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.476 -1.39 . . . . 0.0 110.943 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.99 9.35 11.85 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 11' ' ' ARG . 15.0 p -44.02 -35.1 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 162.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.466 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.5 ptt? -53.72 -29.8 41.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.492 1.117 . . . . 0.0 111.493 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.96 -29.67 66.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.192 0.997 . . . . 0.0 111.472 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.79 168.49 24.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.8 tp -8.79 -84.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.083 2.953 . . . . 0.0 114.287 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.42 -64.95 1.01 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.5 mm 40.25 61.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 110.839 -163.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.42 142.8 42.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.502 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -104.12 140.55 37.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -164.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -85.92 -159.4 0.46 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 0.0 109.165 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -60.62 77.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.817 1.647 . . . . 0.0 112.477 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.32 8.35 62.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.044 2.735 . . . . 0.0 113.165 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -137.15 120.89 17.39 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.449 1.1 . . . . 0.0 108.837 -162.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 5' ' ' VAL 0.284 31.2 p -98.66 68.42 1.8 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.837 1.653 . . . . 0.0 110.669 -165.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -60.41 76.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.25 0 C-N-CA 127.968 2.507 . . . . 0.0 110.74 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.21 -41.35 0.07 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -44.11 -46.56 8.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.09 1.356 . . . . 0.0 112.634 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.451 -0.421 0 C-N-CA 125.308 1.443 . . . . 0.0 107.769 171.958 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.252 82.7 Cg_exo -41.01 -41.04 4.05 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.187 3.258 . . . . 0.0 113.119 165.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -95.17 104.01 13.82 Favored Pre-proline 0 N--CA 1.428 -1.54 0 C-N-CA 125.619 1.568 . . . . 0.0 108.132 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.06 61.65 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 108.241 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.26 5.3 t -124.25 111.46 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -163.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -130.72 172.37 12.05 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-O 122.038 0.923 . . . . 0.0 111.746 -153.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -175.18 152.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.2 -171.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.83 -48.17 15.25 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 159.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -142.87 170.93 14.78 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.084 1.754 . . . . 0.0 110.135 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -46.53 -45.26 18.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 126.89 2.076 . . . . 0.0 113.911 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.654 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -45.56 -38.45 6.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.245 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -6.23 48.91 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.564 1.146 . . . . 0.0 108.425 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 61.1 m -140.38 13.25 2.37 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.2 p -42.4 -39.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 164.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.497 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -55.68 -25.7 41.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.896 1.678 . . . . 0.0 112.019 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.07 -24.82 64.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.759 0.824 . . . . 0.0 111.397 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.87 -73.95 0.17 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -113.81 -144.88 0.39 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.889 1.676 . . . . 0.0 108.134 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.691 ' H ' HD23 ' A' ' 18' ' ' LEU . . . -80.91 53.87 4.64 Favored Glycine 0 C--N 1.318 -0.43 0 C-N-CA 128.241 2.829 . . . . 0.0 108.383 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mm -59.74 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 109.284 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -68.52 141.2 55.62 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.548 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.3 m -95.47 117.31 30.15 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.583 1.553 . . . . 0.0 110.795 -160.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 11.8 mptt -80.02 -171.68 3.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -49.25 71.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.386 2.675 . . . . 0.0 114.87 -171.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.77 12.87 83.74 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.717 3.056 . . . . 0.0 114.302 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -144.54 129.66 18.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.024 1.412 . . . . 0.0 111.34 -160.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 5' ' ' VAL . 28.7 p -103.57 59.35 0.75 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.429 1.468 . . . . 0.0 112.277 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -55.35 117.07 3.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.438 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.6 1.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.7 t -49.08 -44.59 42.16 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 122.487 1.137 . . . . 0.0 109.61 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.444 -0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 106.346 161.455 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -51.01 151.47 11.67 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.676 2.25 . . . . 0.0 110.473 152.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 19.17 74.31 0.21 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 127.296 2.238 . . . . 0.0 114.349 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.76 66.78 6.64 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.398 2.065 . . . . 0.0 108.707 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 116.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-O 122.726 1.25 . . . . 0.0 108.361 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.09 -176.14 2.97 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 112.83 -1.986 . . . . 0.0 108.761 -167.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.86 142.31 0.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.75 1.62 . . . . 0.0 112.574 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -49.99 75.71 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 160.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -164.88 -164.5 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.62 -48.57 19.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 129.696 3.198 . . . . 0.0 114.836 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.725 ' O ' HG12 ' A' ' 14' ' ' VAL . 33.8 ptt180 -44.98 -40.66 6.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.592 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -69.81 -9.24 53.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.316 -0.865 . . . . 0.0 111.507 -172.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.17 4.34 4.06 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 11' ' ' ARG . 11.5 p -36.51 -45.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 163.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.557 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -58.27 -22.67 53.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.606 1.962 . . . . 0.0 112.215 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.0 m -73.71 -10.16 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.04 0.936 . . . . 0.0 111.946 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.31 -91.5 0.08 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 165.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.9 tp -101.04 -84.85 0.43 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.097 0.959 . . . . 0.0 109.036 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -138.7 60.91 0.58 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -54.95 101.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 109.389 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -78.54 162.94 25.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.601 0.76 . . . . 0.0 111.392 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.11 121.9 27.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.87 0.868 . . . . 0.0 110.314 -158.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -70.02 -169.37 0.27 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 164.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -40.77 70.35 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 130.148 3.379 . . . . 0.0 114.4 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 57.05 26.0 54.84 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 127.628 2.537 . . . . 0.0 113.724 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -128.57 131.23 48.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.079 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.12 110.06 21.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.075 1.75 . . . . 0.0 108.042 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -76.31 73.79 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.996 0.519 . . . . 0.0 112.289 -161.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.82 57.02 5.56 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.269 0.462 . . . . 0.0 112.076 166.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.3 m -2.54 -75.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 129.493 3.117 . . . . 0.0 114.255 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.849 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.539 0.549 0 CA-C-O 119.402 -0.332 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.32 100.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 125.055 3.837 . . . . 0.0 112.329 170.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -62.25 135.09 94.94 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.55 -162.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.06 65.83 3.37 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.157 3.238 . . . . 0.0 109.033 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.266 1.3 t -132.03 125.33 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 -171.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.39 175.56 5.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 124.949 1.299 . . . . 0.0 109.61 -167.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 p -175.27 143.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.478 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -28.13 25.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.587 1.155 . . . . 0.0 109.626 168.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -170.5 176.74 4.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.96 -43.63 70.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 126.381 1.873 . . . . 0.0 111.758 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.668 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.1 -36.47 18.8 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.142 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.51 -9.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.855 -1.153 . . . . 0.0 112.564 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 m -136.13 12.89 3.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 11' ' ' ARG . 8.8 p -35.59 -44.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 158.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.556 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -56.59 -25.36 52.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.117 1.767 . . . . 0.0 112.001 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -67.22 -19.9 65.61 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.517 0.727 . . . . 0.0 111.072 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.91 -80.01 0.15 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 168.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -112.11 -139.79 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.88 1.672 . . . . 0.0 108.359 -175.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.658 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.81 51.45 4.04 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 128.382 2.896 . . . . 0.0 108.951 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 mm -57.87 82.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 108.819 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.9 p -72.37 142.15 48.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -164.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -89.03 113.42 24.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.418 1.087 . . . . 0.0 109.971 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.86 -177.93 6.6 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -4.59 -70.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.374 2.27 . . . . 0.0 115.872 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.24 1.2 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 161.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.36 118.45 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.772 2.029 . . . . 0.0 109.09 -157.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -96.89 62.6 1.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 124.807 2.242 . . . . 0.0 110.32 -160.215 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -69.35 112.24 5.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.117 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.27 -47.56 0.58 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.4 t -31.4 -64.24 0.15 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.537 1.935 . . . . 0.0 114.965 -167.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.412 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -75.25 54.48 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.157 1 C-N-CA 125.395 4.063 . . . . 0.0 114.605 -166.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -63.6 118.91 49.21 Favored Pre-proline 0 N--CA 1.434 -1.266 0 O-C-N 121.124 -0.985 . . . . 0.0 109.736 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.5 63.94 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.677 2.251 . . . . 0.0 109.211 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.9 99.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 122.912 1.339 . . . . 0.0 111.704 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -124.38 173.07 8.65 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.138 -159.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 p -163.78 133.92 4.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.181 -159.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -73.1 -30.75 63.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.231 1.012 . . . . 0.0 110.125 160.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -170.16 176.22 4.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.907 1.683 . . . . 0.0 106.817 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.0 -38.46 79.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 110.227 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.673 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -52.36 -36.21 53.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.296 173.015 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.07 -15.45 63.08 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.372 -1.455 . . . . 0.0 111.558 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.1 m -125.26 6.55 7.78 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 124.449 1.099 . . . . 0.0 113.298 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.6 p -41.29 -39.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 164.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.517 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.1 ptm -56.0 -26.4 48.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.84 1.656 . . . . 0.0 111.963 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 45.2 m -68.56 -27.73 66.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.102 0.961 . . . . 0.0 111.483 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.74 -89.67 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -129.49 -101.48 0.32 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.761 1.224 . . . . 0.0 110.097 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.58 50.83 0.83 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.79 85.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.75 122.49 18.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -154.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.1 t -74.56 107.67 6.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.75 0.42 . . . . 0.0 111.615 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 25' ' ' GLY . 6.8 mtmp? -83.35 -167.66 1.78 Allowed 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 166.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -34.31 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 129.78 3.232 . . . . 0.0 114.701 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 58.92 13.69 20.26 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 127.295 2.379 . . . . 0.0 114.557 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.71 113.89 8.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.076 1.438 . . . . 0.0 111.619 -167.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 p -98.11 136.8 37.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.227 -0.921 . . . . 0.0 113.141 -166.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -90.83 132.07 36.1 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.619 0.767 . . . . 0.0 112.481 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.57 41.07 11.63 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 123.39 0.519 . . . . 0.0 113.286 160.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 41.8 t -65.42 77.36 0.06 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.684 1.594 . . . . 0.0 112.865 -174.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 109.011 170.586 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.273 39.8 Cg_exo -66.7 35.39 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 1 C-N-CA 125.799 4.332 . . . . 0.0 116.976 -176.347 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -98.11 153.75 37.99 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.07 52.12 3.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.59 2.193 . . . . 0.0 110.817 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 102.26 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.697 1.237 . . . . 0.0 110.69 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -124.67 175.61 7.1 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.596 -160.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -178.97 157.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.32 1.848 . . . . 0.0 110.663 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -76.16 -61.89 1.79 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -140.81 -178.16 5.41 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.105 1.762 . . . . 0.0 109.283 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -51.4 -48.23 62.68 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.285 1.834 . . . . 0.0 113.354 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -50.81 -33.42 23.48 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.485 176.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.72 -10.55 57.11 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 121.079 -1.013 . . . . 0.0 110.981 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.1 m -136.67 13.23 3.18 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.4 p -31.82 -48.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 157.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.583 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.5 ptp -58.97 -21.85 59.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.207 2.203 . . . . 0.0 112.665 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -66.67 -25.3 66.5 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.302 0.641 . . . . 0.0 110.429 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.74 -78.85 0.05 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.61 -91.36 0.16 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 109.199 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.18 49.08 0.88 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -65.51 78.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.1 p -68.85 153.17 44.27 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -116.28 114.04 23.82 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.527 0.68 . . . . 0.0 109.297 -163.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -160.22 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -47.98 75.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.755 2.422 . . . . 0.0 114.183 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.15 33.56 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 127.8 2.619 . . . . 0.0 113.247 -169.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.23 121.35 26.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.127 0.971 . . . . 0.0 112.438 -166.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.17 63.27 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.163 2.185 . . . . 0.0 109.197 -172.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -56.77 119.92 6.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.158 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.52 6.6 67.96 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.135 -1.369 . . . . 0.0 114.678 165.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 t -10.76 -76.26 0.0 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 127.997 2.519 . . . . 0.0 115.242 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.636 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.244 0.545 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.78 87.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 1 C-N-CA 125.341 4.028 . . . . 0.0 112.726 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -39.54 111.29 0.68 Allowed Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.802 2.041 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.1 57.57 5.28 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.906 2.404 . . . . 0.0 108.208 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.294 3.0 t -117.77 107.67 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -143.73 170.83 15.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.349 1.071 . . . . 0.0 110.103 -144.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.85 144.56 4.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.823 -157.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -88.12 -39.36 14.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.412 1.485 . . . . 0.0 108.534 159.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.93 -179.05 7.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -44.64 -42.03 7.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.631 3.172 . . . . 0.0 113.43 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.68 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.56 -41.44 41.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.663 177.301 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -7.32 49.25 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.062 -169.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.7 m -134.27 10.64 3.82 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 113.264 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.4 p -39.58 -41.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.534 1.159 . . . . 0.0 113.655 161.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.512 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -55.93 -24.43 37.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.778 1.631 . . . . 0.0 111.834 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.9 m -66.18 -22.61 66.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.527 0.731 . . . . 0.0 111.88 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.51 -87.4 0.1 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.028 0.831 . . . . 0.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.729 HD23 ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -96.97 -146.03 0.3 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.291 1.436 . . . . 0.0 107.159 178.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.729 ' H ' HD23 ' A' ' 18' ' ' LEU . . . -81.38 49.57 4.04 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 127.167 2.317 . . . . 0.0 108.829 172.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mm -46.85 127.52 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.13 1.372 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -68.69 125.76 27.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.87 1.268 . . . . 0.0 112.186 -172.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -87.08 113.67 23.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 165.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -90.1 -170.96 2.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.112 1.365 . . . . 0.0 108.105 167.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -44.57 74.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.559 2.744 . . . . 0.0 114.314 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.91 -5.39 32.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 127.903 2.668 . . . . 0.0 114.166 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -133.11 132.93 42.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.093 1.757 . . . . 0.0 107.785 -162.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 p -114.66 82.29 1.7 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.996 1.725 . . . . 0.0 113.427 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -49.22 142.13 7.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.406 166.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.1 5.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 m -58.87 -40.06 83.21 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--O 1.238 0.455 0 C-N-CA 126.032 1.733 . . . . 0.0 107.223 165.436 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.256 29.9 Cg_exo -69.32 38.49 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 125.141 3.894 . . . . 0.0 116.667 -170.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.1 117.39 56.0 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.623 1.169 . . . . 0.0 108.589 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.23 61.97 8.34 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.17 1.913 . . . . 0.0 109.608 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.37 104.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.561 1.172 . . . . 0.0 110.858 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -132.3 175.32 9.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.866 -158.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -172.61 146.31 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.019 -1.9 . . . . 0.0 110.767 -161.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -55.96 4.82 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 158.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.7 p -136.48 176.1 9.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.507 1.923 . . . . 0.0 108.036 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.8 -44.66 39.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 112.405 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.666 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.11 -38.85 18.72 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.214 174.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.25 -10.93 58.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.016 -1.052 . . . . 0.0 112.527 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -129.53 7.09 5.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.2 p -40.17 -41.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 163.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.513 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.7 ptm -57.75 -24.72 58.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.311 1.845 . . . . 0.0 112.347 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.82 -26.87 65.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.959 0.904 . . . . 0.0 110.516 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.2 -82.16 0.06 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 tp -142.97 -97.02 0.12 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.695 1.198 . . . . 0.0 109.501 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.43 40.92 2.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.319 1.438 . . . . 0.0 110.24 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.11 76.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.423 1.089 . . . . 0.0 108.595 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 t -71.8 152.82 42.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.668 1.187 . . . . 0.0 111.855 -166.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.6 t -114.78 136.68 52.81 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.379 1.472 . . . . 0.0 111.58 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.06 129.69 30.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 39.38 53.22 2.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.548 1.539 . . . . 0.0 113.373 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 -19.19 52.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 124.557 1.075 . . . . 0.0 113.644 171.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -115.69 131.54 56.9 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.026 1.331 . . . . 0.0 111.696 -169.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.51 131.81 55.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.151 1.38 . . . . 0.0 111.927 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -100.19 115.92 30.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.481 -153.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.25 53.61 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.584 -0.564 . . . . 0.0 114.382 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t -41.54 -53.17 3.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.581 1.552 . . . . 0.0 114.04 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.587 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 120.994 0.426 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.0 101.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 125.033 3.822 . . . . 0.0 112.666 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -52.01 119.74 14.96 Favored Pre-proline 0 N--CA 1.437 -1.091 0 C-N-CA 124.706 1.203 . . . . 0.0 109.038 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.41 61.88 6.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.436 2.091 . . . . 0.0 108.447 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.256 3.8 t -125.07 115.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -163.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -130.35 174.58 9.71 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 125.514 1.525 . . . . 0.0 108.432 -164.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -176.45 138.88 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.171 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -27.11 33.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.401 0.281 . . . . 0.0 111.272 161.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.42 168.44 26.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.263 1.825 . . . . 0.0 106.943 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -54.98 -39.06 68.59 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 126.352 1.861 . . . . 0.0 110.93 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.702 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -45.36 -41.61 9.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.627 168.078 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.04 -2.55 24.77 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 121.068 -1.02 . . . . 0.0 111.085 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -137.11 7.43 2.9 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 125.492 1.517 . . . . 0.0 113.97 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.9 p -38.17 -41.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 162.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.512 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.2 ptt? -54.18 -27.3 33.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.646 1.578 . . . . 0.0 111.826 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.61 -26.47 67.85 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.271 1.029 . . . . 0.0 111.797 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.58 -90.22 0.1 Allowed Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -91.94 -139.6 0.18 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -58.76 -51.68 57.58 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.598 1.094 . . . . 0.0 111.009 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.8 mm 49.79 71.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.316 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.84 146.96 4.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.786 2.035 . . . . 0.0 114.001 -172.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -111.59 118.2 35.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.715 1.206 . . . . 0.0 110.661 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -89.39 -175.45 4.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -40.44 79.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.932 2.493 . . . . 0.0 114.133 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.34 76.01 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.614 2.53 . . . . 0.0 114.551 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.9 129.93 40.95 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.868 1.334 . . . . 0.0 110.576 -163.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 145.99 33.37 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.102 0.864 . . . . 0.0 111.044 -163.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -131.97 126.69 34.63 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.152 -0.343 . . . . 0.0 110.194 -154.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 -29.1 10.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.313 0.958 . . . . 0.0 111.889 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.5 t -41.68 -56.89 2.48 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.243 1.417 . . . . 0.0 113.312 -169.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.094 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -54.29 161.95 4.85 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 125.079 3.852 . . . . 0.0 113.142 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -49.83 117.58 7.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 124.708 1.203 . . . . 0.0 109.43 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.58 64.82 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.583 2.188 . . . . 0.0 108.359 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.265 5.4 t -124.42 114.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -162.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -143.13 169.25 17.96 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.004 -155.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.8 p -154.52 156.38 36.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.543 -1.662 . . . . 0.0 109.206 -167.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -53.66 5.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 155.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -140.35 168.96 18.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.592 1.957 . . . . 0.0 107.269 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -42.1 -48.21 4.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 127.195 2.198 . . . . 0.0 114.964 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.697 ' O ' HG12 ' A' ' 14' ' ' VAL 0.252 0.0 OUTLIER -60.11 -24.73 64.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.655 -176.887 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.37 -23.77 67.55 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.954 -1.091 . . . . 0.0 111.313 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.07 11.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.532 1.133 . . . . 0.0 113.19 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.3 p -42.48 -39.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.719 1.247 . . . . 0.0 113.413 163.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.508 ' N ' HG13 ' A' ' 14' ' ' VAL . 23.0 ptp -54.25 -25.16 21.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.066 1.346 . . . . 0.0 111.718 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.2 -29.46 68.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.961 0.904 . . . . 0.0 112.377 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.42 -91.73 0.09 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.554 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -95.61 -138.73 0.24 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.554 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -54.36 -48.33 64.91 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.28 0.943 . . . . 0.0 111.565 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 mm 41.44 66.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.361 1.464 . . . . 0.0 109.634 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.52 100.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.547 1.139 . . . . 0.0 111.008 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.4 142.22 58.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.017 -168.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -158.97 0.59 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.74 1.216 . . . . 0.0 108.254 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -53.35 73.88 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 128.001 2.52 . . . . 0.0 113.767 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.99 66.57 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.342 2.401 . . . . 0.0 112.949 -175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.65 119.3 13.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.859 -162.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.291 27.4 p -107.46 66.24 0.66 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 121.236 1.835 . . . . 0.0 111.314 -164.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -16.32 111.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.914 2.885 . . . . 0.0 115.592 165.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.87 28.66 73.42 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.321 159.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 m -22.7 -58.64 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 127.9 2.48 . . . . 0.0 113.98 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 122.541 0.336 . . . . 0.0 110.934 169.336 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.34 0.2 OUTLIER -27.98 -66.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.905 1 C-N-CA 127.644 5.562 . . . . 0.0 118.134 -167.81 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -63.31 116.45 25.46 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.531 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.32 48.86 2.84 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.667 1.631 . . . . 0.0 109.012 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -110.87 107.2 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -160.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -132.73 170.08 15.77 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.843 -154.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -160.2 147.7 16.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.739 -164.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -33.97 57.73 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.775 -0.578 . . . . 0.0 110.009 155.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 t -170.7 -168.57 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 126.586 1.954 . . . . 0.0 106.122 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.84 -46.44 87.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 127.856 2.463 . . . . 0.0 113.221 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.712 ' O ' HG12 ' A' ' 14' ' ' VAL . 23.0 ptt180 -39.68 -41.28 1.05 Allowed 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.332 167.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' N ' ' CG ' ' A' ' 11' ' ' ARG . 0.4 OUTLIER -79.68 -0.26 33.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -159.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -139.94 8.38 2.31 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 11' ' ' ARG . 13.6 p -36.89 -44.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 161.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.552 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptt? -58.35 -22.34 53.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 126.727 2.011 . . . . 0.0 111.812 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -60.45 -28.77 68.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.801 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.42 -89.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -102.61 -90.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.898 0.879 . . . . 0.0 109.872 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.69 57.64 0.7 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.36 92.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.777 0.831 . . . . 0.0 109.469 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -60.81 150.38 32.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.212 1.005 . . . . 0.0 110.894 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 38.2 t -119.53 136.95 54.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.875 0.87 . . . . 0.0 112.528 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -85.37 -154.15 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.112 0.965 . . . . 0.0 110.473 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.53 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.835 2.054 . . . . 0.0 112.87 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.03 16.35 66.35 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 127.427 2.441 . . . . 0.0 112.961 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -141.94 124.4 15.75 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.257 1.029 . . . . 0.0 111.789 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.6 p -118.57 86.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.622 1.556 . . . . 0.0 112.669 -160.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -48.83 155.73 0.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.25 1.42 . . . . 0.0 112.925 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.59 69.12 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.245 -0.753 . . . . 0.0 114.914 159.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 56.7 m -52.38 -38.83 59.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.317 1.058 . . . . 0.0 111.118 173.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.763 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.267 85.9 Cg_exo -44.56 -50.91 7.69 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 124.811 3.674 . . . . 0.0 114.479 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -85.43 110.62 30.73 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 125.478 1.511 . . . . 0.0 108.312 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.07 64.38 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.365 2.043 . . . . 0.0 108.133 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.271 6.6 t -124.47 109.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 -165.28 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -135.46 166.14 23.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.623 -150.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 p -166.57 155.84 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.966 -162.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 -50.43 4.17 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.813 1.645 . . . . 0.0 107.447 161.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -132.59 170.67 14.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.698 1.999 . . . . 0.0 107.673 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -57.61 -40.03 78.2 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.569 1.548 . . . . 0.0 111.425 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.685 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -60.3 -22.45 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.624 177.819 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.11 -23.26 67.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.742 1.155 . . . . 0.0 109.797 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -120.23 13.82 12.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.824 1.65 . . . . 0.0 113.372 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.5 p -36.36 -43.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 159.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.537 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.0 ptp -54.39 -26.28 29.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.479 1.511 . . . . 0.0 111.656 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.96 -32.45 72.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.168 0.587 . . . . 0.0 111.31 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.47 -80.83 0.08 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.681 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -104.9 -142.53 0.37 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.768 1.627 . . . . 0.0 108.412 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.681 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -81.6 52.79 4.62 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 128.11 2.767 . . . . 0.0 108.276 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.4 mm -58.68 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.092 1.357 . . . . 0.0 110.624 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 t -36.52 136.54 0.34 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.388 2.275 . . . . 0.0 113.389 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.6 t -102.25 122.5 44.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.425 1.49 . . . . 0.0 109.847 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -96.65 -172.13 2.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.943 1.297 . . . . 0.0 108.2 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.37 77.47 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.73 2.412 . . . . 0.0 113.156 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.26 -2.28 66.81 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 127.998 2.713 . . . . 0.0 114.26 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -133.12 135.07 45.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.651 1.58 . . . . 0.0 107.771 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 5' ' ' VAL . 30.2 p -111.82 138.47 48.37 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 121.113 1.778 . . . . 0.0 111.709 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -102.85 125.36 49.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.235 -156.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.67 56.15 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.645 168.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.1 m -45.01 -44.87 10.32 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.178 0.991 . . . . 0.0 111.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 123.026 0.53 . . . . 0.0 109.585 164.045 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -59.95 172.89 2.02 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 124.308 3.339 . . . . 0.0 113.253 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -56.22 126.74 68.89 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.71 168.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.07 55.88 4.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.654 2.236 . . . . 0.0 108.566 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.255 2.1 t -119.82 114.93 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 -175.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -119.75 164.17 16.35 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 -144.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.81 156.81 33.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.636 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.28 -28.87 20.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 152.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -170.7 -178.33 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.358 1.863 . . . . 0.0 107.391 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.26 -49.29 34.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.753 2.021 . . . . 0.0 113.931 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.687 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -46.93 -38.58 10.78 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.06 174.529 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.28 -6.61 44.29 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 121.43 -0.794 . . . . 0.0 110.578 -170.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.0 m -131.25 6.44 4.52 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.696 1.198 . . . . 0.0 114.113 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 11' ' ' ARG . 13.2 p -41.2 -38.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 122.394 1.093 . . . . 0.0 113.838 163.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.473 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.2 ptp -54.18 -27.12 31.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.435 1.494 . . . . 0.0 111.812 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -62.14 -27.6 69.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.217 0.607 . . . . 0.0 112.075 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.38 -86.85 0.1 OUTLIER Glycine 0 C--N 1.338 0.682 0 CA-C-N 119.21 0.913 . . . . 0.0 111.549 174.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -92.88 -138.88 0.19 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.57 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -59.83 -52.16 54.61 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.432 1.015 . . . . 0.0 110.998 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.9 mm 46.79 69.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.633 1.573 . . . . 0.0 110.546 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 153.69 17.0 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.072 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -120.84 136.79 54.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -95.0 -173.29 2.92 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.145 1.378 . . . . 0.0 108.16 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.57 69.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.605 2.362 . . . . 0.0 113.464 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.6 -35.81 2.7 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.864 3.126 . . . . 0.0 113.31 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -141.59 133.5 27.43 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -141.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.1 p -109.24 128.46 55.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.968 1.258 . . . . 0.0 113.456 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.43 86.35 2.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.988 -148.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.31 -25.91 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 32.3 t -40.53 -49.16 2.92 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.893 1.677 . . . . 0.0 113.413 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 124.574 1.15 . . . . 0.0 108.318 169.016 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 N--CA 1.457 -0.671 0 N-CA-C 110.272 -0.703 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.54 111.61 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.311 1.053 . . . . 0.0 109.281 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -130.11 175.08 9.19 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.027 -163.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p 174.46 144.09 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.763 1.625 . . . . 0.0 112.721 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -70.87 -39.81 72.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.358 162.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -166.5 -170.66 1.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.409 1.084 . . . . 0.0 109.073 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -55.86 -47.54 77.14 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.496 1.518 . . . . 0.0 111.824 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.696 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -47.91 -40.96 23.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 122.179 -0.325 . . . . 0.0 110.828 172.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.69 -0.91 16.95 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 120.951 -1.093 . . . . 0.0 111.588 -168.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.99 9.39 2.13 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.1 p -31.72 -47.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 159.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.575 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.1 ptt? -55.32 -26.56 41.38 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.216 1.806 . . . . 0.0 112.015 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -70.17 -17.85 63.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 112.416 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.32 -91.66 0.09 OUTLIER Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.377 0.989 . . . . 0.0 111.466 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 tp -99.53 -100.48 0.23 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.91 -42.86 4.29 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 mm 52.87 65.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 123.117 1.437 . . . . 0.0 109.261 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -60.22 145.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.742 1.617 . . . . 0.0 112.012 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.03 132.57 38.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.862 -141.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -74.65 166.51 23.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -66.12 69.38 0.06 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.11 1.764 . . . . 0.0 111.278 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.55 -34.08 2.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 126.946 2.212 . . . . 0.0 112.455 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.45 118.8 26.61 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.073 0.937 . . . . 0.0 113.067 -153.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.04 58.95 5.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.67 1.588 . . . . 0.0 109.418 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 67.04 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.225 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.66 -52.7 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 128.358 2.663 . . . . 0.0 115.091 -172.048 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 N--CA 1.448 -1.148 0 N-CA-C 109.162 -1.13 . . . . 0.0 109.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.5 93.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 121.937 0.875 . . . . 0.0 109.308 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.12 160.43 17.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.949 -150.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 32.1 p -147.42 122.67 10.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.132 -1.849 . . . . 0.0 114.955 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -69.58 -31.81 70.19 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.932 150.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -171.14 -178.92 2.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.471 1.508 . . . . 0.0 107.784 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.97 -47.23 81.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.634 1.574 . . . . 0.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.655 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.63 -33.76 16.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.506 173.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.98 -6.75 35.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 119.847 1.203 . . . . 0.0 112.112 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 7' ' ' CYS 0.296 21.1 m -133.68 5.09 3.66 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.157 0.983 . . . . 0.0 113.412 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.0 p -39.08 -40.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 122.226 1.013 . . . . 0.0 113.53 163.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.494 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -56.28 -24.95 46.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.953 1.701 . . . . 0.0 112.135 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.1 m -65.05 -23.91 67.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.345 0.658 . . . . 0.0 111.864 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.13 -84.91 0.08 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -116.87 -99.67 0.44 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.6 1.16 . . . . 0.0 109.016 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.47 -73.43 1.06 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' A' ' 27' ' ' CYS . 18.3 mm 49.47 73.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.095 1.358 . . . . 0.0 109.93 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.9 p -82.45 160.36 22.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.711 1.205 . . . . 0.0 112.85 -167.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.2 t -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.335 2.254 . . . . 0.0 113.55 -166.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -92.89 139.38 30.59 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 156.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -39.79 70.68 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.759 2.823 . . . . 0.0 115.969 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.73 0.46 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.62 1.581 . . . . 0.0 112.466 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -123.42 136.7 54.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.786 1.634 . . . . 0.0 109.327 -166.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.2 m -82.2 166.96 19.16 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.283 0.947 . . . . 0.0 112.055 164.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -121.89 118.38 28.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.33 1.052 . . . . 0.0 109.393 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 0.75 37.2 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.991 -0.894 . . . . 0.0 114.077 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.1 t . . . . . 0 N--CA 1.465 0.3 0 CA-C-N 119.003 1.402 . . . . 0.0 111.557 175.755 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 N-CA-C 108.762 -1.284 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.9 115.26 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.12 162.89 22.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 124.776 1.23 . . . . 0.0 109.966 -148.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 2.6 p -175.85 142.32 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -166.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -79.38 -32.15 43.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.597 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -165.27 -179.85 5.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.328 1.051 . . . . 0.0 108.583 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -56.72 -43.97 81.15 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.178 1.391 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.617 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.04 -36.85 41.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.141 172.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -74.5 -5.59 43.55 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.995 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -127.27 1.83 6.38 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.501 1.12 . . . . 0.0 114.013 174.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 11' ' ' ARG . 14.5 p -41.47 -34.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.474 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.9 ptp -52.33 -31.53 33.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 111.47 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 66.6 m -65.04 -25.87 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 112.716 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.25 -92.47 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 118.937 0.789 . . . . 0.0 111.319 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 tp -133.01 -106.03 0.25 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.744 1.218 . . . . 0.0 109.167 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.8 45.52 2.89 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.2 mm -65.92 97.75 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -88.18 127.87 35.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.835 0.854 . . . . 0.0 111.796 -164.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.99 115.95 20.71 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.882 0.873 . . . . 0.0 112.272 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -88.36 88.48 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 39.83 38.13 0.42 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.017 2.527 . . . . 0.0 114.72 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.02 -49.56 0.44 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.334 -0.703 . . . . 0.0 111.387 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -127.31 147.92 50.24 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.31 -161.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.257 1.0 OUTLIER -105.56 160.35 15.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 111.152 170.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -131.63 141.39 49.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.323 1.449 . . . . 0.0 108.164 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.95 40.57 93.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.41 0.55 . . . . 0.0 112.195 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 26.8 t . . . . . 0 N--CA 1.439 -0.98 0 C-N-CA 127.008 2.123 . . . . 0.0 110.889 -175.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.557 -0.594 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.22 110.77 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.139 0.971 . . . . 0.0 108.948 173.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -130.03 176.2 8.27 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.962 -161.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.9 p -171.57 152.59 3.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.195 -1.821 . . . . 0.0 109.624 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -24.47 17.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.94 160.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -168.27 -177.43 3.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 106.966 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -43.81 98.31 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.38 1.072 . . . . 0.0 110.821 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.688 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.04 -35.11 14.83 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.971 170.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.69 -3.55 28.92 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.562 -1.336 . . . . 0.0 111.992 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 m -135.42 8.36 3.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 124.429 1.092 . . . . 0.0 113.802 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 11' ' ' ARG . 11.9 p -37.6 -42.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 161.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.2 ptm -56.16 -26.07 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.574 1.55 . . . . 0.0 111.957 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 64.7 m -69.81 -18.79 63.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.233 1.013 . . . . 0.0 111.489 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.53 -88.08 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.154 0.888 . . . . 0.0 111.473 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.662 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -105.6 -140.07 0.37 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.638 1.575 . . . . 0.0 108.017 -177.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.662 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -80.24 49.84 3.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 128.054 2.74 . . . . 0.0 109.08 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.37 103.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.718 1.607 . . . . 0.0 108.798 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -72.33 141.87 48.82 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.8 0.84 . . . . 0.0 112.201 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.3 t -107.66 110.6 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.177 1.791 . . . . 0.0 111.47 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -76.25 169.8 17.52 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 164.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -1.38 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.389 2.676 . . . . 0.0 115.414 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.42 21.93 2.05 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.682 164.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.27 119.22 27.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.299 1.84 . . . . 0.0 108.392 -170.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 151.19 23.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.105 1.362 . . . . 0.0 110.924 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -127.87 126.33 41.39 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.856 -0.528 . . . . 0.0 111.107 -154.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.34 45.24 31.11 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.317 0.398 . . . . 0.0 112.385 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 42.6 t . . . . . 0 N--CA 1.441 -0.918 0 C-N-CA 125.82 1.648 . . . . 0.0 112.258 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 N--CA 1.452 -0.913 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.7 113.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 C-N-CA 124.318 1.047 . . . . 0.0 109.077 172.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -129.41 -179.92 5.43 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.005 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -178.28 156.96 1.02 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.333 -168.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -40.99 19.4 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.961 1.305 . . . . 0.0 108.904 166.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -165.54 -174.81 3.28 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.88 -46.9 64.68 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 127.037 2.135 . . . . 0.0 112.755 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.669 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.33 -38.03 26.48 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.972 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.18 -12.38 60.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.101 -0.999 . . . . 0.0 111.503 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.03 12.9 3.95 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.3 p -36.62 -44.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 160.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.55 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.7 ptm -59.05 -22.75 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.439 1.895 . . . . 0.0 112.337 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -64.58 -21.47 66.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.629 0.772 . . . . 0.0 110.672 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.35 -68.97 0.2 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.63 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -129.54 -138.71 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.118 1.767 . . . . 0.0 108.383 -173.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.63 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.61 52.8 4.2 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 128.546 2.974 . . . . 0.0 109.199 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 mm -59.04 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 126.284 1.834 . . . . 0.0 108.38 168.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 p -81.51 144.11 31.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.462 0.705 . . . . 0.0 112.446 -162.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.18 118.48 33.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.722 0.772 . . . . 0.0 111.205 -149.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -79.37 -173.05 3.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.711 1.205 . . . . 0.0 108.633 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -58.49 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.443 1.897 . . . . 0.0 112.147 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.56 71.68 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 128.072 2.749 . . . . 0.0 113.468 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -122.07 121.58 37.3 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 1.389 . . . . 0.0 113.641 -155.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.77 68.85 2.43 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 126.738 2.015 . . . . 0.0 109.147 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -48.09 150.22 1.24 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.551 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.69 -40.64 2.91 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.502 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 114.3 -169.285 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 N-CA-C 110.564 -0.591 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 27' ' ' CYS 0.286 6.1 t -94.12 114.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 101.314 -3.587 . . . . 0.0 101.314 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -123.39 178.75 5.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 124.759 1.224 . . . . 0.0 108.68 -160.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p 179.67 145.08 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.336 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -39.73 53.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.515 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -166.71 -175.54 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.635 1.574 . . . . 0.0 107.083 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -45.2 -46.84 12.5 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 128.483 2.713 . . . . 0.0 113.865 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.695 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -44.24 -44.6 8.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.986 176.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -4.73 30.62 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.291 -0.88 . . . . 0.0 111.621 -168.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.79 6.26 3.17 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.9 p -34.76 -45.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 161.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.572 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -55.74 -25.86 42.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.916 1.686 . . . . 0.0 111.731 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 59.8 m -75.45 -6.84 52.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.167 0.987 . . . . 0.0 112.627 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.65 -95.86 0.11 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 tp -105.7 -99.17 0.33 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -47.11 6.03 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mm 47.53 63.79 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.036 1.334 . . . . 0.0 108.853 -168.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -67.18 136.49 55.12 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.464 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.51 164.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -148.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -117.04 171.82 7.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.15 71.95 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 126.465 1.906 . . . . 0.0 113.141 -166.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.56 -23.68 19.44 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.82 2.628 . . . . 0.0 112.447 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.8 140.22 49.99 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.758 1.223 . . . . 0.0 108.549 -160.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' HG12 ' A' ' 5' ' ' VAL . 2.5 t -108.69 149.05 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.4 111.77 7.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.906 0.483 . . . . 0.0 110.78 -155.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.54 55.26 6.16 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 2.0 m . . . . . 0 CA--C 1.538 0.519 0 C-N-CA 125.326 1.45 . . . . 0.0 110.548 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 N--CA 1.453 -0.896 0 N-CA-C 109.37 -1.05 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.37 106.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.509 1.147 . . . . 0.0 109.714 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -127.08 175.87 7.79 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.278 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.67 166.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.355 1.862 . . . . 0.0 111.103 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -43.46 9.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.184 1.393 . . . . 0.0 108.446 160.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -158.05 -170.95 3.32 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -41.56 67.55 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.996 2.118 . . . . 0.0 112.509 -171.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.68 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.48 -42.33 32.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.739 176.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -7.25 47.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.749 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -137.41 12.73 3.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.138 1.375 . . . . 0.0 114.08 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.2 p -35.09 -45.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 159.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.527 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.6 ptp -54.79 -25.65 29.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.613 1.565 . . . . 0.0 112.273 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 m -67.5 -22.49 65.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 111.862 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.74 -95.16 0.11 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.659 1.118 . . . . 0.0 111.686 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.584 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -89.88 -140.26 0.14 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 170.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.584 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -56.91 -41.27 91.62 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.99 0.805 . . . . 0.0 111.306 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . 0.274 9.8 mm 50.19 64.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 123.008 1.385 . . . . 0.0 109.386 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.63 118.58 2.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.155 2.182 . . . . 0.0 111.378 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 127.54 43.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.64 0.776 . . . . 0.0 110.826 -160.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.17 -167.54 0.52 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.001 0.92 . . . . 0.0 109.653 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -39.14 70.03 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 130.811 3.644 . . . . 0.0 114.028 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.34 31.93 13.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.75 2.119 . . . . 0.0 113.445 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 120.19 24.12 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.317 1.047 . . . . 0.0 111.954 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -90.8 68.32 6.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.503 1.521 . . . . 0.0 110.391 -170.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.83 156.45 0.97 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.284 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.86 -30.48 3.87 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.998 -0.89 . . . . 0.0 113.377 164.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.34 0.194 0 C-N-CA 125.518 1.527 . . . . 0.0 113.855 -172.432 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.536 0.621 0 N-CA-C 109.373 -1.049 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.446 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.251 2.9 t -96.66 105.25 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 -166.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -121.77 163.8 18.5 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.495 -156.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.79 126.26 16.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.233 -169.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.67 -33.54 75.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 161.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -168.82 -177.88 3.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.577 2.351 . . . . 0.0 104.971 164.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.69 -49.41 65.39 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.525 -169.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -54.89 -22.09 13.62 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 176.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.05 -20.68 66.6 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.476 -1.39 . . . . 0.0 110.943 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.99 9.35 11.85 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 11' ' ' ARG . 15.0 p -44.02 -35.1 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 162.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.466 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.5 ptt? -53.72 -29.8 41.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.492 1.117 . . . . 0.0 111.493 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.96 -29.67 66.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.192 0.997 . . . . 0.0 111.472 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.79 168.49 24.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.8 tp -8.79 -84.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.083 2.953 . . . . 0.0 114.287 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.42 -64.95 1.01 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.5 mm 40.25 61.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 110.839 -163.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.42 142.8 42.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.502 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -104.12 140.55 37.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -164.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -85.92 -159.4 0.46 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 0.0 109.165 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -60.62 77.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.817 1.647 . . . . 0.0 112.477 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.32 8.35 62.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.044 2.735 . . . . 0.0 113.165 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -137.15 120.89 17.39 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.449 1.1 . . . . 0.0 108.837 -162.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 5' ' ' VAL 0.284 31.2 p -98.66 68.42 1.8 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.837 1.653 . . . . 0.0 110.669 -165.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -60.41 76.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.25 0 C-N-CA 127.968 2.507 . . . . 0.0 110.74 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.21 -41.35 0.07 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t . . . . . 0 N--CA 1.455 -0.195 0 C-N-CA 125.09 1.356 . . . . 0.0 112.634 176.183 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo . . . . . 0 N--CA 1.457 -0.662 0 N-CA-C 108.241 -1.484 . . . . 0.0 108.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.514 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.26 5.3 t -124.25 111.46 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -163.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -130.72 172.37 12.05 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-O 122.038 0.923 . . . . 0.0 111.746 -153.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -175.18 152.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.2 -171.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.83 -48.17 15.25 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 159.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -142.87 170.93 14.78 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.084 1.754 . . . . 0.0 110.135 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -46.53 -45.26 18.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 126.89 2.076 . . . . 0.0 113.911 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.654 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -45.56 -38.45 6.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.245 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -6.23 48.91 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.564 1.146 . . . . 0.0 108.425 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 61.1 m -140.38 13.25 2.37 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.2 p -42.4 -39.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 164.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.497 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -55.68 -25.7 41.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.896 1.678 . . . . 0.0 112.019 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.07 -24.82 64.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.759 0.824 . . . . 0.0 111.397 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.87 -73.95 0.17 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -113.81 -144.88 0.39 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.889 1.676 . . . . 0.0 108.134 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.691 ' H ' HD23 ' A' ' 18' ' ' LEU . . . -80.91 53.87 4.64 Favored Glycine 0 C--N 1.318 -0.43 0 C-N-CA 128.241 2.829 . . . . 0.0 108.383 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mm -59.74 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 109.284 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -68.52 141.2 55.62 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.548 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.3 m -95.47 117.31 30.15 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.583 1.553 . . . . 0.0 110.795 -160.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 11.8 mptt -80.02 -171.68 3.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -49.25 71.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.386 2.675 . . . . 0.0 114.87 -171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.77 12.87 83.74 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.717 3.056 . . . . 0.0 114.302 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -144.54 129.66 18.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.024 1.412 . . . . 0.0 111.34 -160.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 5' ' ' VAL . 28.7 p -103.57 59.35 0.75 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.429 1.468 . . . . 0.0 112.277 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -55.35 117.07 3.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.438 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.6 1.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.34 0.171 0 CA-C-O 122.487 1.137 . . . . 0.0 109.61 169.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo . . . . . 0 N--CA 1.453 -0.899 0 N-CA-C 108.707 -1.305 . . . . 0.0 108.707 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 116.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-O 122.726 1.25 . . . . 0.0 108.361 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.09 -176.14 2.97 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 112.83 -1.986 . . . . 0.0 108.761 -167.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.86 142.31 0.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.75 1.62 . . . . 0.0 112.574 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -49.99 75.71 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 160.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -164.88 -164.5 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.62 -48.57 19.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 129.696 3.198 . . . . 0.0 114.836 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.725 ' O ' HG12 ' A' ' 14' ' ' VAL . 33.8 ptt180 -44.98 -40.66 6.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.592 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -69.81 -9.24 53.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.316 -0.865 . . . . 0.0 111.507 -172.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.17 4.34 4.06 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 11' ' ' ARG . 11.5 p -36.51 -45.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 163.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.557 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -58.27 -22.67 53.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.606 1.962 . . . . 0.0 112.215 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.0 m -73.71 -10.16 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.04 0.936 . . . . 0.0 111.946 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.31 -91.5 0.08 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 165.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.9 tp -101.04 -84.85 0.43 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.097 0.959 . . . . 0.0 109.036 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -138.7 60.91 0.58 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -54.95 101.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 109.389 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -78.54 162.94 25.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.601 0.76 . . . . 0.0 111.392 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.11 121.9 27.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.87 0.868 . . . . 0.0 110.314 -158.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -70.02 -169.37 0.27 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 164.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -40.77 70.35 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 130.148 3.379 . . . . 0.0 114.4 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 57.05 26.0 54.84 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 127.628 2.537 . . . . 0.0 113.724 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -128.57 131.23 48.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.079 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.12 110.06 21.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.075 1.75 . . . . 0.0 108.042 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -76.31 73.79 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.996 0.519 . . . . 0.0 112.289 -161.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.82 57.02 5.56 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.269 0.462 . . . . 0.0 112.076 166.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.3 m . . . . . 0 CA--C 1.529 0.145 0 C-N-CA 129.493 3.117 . . . . 0.0 114.255 174.89 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo . . . . . 0 N--CA 1.454 -0.829 0 N-CA-C 109.033 -1.179 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.266 1.3 t -132.03 125.33 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 -171.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.39 175.56 5.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 124.949 1.299 . . . . 0.0 109.61 -167.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 p -175.27 143.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.478 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -28.13 25.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.587 1.155 . . . . 0.0 109.626 168.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -170.5 176.74 4.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.96 -43.63 70.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 126.381 1.873 . . . . 0.0 111.758 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.668 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.1 -36.47 18.8 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.142 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.51 -9.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.855 -1.153 . . . . 0.0 112.564 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 m -136.13 12.89 3.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 11' ' ' ARG . 8.8 p -35.59 -44.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 158.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.556 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -56.59 -25.36 52.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.117 1.767 . . . . 0.0 112.001 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -67.22 -19.9 65.61 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.517 0.727 . . . . 0.0 111.072 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.91 -80.01 0.15 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 168.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.658 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -112.11 -139.79 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.88 1.672 . . . . 0.0 108.359 -175.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.658 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.81 51.45 4.04 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 128.382 2.896 . . . . 0.0 108.951 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 mm -57.87 82.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 108.819 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.9 p -72.37 142.15 48.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -164.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -89.03 113.42 24.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.418 1.087 . . . . 0.0 109.971 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.86 -177.93 6.6 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -4.59 -70.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.374 2.27 . . . . 0.0 115.872 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.24 1.2 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 161.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.36 118.45 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.772 2.029 . . . . 0.0 109.09 -157.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -96.89 62.6 1.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 124.807 2.242 . . . . 0.0 110.32 -160.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -69.35 112.24 5.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.117 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.27 -47.56 0.58 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.341 0.205 0 C-N-CA 126.537 1.935 . . . . 0.0 114.965 -167.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.9 99.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 122.912 1.339 . . . . 0.0 111.704 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -124.38 173.07 8.65 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.138 -159.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 p -163.78 133.92 4.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.181 -159.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -73.1 -30.75 63.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.231 1.012 . . . . 0.0 110.125 160.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -170.16 176.22 4.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.907 1.683 . . . . 0.0 106.817 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.0 -38.46 79.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 110.227 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.673 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -52.36 -36.21 53.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.296 173.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.07 -15.45 63.08 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.372 -1.455 . . . . 0.0 111.558 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.1 m -125.26 6.55 7.78 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 124.449 1.099 . . . . 0.0 113.298 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.6 p -41.29 -39.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 164.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.517 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.1 ptm -56.0 -26.4 48.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.84 1.656 . . . . 0.0 111.963 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 45.2 m -68.56 -27.73 66.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.102 0.961 . . . . 0.0 111.483 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.74 -89.67 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -129.49 -101.48 0.32 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.761 1.224 . . . . 0.0 110.097 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.58 50.83 0.83 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.79 85.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.75 122.49 18.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -154.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.1 t -74.56 107.67 6.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.75 0.42 . . . . 0.0 111.615 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 25' ' ' GLY . 6.8 mtmp? -83.35 -167.66 1.78 Allowed 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 166.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -34.31 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 129.78 3.232 . . . . 0.0 114.701 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 58.92 13.69 20.26 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 127.295 2.379 . . . . 0.0 114.557 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.71 113.89 8.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.076 1.438 . . . . 0.0 111.619 -167.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 p -98.11 136.8 37.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.227 -0.921 . . . . 0.0 113.141 -166.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -90.83 132.07 36.1 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.619 0.767 . . . . 0.0 112.481 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.57 41.07 11.63 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 123.39 0.519 . . . . 0.0 113.286 160.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 41.8 t . . . . . 0 N--CA 1.441 -0.877 0 C-N-CA 125.684 1.594 . . . . 0.0 112.865 -174.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 N-CA-C 110.817 -0.493 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 102.26 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.697 1.237 . . . . 0.0 110.69 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -124.67 175.61 7.1 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.596 -160.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -178.97 157.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.32 1.848 . . . . 0.0 110.663 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -76.16 -61.89 1.79 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -140.81 -178.16 5.41 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.105 1.762 . . . . 0.0 109.283 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -51.4 -48.23 62.68 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.285 1.834 . . . . 0.0 113.354 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -50.81 -33.42 23.48 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.485 176.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.72 -10.55 57.11 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 121.079 -1.013 . . . . 0.0 110.981 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.1 m -136.67 13.23 3.18 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.4 p -31.82 -48.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 157.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.583 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.5 ptp -58.97 -21.85 59.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.207 2.203 . . . . 0.0 112.665 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -66.67 -25.3 66.5 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.302 0.641 . . . . 0.0 110.429 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.74 -78.85 0.05 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.61 -91.36 0.16 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 109.199 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.18 49.08 0.88 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -65.51 78.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.1 p -68.85 153.17 44.27 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -116.28 114.04 23.82 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.527 0.68 . . . . 0.0 109.297 -163.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -160.22 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -47.98 75.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.755 2.422 . . . . 0.0 114.183 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.15 33.56 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 127.8 2.619 . . . . 0.0 113.247 -169.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.23 121.35 26.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.127 0.971 . . . . 0.0 112.438 -166.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.17 63.27 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.163 2.185 . . . . 0.0 109.197 -172.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -56.77 119.92 6.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.158 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.52 6.6 67.96 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.135 -1.369 . . . . 0.0 114.678 165.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 t . . . . . 0 C--N 1.343 0.323 0 C-N-CA 127.997 2.519 . . . . 0.0 115.242 179.591 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo . . . . . 0 N--CA 1.457 -0.639 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.294 3.0 t -117.77 107.67 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -143.73 170.83 15.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.349 1.071 . . . . 0.0 110.103 -144.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.85 144.56 4.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.823 -157.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -88.12 -39.36 14.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.412 1.485 . . . . 0.0 108.534 159.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.93 -179.05 7.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -44.64 -42.03 7.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.631 3.172 . . . . 0.0 113.43 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.68 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.56 -41.44 41.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.663 177.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -7.32 49.25 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.062 -169.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.7 m -134.27 10.64 3.82 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 113.264 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.4 p -39.58 -41.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.534 1.159 . . . . 0.0 113.655 161.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.512 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -55.93 -24.43 37.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.778 1.631 . . . . 0.0 111.834 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.9 m -66.18 -22.61 66.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.527 0.731 . . . . 0.0 111.88 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.51 -87.4 0.1 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.028 0.831 . . . . 0.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.729 HD23 ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -96.97 -146.03 0.3 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.291 1.436 . . . . 0.0 107.159 178.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.729 ' H ' HD23 ' A' ' 18' ' ' LEU . . . -81.38 49.57 4.04 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 127.167 2.317 . . . . 0.0 108.829 172.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mm -46.85 127.52 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.13 1.372 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -68.69 125.76 27.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.87 1.268 . . . . 0.0 112.186 -172.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -87.08 113.67 23.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 165.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -90.1 -170.96 2.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.112 1.365 . . . . 0.0 108.105 167.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -44.57 74.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.559 2.744 . . . . 0.0 114.314 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.91 -5.39 32.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 127.903 2.668 . . . . 0.0 114.166 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -133.11 132.93 42.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.093 1.757 . . . . 0.0 107.785 -162.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 p -114.66 82.29 1.7 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.996 1.725 . . . . 0.0 113.427 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -49.22 142.13 7.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.406 166.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.1 5.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 167.543 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 N-CA-C 109.608 -0.959 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.37 104.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.561 1.172 . . . . 0.0 110.858 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -132.3 175.32 9.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.866 -158.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -172.61 146.31 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.019 -1.9 . . . . 0.0 110.767 -161.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -55.96 4.82 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 158.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.7 p -136.48 176.1 9.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.507 1.923 . . . . 0.0 108.036 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.8 -44.66 39.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 112.405 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.666 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.11 -38.85 18.72 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.214 174.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.25 -10.93 58.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.016 -1.052 . . . . 0.0 112.527 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -129.53 7.09 5.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.2 p -40.17 -41.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 163.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.513 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.7 ptm -57.75 -24.72 58.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.311 1.845 . . . . 0.0 112.347 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.82 -26.87 65.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.959 0.904 . . . . 0.0 110.516 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.2 -82.16 0.06 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 tp -142.97 -97.02 0.12 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.695 1.198 . . . . 0.0 109.501 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.43 40.92 2.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.319 1.438 . . . . 0.0 110.24 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.11 76.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.423 1.089 . . . . 0.0 108.595 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 t -71.8 152.82 42.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.668 1.187 . . . . 0.0 111.855 -166.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.6 t -114.78 136.68 52.81 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.379 1.472 . . . . 0.0 111.58 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.06 129.69 30.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 39.38 53.22 2.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.548 1.539 . . . . 0.0 113.373 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 -19.19 52.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 124.557 1.075 . . . . 0.0 113.644 171.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -115.69 131.54 56.9 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.026 1.331 . . . . 0.0 111.696 -169.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.51 131.81 55.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.151 1.38 . . . . 0.0 111.927 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -100.19 115.92 30.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.481 -153.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.25 53.61 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.584 -0.564 . . . . 0.0 114.382 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t . . . . . 0 N--CA 1.451 -0.395 0 C-N-CA 125.581 1.552 . . . . 0.0 114.04 -178.45 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 108.447 -1.405 . . . . 0.0 108.447 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.256 3.8 t -125.07 115.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -163.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -130.35 174.58 9.71 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 125.514 1.525 . . . . 0.0 108.432 -164.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -176.45 138.88 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.171 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -27.11 33.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.401 0.281 . . . . 0.0 111.272 161.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.42 168.44 26.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.263 1.825 . . . . 0.0 106.943 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -54.98 -39.06 68.59 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 126.352 1.861 . . . . 0.0 110.93 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.702 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -45.36 -41.61 9.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.627 168.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.04 -2.55 24.77 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 121.068 -1.02 . . . . 0.0 111.085 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -137.11 7.43 2.9 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 125.492 1.517 . . . . 0.0 113.97 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.9 p -38.17 -41.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 162.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.512 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.2 ptt? -54.18 -27.3 33.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.646 1.578 . . . . 0.0 111.826 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.61 -26.47 67.85 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.271 1.029 . . . . 0.0 111.797 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.58 -90.22 0.1 Allowed Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -91.94 -139.6 0.18 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -58.76 -51.68 57.58 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.598 1.094 . . . . 0.0 111.009 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.8 mm 49.79 71.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.316 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.84 146.96 4.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.786 2.035 . . . . 0.0 114.001 -172.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -111.59 118.2 35.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.715 1.206 . . . . 0.0 110.661 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -89.39 -175.45 4.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -40.44 79.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.932 2.493 . . . . 0.0 114.133 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.34 76.01 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.614 2.53 . . . . 0.0 114.551 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.9 129.93 40.95 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.868 1.334 . . . . 0.0 110.576 -163.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 145.99 33.37 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.102 0.864 . . . . 0.0 111.044 -163.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -131.97 126.69 34.63 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.152 -0.343 . . . . 0.0 110.194 -154.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 -29.1 10.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.313 0.958 . . . . 0.0 111.889 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 C--N 1.341 0.223 0 C-N-CA 125.243 1.417 . . . . 0.0 113.312 -169.497 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.456 -0.684 0 N-CA-C 108.359 -1.439 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.265 5.4 t -124.42 114.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -162.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -143.13 169.25 17.96 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.004 -155.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.8 p -154.52 156.38 36.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.543 -1.662 . . . . 0.0 109.206 -167.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -53.66 5.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 155.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -140.35 168.96 18.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.592 1.957 . . . . 0.0 107.269 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -42.1 -48.21 4.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 127.195 2.198 . . . . 0.0 114.964 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.697 ' O ' HG12 ' A' ' 14' ' ' VAL 0.252 0.0 OUTLIER -60.11 -24.73 64.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.655 -176.887 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.37 -23.77 67.55 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.954 -1.091 . . . . 0.0 111.313 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.07 11.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.532 1.133 . . . . 0.0 113.19 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.3 p -42.48 -39.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.719 1.247 . . . . 0.0 113.413 163.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.508 ' N ' HG13 ' A' ' 14' ' ' VAL . 23.0 ptp -54.25 -25.16 21.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.066 1.346 . . . . 0.0 111.718 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.2 -29.46 68.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.961 0.904 . . . . 0.0 112.377 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.42 -91.73 0.09 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.554 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -95.61 -138.73 0.24 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.554 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -54.36 -48.33 64.91 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.28 0.943 . . . . 0.0 111.565 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 mm 41.44 66.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.361 1.464 . . . . 0.0 109.634 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.52 100.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.547 1.139 . . . . 0.0 111.008 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.4 142.22 58.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.017 -168.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -158.97 0.59 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.74 1.216 . . . . 0.0 108.254 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -53.35 73.88 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 128.001 2.52 . . . . 0.0 113.767 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.99 66.57 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.342 2.401 . . . . 0.0 112.949 -175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.65 119.3 13.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.859 -162.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.291 27.4 p -107.46 66.24 0.66 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 121.236 1.835 . . . . 0.0 111.314 -164.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -16.32 111.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.914 2.885 . . . . 0.0 115.592 165.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.87 28.66 73.42 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.321 159.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.457 -0.094 0 C-N-CA 127.9 2.48 . . . . 0.0 113.98 174.204 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo . . . . . 0 N--CA 1.457 -0.621 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -110.87 107.2 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -160.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -132.73 170.08 15.77 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.843 -154.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -160.2 147.7 16.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.739 -164.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -33.97 57.73 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.775 -0.578 . . . . 0.0 110.009 155.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 t -170.7 -168.57 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 126.586 1.954 . . . . 0.0 106.122 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.84 -46.44 87.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 127.856 2.463 . . . . 0.0 113.221 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.712 ' O ' HG12 ' A' ' 14' ' ' VAL . 23.0 ptt180 -39.68 -41.28 1.05 Allowed 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.332 167.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' N ' ' CG ' ' A' ' 11' ' ' ARG . 0.4 OUTLIER -79.68 -0.26 33.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -159.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -139.94 8.38 2.31 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 11' ' ' ARG . 13.6 p -36.89 -44.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 161.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.552 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptt? -58.35 -22.34 53.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 126.727 2.011 . . . . 0.0 111.812 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -60.45 -28.77 68.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.801 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.42 -89.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -102.61 -90.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.898 0.879 . . . . 0.0 109.872 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.69 57.64 0.7 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.36 92.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.777 0.831 . . . . 0.0 109.469 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -60.81 150.38 32.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.212 1.005 . . . . 0.0 110.894 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 38.2 t -119.53 136.95 54.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.875 0.87 . . . . 0.0 112.528 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -85.37 -154.15 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.112 0.965 . . . . 0.0 110.473 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.53 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.835 2.054 . . . . 0.0 112.87 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.03 16.35 66.35 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 127.427 2.441 . . . . 0.0 112.961 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -141.94 124.4 15.75 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.257 1.029 . . . . 0.0 111.789 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.6 p -118.57 86.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.622 1.556 . . . . 0.0 112.669 -160.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -48.83 155.73 0.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.25 1.42 . . . . 0.0 112.925 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.59 69.12 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.245 -0.753 . . . . 0.0 114.914 159.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.454 -0.255 0 CA-C-N 118.317 1.058 . . . . 0.0 111.118 173.942 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.457 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.271 6.6 t -124.47 109.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 -165.28 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -135.46 166.14 23.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.623 -150.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 p -166.57 155.84 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.966 -162.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 -50.43 4.17 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.813 1.645 . . . . 0.0 107.447 161.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -132.59 170.67 14.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.698 1.999 . . . . 0.0 107.673 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -57.61 -40.03 78.2 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.569 1.548 . . . . 0.0 111.425 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.685 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -60.3 -22.45 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.624 177.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.11 -23.26 67.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.742 1.155 . . . . 0.0 109.797 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -120.23 13.82 12.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.824 1.65 . . . . 0.0 113.372 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.5 p -36.36 -43.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 159.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.537 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.0 ptp -54.39 -26.28 29.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.479 1.511 . . . . 0.0 111.656 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.96 -32.45 72.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.168 0.587 . . . . 0.0 111.31 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.47 -80.83 0.08 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.681 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -104.9 -142.53 0.37 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.768 1.627 . . . . 0.0 108.412 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.681 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -81.6 52.79 4.62 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 128.11 2.767 . . . . 0.0 108.276 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.4 mm -58.68 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.092 1.357 . . . . 0.0 110.624 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 t -36.52 136.54 0.34 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.388 2.275 . . . . 0.0 113.389 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.6 t -102.25 122.5 44.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.425 1.49 . . . . 0.0 109.847 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -96.65 -172.13 2.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.943 1.297 . . . . 0.0 108.2 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.37 77.47 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.73 2.412 . . . . 0.0 113.156 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.26 -2.28 66.81 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 127.998 2.713 . . . . 0.0 114.26 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -133.12 135.07 45.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.651 1.58 . . . . 0.0 107.771 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 5' ' ' VAL . 30.2 p -111.82 138.47 48.37 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 121.113 1.778 . . . . 0.0 111.709 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -102.85 125.36 49.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.235 -156.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.67 56.15 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.645 168.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.1 m . . . . . 0 C--O 1.226 -0.157 0 C-N-CA 124.178 0.991 . . . . 0.0 111.06 173.905 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo . . . . . 0 N--CA 1.455 -0.748 0 N-CA-C 108.566 -1.359 . . . . 0.0 108.566 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.255 2.1 t -119.82 114.93 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 -175.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -119.75 164.17 16.35 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 -144.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.81 156.81 33.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.636 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.28 -28.87 20.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 152.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -170.7 -178.33 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.358 1.863 . . . . 0.0 107.391 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.26 -49.29 34.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.753 2.021 . . . . 0.0 113.931 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.687 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -46.93 -38.58 10.78 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.06 174.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.28 -6.61 44.29 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 121.43 -0.794 . . . . 0.0 110.578 -170.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.0 m -131.25 6.44 4.52 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.696 1.198 . . . . 0.0 114.113 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 11' ' ' ARG . 13.2 p -41.2 -38.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 122.394 1.093 . . . . 0.0 113.838 163.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.473 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.2 ptp -54.18 -27.12 31.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.435 1.494 . . . . 0.0 111.812 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -62.14 -27.6 69.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.217 0.607 . . . . 0.0 112.075 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.38 -86.85 0.1 OUTLIER Glycine 0 C--N 1.338 0.682 0 CA-C-N 119.21 0.913 . . . . 0.0 111.549 174.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -92.88 -138.88 0.19 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.57 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -59.83 -52.16 54.61 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.432 1.015 . . . . 0.0 110.998 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.9 mm 46.79 69.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.633 1.573 . . . . 0.0 110.546 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 153.69 17.0 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.072 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -120.84 136.79 54.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -95.0 -173.29 2.92 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.145 1.378 . . . . 0.0 108.16 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.57 69.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.605 2.362 . . . . 0.0 113.464 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.6 -35.81 2.7 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.864 3.126 . . . . 0.0 113.31 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -141.59 133.5 27.43 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -141.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.1 p -109.24 128.46 55.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.968 1.258 . . . . 0.0 113.456 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.43 86.35 2.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.988 -148.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.31 -25.91 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 32.3 t . . . . . 0 C--N 1.341 0.217 0 C-N-CA 125.893 1.677 . . . . 0.0 113.413 -173.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 45.7 m . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.25 21.4 Cg_exo -73.22 40.81 0.54 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 124.789 3.659 . . . . 0.0 116.033 -167.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -67.8 118.32 56.7 Favored Pre-proline 0 N--CA 1.435 -1.184 0 O-C-N 120.98 -1.075 . . . . 0.0 108.437 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 50.82 3.63 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.76 2.307 . . . . 0.0 110.272 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.54 111.61 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.311 1.053 . . . . 0.0 109.281 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -130.11 175.08 9.19 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 112.899 -1.955 . . . . 0.0 110.027 -163.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p 174.46 144.09 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 125.763 1.625 . . . . 0.0 112.721 -171.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -70.87 -39.81 72.67 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.358 162.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 t -166.5 -170.66 1.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.409 1.084 . . . . 0.0 109.073 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -55.86 -47.54 77.14 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.496 1.518 . . . . 0.0 111.824 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.696 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -47.91 -40.96 23.4 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 122.179 -0.325 . . . . 0.0 110.828 172.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.69 -0.91 16.95 Favored 'General case' 0 N--CA 1.432 -1.345 0 O-C-N 120.951 -1.093 . . . . 0.0 111.588 -168.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.99 9.39 2.13 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.1 p -31.72 -47.17 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 159.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.575 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.1 ptt? -55.32 -26.56 41.38 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.216 1.806 . . . . 0.0 112.015 -177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -70.17 -17.85 63.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.582 0.753 . . . . 0.0 112.416 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.32 -91.66 0.09 OUTLIER Glycine 0 C--N 1.337 0.6 0 CA-C-N 119.377 0.989 . . . . 0.0 111.466 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 tp -99.53 -100.48 0.23 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -92.91 -42.86 4.29 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 mm 52.87 65.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 123.117 1.437 . . . . 0.0 109.261 -173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 m -60.22 145.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.742 1.617 . . . . 0.0 112.012 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.03 132.57 38.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.862 -141.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -74.65 166.51 23.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -66.12 69.38 0.06 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.11 1.764 . . . . 0.0 111.278 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.55 -34.08 2.4 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 126.946 2.212 . . . . 0.0 112.455 -176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -125.45 118.8 26.61 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.073 0.937 . . . . 0.0 113.067 -153.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.04 58.95 5.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 125.67 1.588 . . . . 0.0 109.418 -178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 67.04 0.39 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.225 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -164.66 -52.7 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.5 t -20.25 -57.24 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.358 2.663 . . . . 0.0 115.091 -172.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 125.186 1.394 . . . . 0.0 111.822 162.198 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.3 m . . . . . 0 CA--C 1.536 0.414 0 CA-C-O 118.602 -0.713 . . . . 0.0 112.04 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.83 65.62 1.28 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 1 C-N-CA 125.395 4.063 . . . . 0.0 113.33 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 16.36 77.21 0.13 Allowed Pre-proline 0 N--CA 1.454 -0.232 0 C-N-CA 128.869 2.867 . . . . 0.0 114.143 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.16 69.44 3.19 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.243 1.962 . . . . 0.0 109.162 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.5 93.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-O 121.937 0.875 . . . . 0.0 109.308 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -88.12 160.43 17.79 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 113.602 -1.635 . . . . 0.0 110.949 -150.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.491 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 32.1 p -147.42 122.67 10.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.132 -1.849 . . . . 0.0 114.955 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -69.58 -31.81 70.19 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.932 150.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -171.14 -178.92 2.55 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.471 1.508 . . . . 0.0 107.784 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -56.97 -47.23 81.25 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 125.634 1.574 . . . . 0.0 111.379 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.655 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.63 -33.76 16.34 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.506 173.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.98 -6.75 35.46 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 119.847 1.203 . . . . 0.0 112.112 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' ' 7' ' ' CYS 0.296 21.1 m -133.68 5.09 3.66 Favored 'General case' 0 CA--C 1.505 -0.752 0 C-N-CA 124.157 0.983 . . . . 0.0 113.412 -177.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.0 p -39.08 -40.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 122.226 1.013 . . . . 0.0 113.53 163.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.494 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -56.28 -24.95 46.43 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.953 1.701 . . . . 0.0 112.135 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 20.1 m -65.05 -23.91 67.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 123.345 0.658 . . . . 0.0 111.864 176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 171.13 -84.91 0.08 OUTLIER Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -116.87 -99.67 0.44 Allowed 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.6 1.16 . . . . 0.0 109.016 -176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -77.47 -73.43 1.06 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' A' ' 27' ' ' CYS . 18.3 mm 49.47 73.86 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.095 1.358 . . . . 0.0 109.93 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.9 p -82.45 160.36 22.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.711 1.205 . . . . 0.0 112.85 -167.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.2 t -102.97 122.62 44.97 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 127.335 2.254 . . . . 0.0 113.55 -166.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -92.89 139.38 30.59 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 156.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -39.79 70.68 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 128.759 2.823 . . . . 0.0 115.969 -171.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.85 -58.73 0.46 Allowed Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.62 1.581 . . . . 0.0 112.466 -173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -123.42 136.7 54.75 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.786 1.634 . . . . 0.0 109.327 -166.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 95.2 m -82.2 166.96 19.16 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.283 0.947 . . . . 0.0 112.055 164.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -121.89 118.38 28.79 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.33 1.052 . . . . 0.0 109.393 -170.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 0.75 37.2 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 118.991 -0.894 . . . . 0.0 114.077 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 13.1 t -51.72 -35.69 44.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.003 1.402 . . . . 0.0 111.557 175.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 164.397 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.539 0.536 0 CA-C-O 118.7 -0.667 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -75.01 51.78 2.88 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 124.773 3.649 . . . . 0.0 114.158 -171.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -64.0 119.25 53.58 Favored Pre-proline 0 N--CA 1.435 -1.21 0 O-C-N 121.193 -0.942 . . . . 0.0 109.07 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.38 52.3 3.84 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.235 1.957 . . . . 0.0 108.762 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -118.9 115.26 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 N-CA-C 101.963 -3.347 . . . . 0.0 101.963 -177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -124.12 162.89 22.62 Favored 'General case' 0 N--CA 1.421 -1.908 0 C-N-CA 124.776 1.23 . . . . 0.0 109.966 -148.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 2.6 p -175.85 142.32 0.52 Allowed 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -166.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -79.38 -32.15 43.03 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.597 1.159 . . . . 0.0 110.597 165.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.7 t -165.27 -179.85 5.83 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.328 1.051 . . . . 0.0 108.583 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -56.72 -43.97 81.15 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.178 1.391 . . . . 0.0 111.535 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.617 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -51.04 -36.85 41.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.141 172.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -74.5 -5.59 43.55 Favored 'General case' 0 N--CA 1.429 -1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.995 -170.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -127.27 1.83 6.38 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 124.501 1.12 . . . . 0.0 114.013 174.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.617 HG12 ' O ' ' A' ' 11' ' ' ARG . 14.5 p -41.47 -34.8 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 171.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.474 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.9 ptp -52.33 -31.53 33.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.988 1.315 . . . . 0.0 111.47 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.498 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 66.6 m -65.04 -25.87 68.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 112.716 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.25 -92.47 0.09 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-N 118.937 0.789 . . . . 0.0 111.319 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.8 tp -133.01 -106.03 0.25 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 124.744 1.218 . . . . 0.0 109.167 -177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -90.8 45.52 2.89 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.2 mm -65.92 97.75 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -88.18 127.87 35.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.835 0.854 . . . . 0.0 111.796 -164.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -80.99 115.95 20.71 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 123.882 0.873 . . . . 0.0 112.272 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -88.36 88.48 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 39.83 38.13 0.42 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.017 2.527 . . . . 0.0 114.72 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 157.02 -49.56 0.44 Allowed Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.334 -0.703 . . . . 0.0 111.387 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -127.31 147.92 50.24 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-O 118.142 -0.933 . . . . 0.0 112.31 -161.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.257 1.0 OUTLIER -105.56 160.35 15.24 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 111.152 170.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -131.63 141.39 49.62 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.323 1.449 . . . . 0.0 108.164 -164.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.95 40.57 93.45 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 118.41 0.55 . . . . 0.0 112.195 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 26.8 t -68.39 74.17 0.24 Allowed 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.008 2.123 . . . . 0.0 110.889 -175.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 125.591 1.556 . . . . 0.0 111.739 176.63 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.15 -175.45 0.18 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.72 3.613 . . . . 0.0 113.492 172.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -55.05 145.72 42.8 Favored Pre-proline 0 N--CA 1.436 -1.152 0 O-C-N 121.526 -0.734 . . . . 0.0 109.228 165.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.31 55.14 4.52 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.186 2.591 . . . . 0.0 110.557 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.22 110.77 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.139 0.971 . . . . 0.0 108.948 173.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -130.03 176.2 8.27 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.962 -161.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.9 p -171.57 152.59 3.23 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.195 -1.821 . . . . 0.0 109.624 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -24.47 17.16 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.94 160.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 t -168.27 -177.43 3.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.496 1.518 . . . . 0.0 106.966 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -60.99 -43.81 98.31 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 124.38 1.072 . . . . 0.0 110.821 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.688 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.04 -35.11 14.83 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.971 170.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -73.69 -3.55 28.92 Favored 'General case' 0 N--CA 1.437 -1.088 0 O-C-N 120.562 -1.336 . . . . 0.0 111.992 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.4 m -135.42 8.36 3.38 Favored 'General case' 0 CA--C 1.502 -0.874 0 C-N-CA 124.429 1.092 . . . . 0.0 113.802 174.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 11' ' ' ARG . 11.9 p -37.6 -42.22 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 161.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.2 ptm -56.16 -26.07 49.01 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.574 1.55 . . . . 0.0 111.957 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.513 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 64.7 m -69.81 -18.79 63.48 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.233 1.013 . . . . 0.0 111.489 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.53 -88.08 0.11 Allowed Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.154 0.888 . . . . 0.0 111.473 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.662 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -105.6 -140.07 0.37 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.638 1.575 . . . . 0.0 108.017 -177.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.662 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -80.24 49.84 3.86 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 128.054 2.74 . . . . 0.0 109.08 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.0 mm -53.37 103.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.718 1.607 . . . . 0.0 108.798 174.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.7 p -72.33 141.87 48.82 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 123.8 0.84 . . . . 0.0 112.201 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.3 t -107.66 110.6 22.5 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.177 1.791 . . . . 0.0 111.47 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -76.25 169.8 17.52 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 164.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -1.38 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.389 2.676 . . . . 0.0 115.414 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -144.42 21.93 2.05 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.672 -0.516 . . . . 0.0 112.682 164.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -125.27 119.22 27.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.299 1.84 . . . . 0.0 108.392 -170.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.08 151.19 23.56 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.105 1.362 . . . . 0.0 110.924 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -127.87 126.33 41.39 Favored 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.856 -0.528 . . . . 0.0 111.107 -154.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.34 45.24 31.11 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.317 0.398 . . . . 0.0 112.385 172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 42.6 t -67.41 75.15 0.16 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.82 1.648 . . . . 0.0 112.258 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 C--N 1.331 -0.217 0 C-N-CA 124.672 1.189 . . . . 0.0 109.292 174.612 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.77 167.39 5.38 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 124.401 3.401 . . . . 0.0 113.609 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -57.36 141.18 78.32 Favored Pre-proline 0 N--CA 1.436 -1.129 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 167.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.64 63.71 6.54 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.784 2.322 . . . . 0.0 109.65 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -56.7 113.7 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.794 0 C-N-CA 124.318 1.047 . . . . 0.0 109.077 172.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -129.41 -179.92 5.43 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.005 -168.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -178.28 156.96 1.02 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.677 -1.601 . . . . 0.0 112.333 -168.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -40.99 19.4 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.961 1.305 . . . . 0.0 108.904 166.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -165.54 -174.81 3.28 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -51.88 -46.9 64.68 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 127.037 2.135 . . . . 0.0 112.755 -171.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.669 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.33 -38.03 26.48 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.972 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.18 -12.38 60.84 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.101 -0.999 . . . . 0.0 111.503 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -134.03 12.9 3.95 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.3 p -36.62 -44.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 160.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.55 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.7 ptm -59.05 -22.75 61.24 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 126.439 1.895 . . . . 0.0 112.337 -177.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -64.58 -21.47 66.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.629 0.772 . . . . 0.0 110.672 175.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 165.35 -68.97 0.2 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 166.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.63 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.9 OUTLIER -129.54 -138.71 0.22 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 126.118 1.767 . . . . 0.0 108.383 -173.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.63 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.61 52.8 4.2 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 128.546 2.974 . . . . 0.0 109.199 176.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.0 mm -59.04 77.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 126.284 1.834 . . . . 0.0 108.38 168.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 p -81.51 144.11 31.56 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 123.462 0.705 . . . . 0.0 112.446 -162.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -115.18 118.48 33.45 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.722 0.772 . . . . 0.0 111.205 -149.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.9 mtmt -79.37 -173.05 3.5 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.711 1.205 . . . . 0.0 108.633 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -58.49 77.88 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.443 1.897 . . . . 0.0 112.147 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.56 71.68 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 128.072 2.749 . . . . 0.0 113.468 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -122.07 121.58 37.3 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.979 1.389 . . . . 0.0 113.641 -155.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.4 t -96.77 68.85 2.43 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 126.738 2.015 . . . . 0.0 109.147 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -48.09 150.22 1.24 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.551 170.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.69 -40.64 2.91 Favored Glycine 0 CA--C 1.524 0.608 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.502 164.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -29.13 -56.66 0.14 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 114.3 -169.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 123.799 0.84 . . . . 0.0 110.783 169.169 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.252 35.3 Cg_exo -61.67 77.23 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.502 0 C-N-CA 124.803 3.669 . . . . 0.0 113.663 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.496 ' C ' ' H ' ' A' ' 5' ' ' VAL . 19.0 m-85 -50.18 118.95 9.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.809 1.243 . . . . 0.0 109.905 177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.49 24.43 0.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.856 1.704 . . . . 0.0 110.564 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB3' ' A' ' 27' ' ' CYS 0.286 6.1 t -94.12 114.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.228 0 N-CA-C 101.314 -3.587 . . . . 0.0 101.314 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -123.39 178.75 5.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 124.759 1.224 . . . . 0.0 108.68 -160.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.2 p 179.67 145.08 0.18 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.336 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.26 -39.73 53.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.515 162.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.2 t -166.71 -175.54 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.635 1.574 . . . . 0.0 107.083 173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -45.2 -46.84 12.5 Favored 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 128.483 2.713 . . . . 0.0 113.865 -175.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.695 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -44.24 -44.6 8.04 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.986 176.066 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -4.73 30.62 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.291 -0.88 . . . . 0.0 111.621 -168.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -135.79 6.26 3.17 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 115.235 1.568 . . . . 0.0 115.235 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.695 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.9 p -34.76 -45.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 161.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.572 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -55.74 -25.86 42.65 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.916 1.686 . . . . 0.0 111.731 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.49 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 59.8 m -75.45 -6.84 52.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.167 0.987 . . . . 0.0 112.627 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.65 -95.86 0.11 Allowed Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 171.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.2 tp -105.7 -99.17 0.33 Allowed 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.79 -47.11 6.03 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 mm 47.53 63.79 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.036 1.334 . . . . 0.0 108.853 -168.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 p -67.18 136.49 55.12 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.464 -166.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.51 164.62 11.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -148.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -117.04 171.82 7.67 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -65.15 71.95 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 126.465 1.906 . . . . 0.0 113.141 -166.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.56 -23.68 19.44 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.82 2.628 . . . . 0.0 112.447 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.8 140.22 49.99 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 124.758 1.223 . . . . 0.0 108.549 -160.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.511 ' HB3' HG12 ' A' ' 5' ' ' VAL . 2.5 t -108.69 149.05 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 -177.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.4 111.77 7.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.906 0.483 . . . . 0.0 110.78 -155.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.54 55.26 6.16 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 2.0 m -67.79 66.98 0.1 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.326 1.45 . . . . 0.0 110.548 176.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 CA--C 1.532 0.268 0 O-C-N 121.146 -0.971 . . . . 0.0 110.225 -179.772 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 112.864 0.691 . . . . 0.0 112.864 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.77 65.69 1.8 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 124.873 3.715 . . . . 0.0 113.296 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -55.02 115.83 9.94 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 124.345 1.058 . . . . 0.0 109.514 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -79.56 60.58 7.87 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.149 1.899 . . . . 0.0 109.37 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.37 106.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 CA-C-O 122.509 1.147 . . . . 0.0 109.714 178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -127.08 175.87 7.79 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 113.148 -1.842 . . . . 0.0 109.278 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p 178.67 166.01 0.85 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.355 1.862 . . . . 0.0 111.103 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -92.68 -43.46 9.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.184 1.393 . . . . 0.0 108.446 160.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.9 t -158.05 -170.95 3.32 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 170.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.84 -41.56 67.55 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 126.996 2.118 . . . . 0.0 112.509 -171.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.68 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.48 -42.33 32.45 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.739 176.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -7.25 47.11 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.749 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -137.41 12.73 3.01 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 125.138 1.375 . . . . 0.0 114.08 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.2 p -35.09 -45.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 159.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.527 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.6 ptp -54.79 -25.65 29.49 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.613 1.565 . . . . 0.0 112.273 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.1 m -67.5 -22.49 65.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.526 1.13 . . . . 0.0 111.862 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 170.74 -95.16 0.11 Allowed Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.659 1.118 . . . . 0.0 111.686 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.584 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -89.88 -140.26 0.14 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 170.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.584 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -56.91 -41.27 91.62 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.99 0.805 . . . . 0.0 111.306 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . 0.274 9.8 mm 50.19 64.92 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 123.008 1.385 . . . . 0.0 109.386 -171.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.63 118.58 2.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.155 2.182 . . . . 0.0 111.378 -176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.4 127.54 43.45 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.64 0.776 . . . . 0.0 110.826 -160.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.17 -167.54 0.52 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.001 0.92 . . . . 0.0 109.653 173.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -39.14 70.03 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 130.811 3.644 . . . . 0.0 114.028 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 49.34 31.93 13.72 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.75 2.119 . . . . 0.0 113.445 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.2 120.19 24.12 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 124.317 1.047 . . . . 0.0 111.954 -169.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 t -90.8 68.32 6.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.503 1.521 . . . . 0.0 110.391 -170.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.83 156.45 0.97 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.595 -1.639 . . . . 0.0 111.284 167.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.86 -30.48 3.87 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.998 -0.89 . . . . 0.0 113.377 164.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.4 t -34.83 -55.21 0.57 Allowed 'General case' 0 C--N 1.34 0.194 0 C-N-CA 125.518 1.527 . . . . 0.0 113.855 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.9 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 172.237 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -58.31 168.22 4.02 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 123.562 2.842 . . . . 0.0 111.532 162.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -47.64 115.73 3.99 Favored Pre-proline 0 N--CA 1.438 -1.059 0 C-N-CA 124.385 1.074 . . . . 0.0 110.288 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 40.53 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.581 2.188 . . . . 0.0 109.373 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.446 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.251 2.9 t -96.66 105.25 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.321 0 N-CA-C 102.717 -3.068 . . . . 0.0 102.717 -166.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -121.77 163.8 18.5 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.495 -156.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.79 126.26 16.75 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 111.874 -2.421 . . . . 0.0 109.233 -169.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.67 -33.54 75.88 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 161.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -168.82 -177.88 3.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.577 2.351 . . . . 0.0 104.971 164.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -52.69 -49.41 65.39 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 126.722 2.009 . . . . 0.0 114.525 -169.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.705 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -54.89 -22.09 13.62 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 176.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.05 -20.68 66.6 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 120.476 -1.39 . . . . 0.0 110.943 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.99 9.35 11.85 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 11' ' ' ARG . 15.0 p -44.02 -35.1 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 113.896 1.072 . . . . 0.0 113.896 162.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.466 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.5 ptt? -53.72 -29.8 41.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.492 1.117 . . . . 0.0 111.493 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.9 m -69.96 -29.67 66.85 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.192 0.997 . . . . 0.0 111.472 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.79 168.49 24.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.8 tp -8.79 -84.4 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.083 2.953 . . . . 0.0 114.287 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.42 -64.95 1.01 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.5 mm 40.25 61.79 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.145 1.378 . . . . 0.0 110.839 -163.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.42 142.8 42.66 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.502 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.0 t -104.12 140.55 37.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -164.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -85.92 -159.4 0.46 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.457 1.103 . . . . 0.0 109.165 173.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -60.62 77.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.817 1.647 . . . . 0.0 112.477 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.32 8.35 62.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.044 2.735 . . . . 0.0 113.165 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -137.15 120.89 17.39 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.449 1.1 . . . . 0.0 108.837 -162.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.446 ' SG ' HG12 ' A' ' 5' ' ' VAL 0.284 31.2 p -98.66 68.42 1.8 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 120.837 1.653 . . . . 0.0 110.669 -165.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -60.41 76.04 0.01 OUTLIER 'General case' 0 C--N 1.342 0.25 0 C-N-CA 127.968 2.507 . . . . 0.0 110.74 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -178.21 -41.35 0.07 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -176.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.9 t -44.11 -46.56 8.71 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.09 1.356 . . . . 0.0 112.634 176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.451 -0.421 0 C-N-CA 125.308 1.443 . . . . 0.0 107.769 171.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.252 82.7 Cg_exo -41.01 -41.04 4.05 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 124.187 3.258 . . . . 0.0 113.119 165.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -95.17 104.01 13.82 Favored Pre-proline 0 N--CA 1.428 -1.54 0 C-N-CA 125.619 1.568 . . . . 0.0 108.132 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.06 61.65 5.76 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.441 2.094 . . . . 0.0 108.241 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.26 5.3 t -124.25 111.46 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.965 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -163.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -130.72 172.37 12.05 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-O 122.038 0.923 . . . . 0.0 111.746 -153.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -175.18 152.33 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.2 -171.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -78.83 -48.17 15.25 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 159.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -142.87 170.93 14.78 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 126.084 1.754 . . . . 0.0 110.135 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -46.53 -45.26 18.49 Favored 'General case' 0 CA--C 1.508 -0.651 0 C-N-CA 126.89 2.076 . . . . 0.0 113.911 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.654 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.0 OUTLIER -45.56 -38.45 6.45 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.245 177.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.36 -6.23 48.91 Favored 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.564 1.146 . . . . 0.0 108.425 -165.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 61.1 m -140.38 13.25 2.37 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.2 p -42.4 -39.13 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 164.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.497 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -55.68 -25.7 41.12 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.896 1.678 . . . . 0.0 112.019 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.07 -24.82 64.9 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.759 0.824 . . . . 0.0 111.397 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.87 -73.95 0.17 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 168.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 19' ' ' GLY . 0.7 OUTLIER -113.81 -144.88 0.39 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.889 1.676 . . . . 0.0 108.134 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.691 ' H ' HD23 ' A' ' 18' ' ' LEU . . . -80.91 53.87 4.64 Favored Glycine 0 C--N 1.318 -0.43 0 C-N-CA 128.241 2.829 . . . . 0.0 108.383 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mm -59.74 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.631 1.572 . . . . 0.0 109.284 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 t -68.52 141.2 55.62 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.548 -169.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 27' ' ' CYS . 1.3 m -95.47 117.31 30.15 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.583 1.553 . . . . 0.0 110.795 -160.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 11.8 mptt -80.02 -171.68 3.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 174.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -49.25 71.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.386 2.675 . . . . 0.0 114.87 -171.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.77 12.87 83.74 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 128.717 3.056 . . . . 0.0 114.302 -176.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -144.54 129.66 18.59 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.024 1.412 . . . . 0.0 111.34 -160.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 5' ' ' VAL . 28.7 p -103.57 59.35 0.75 Allowed 'General case' 0 C--N 1.345 0.403 0 CA-C-N 120.429 1.468 . . . . 0.0 112.277 -170.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -55.35 117.07 3.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.438 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.46 -44.6 1.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -166.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.7 t -49.08 -44.59 42.16 Favored 'General case' 0 C--N 1.34 0.171 0 CA-C-O 122.487 1.137 . . . . 0.0 109.61 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.444 -0.768 0 C-N-CA 126.752 2.021 . . . . 0.0 106.346 161.455 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -51.01 151.47 11.67 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.676 2.25 . . . . 0.0 110.473 152.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 19.17 74.31 0.21 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 127.296 2.238 . . . . 0.0 114.349 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.76 66.78 6.64 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.398 2.065 . . . . 0.0 108.707 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 116.39 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-O 122.726 1.25 . . . . 0.0 108.361 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.09 -176.14 2.97 Favored 'General case' 0 N--CA 1.434 -1.272 0 CA-C-N 112.83 -1.986 . . . . 0.0 108.761 -167.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -173.86 142.31 0.88 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.75 1.62 . . . . 0.0 112.574 177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -49.99 75.71 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 160.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -164.88 -164.5 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 104.578 -2.379 . . . . 0.0 104.578 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -46.62 -48.57 19.78 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 129.696 3.198 . . . . 0.0 114.836 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.725 ' O ' HG12 ' A' ' 14' ' ' VAL . 33.8 ptt180 -44.98 -40.66 6.64 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.592 174.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -69.81 -9.24 53.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 121.316 -0.865 . . . . 0.0 111.507 -172.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -132.17 4.34 4.06 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.725 HG12 ' O ' ' A' ' 11' ' ' ARG . 11.5 p -36.51 -45.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 163.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.557 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -58.27 -22.67 53.5 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.606 1.962 . . . . 0.0 112.215 -175.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.0 m -73.71 -10.16 59.4 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.04 0.936 . . . . 0.0 111.946 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -178.31 -91.5 0.08 OUTLIER Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 165.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.9 tp -101.04 -84.85 0.43 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.097 0.959 . . . . 0.0 109.036 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -138.7 60.91 0.58 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 107.046 -2.422 . . . . 0.0 107.046 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -54.95 101.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.531 0.732 . . . . 0.0 109.389 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -78.54 162.94 25.95 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.601 0.76 . . . . 0.0 111.392 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -130.11 121.9 27.23 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.87 0.868 . . . . 0.0 110.314 -158.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -70.02 -169.37 0.27 Allowed 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 164.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -40.77 70.35 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 130.148 3.379 . . . . 0.0 114.4 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 57.05 26.0 54.84 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 127.628 2.537 . . . . 0.0 113.724 -170.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -128.57 131.23 48.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.079 -173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.4 t -108.12 110.06 21.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.075 1.75 . . . . 0.0 108.042 -167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -76.31 73.79 3.1 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.996 0.519 . . . . 0.0 112.289 -161.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.82 57.02 5.56 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.269 0.462 . . . . 0.0 112.076 166.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.3 m -2.54 -75.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 129.493 3.117 . . . . 0.0 114.255 174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.849 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.539 0.549 0 CA-C-O 119.402 -0.332 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.32 100.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.397 0 C-N-CA 125.055 3.837 . . . . 0.0 112.329 170.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -62.25 135.09 94.94 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.55 -162.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.06 65.83 3.37 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 124.157 3.238 . . . . 0.0 109.033 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.266 1.3 t -132.03 125.33 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 101.366 -3.568 . . . . 0.0 101.366 -171.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.39 175.56 5.56 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 124.949 1.299 . . . . 0.0 109.61 -167.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.2 p -175.27 143.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.478 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.45 -28.13 25.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.587 1.155 . . . . 0.0 109.626 168.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 t -170.5 176.74 4.26 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.96 -43.63 70.06 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 126.381 1.873 . . . . 0.0 111.758 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.668 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.1 -36.47 18.8 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.142 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -68.51 -9.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.932 0 O-C-N 120.855 -1.153 . . . . 0.0 112.564 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.1 m -136.13 12.89 3.32 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.668 HG12 ' O ' ' A' ' 11' ' ' ARG . 8.8 p -35.59 -44.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 158.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.556 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.4 ptt? -56.59 -25.36 52.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.117 1.767 . . . . 0.0 112.001 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -67.22 -19.9 65.61 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.517 0.727 . . . . 0.0 111.072 178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.91 -80.01 0.15 Allowed Glycine 0 C--N 1.338 0.683 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 168.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.658 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.0 OUTLIER -112.11 -139.79 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.88 1.672 . . . . 0.0 108.359 -175.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.658 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -79.81 51.45 4.04 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 128.382 2.896 . . . . 0.0 108.951 173.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 mm -57.87 82.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.86 1.664 . . . . 0.0 108.819 170.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.9 p -72.37 142.15 48.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -164.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.3 t -89.03 113.42 24.53 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.418 1.087 . . . . 0.0 109.971 -176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.86 -177.93 6.6 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -4.59 -70.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.374 2.27 . . . . 0.0 115.872 -171.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.18 34.24 1.2 Allowed Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 161.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -138.36 118.45 13.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.772 2.029 . . . . 0.0 109.09 -157.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.281 0.0 OUTLIER -96.89 62.6 1.89 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 124.807 2.242 . . . . 0.0 110.32 -160.215 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -69.35 112.24 5.77 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.117 -175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.27 -47.56 0.58 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.4 t -31.4 -64.24 0.15 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.537 1.935 . . . . 0.0 114.965 -167.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 169.412 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 110.629 -0.138 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -75.25 54.48 3.77 Favored 'Trans proline' 0 N--CA 1.448 -1.157 1 C-N-CA 125.395 4.063 . . . . 0.0 114.605 -166.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -63.6 118.91 49.21 Favored Pre-proline 0 N--CA 1.434 -1.266 0 O-C-N 121.124 -0.985 . . . . 0.0 109.736 -179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.5 63.94 8.5 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.677 2.251 . . . . 0.0 109.211 -178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.9 99.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 122.912 1.339 . . . . 0.0 111.704 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -124.38 173.07 8.65 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 112.898 -1.955 . . . . 0.0 110.138 -159.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.3 p -163.78 133.92 4.25 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.181 -159.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -73.1 -30.75 63.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.231 1.012 . . . . 0.0 110.125 160.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 t -170.16 176.22 4.68 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.907 1.683 . . . . 0.0 106.817 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.0 -38.46 79.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 110.227 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.673 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -52.36 -36.21 53.16 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.296 173.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -66.07 -15.45 63.08 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 120.372 -1.455 . . . . 0.0 111.558 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 43.1 m -125.26 6.55 7.78 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 124.449 1.099 . . . . 0.0 113.298 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.6 p -41.29 -39.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 164.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.517 ' N ' HG13 ' A' ' 14' ' ' VAL . 27.1 ptm -56.0 -26.4 48.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.84 1.656 . . . . 0.0 111.963 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 45.2 m -68.56 -27.73 66.34 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.102 0.961 . . . . 0.0 111.483 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 177.74 -89.67 0.08 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.0 tp -129.49 -101.48 0.32 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 124.761 1.224 . . . . 0.0 110.097 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.58 50.83 0.83 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.0 mm -62.79 85.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.543 1.537 . . . . 0.0 108.293 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.75 122.49 18.67 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.483 -154.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.1 t -74.56 107.67 6.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.75 0.42 . . . . 0.0 111.615 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' A' ' 25' ' ' GLY . 6.8 mtmp? -83.35 -167.66 1.78 Allowed 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 166.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -34.31 72.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 129.78 3.232 . . . . 0.0 114.701 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 58.92 13.69 20.26 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 127.295 2.379 . . . . 0.0 114.557 -172.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -140.71 113.89 8.51 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.076 1.438 . . . . 0.0 111.619 -167.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.0 p -98.11 136.8 37.83 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 121.227 -0.921 . . . . 0.0 113.141 -166.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -90.83 132.07 36.1 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.619 0.767 . . . . 0.0 112.481 -169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.57 41.07 11.63 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 123.39 0.519 . . . . 0.0 113.286 160.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.504 ' HA ' ' HB3' ' A' ' 16' ' ' CYS . 41.8 t -65.42 77.36 0.06 Allowed 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.684 1.594 . . . . 0.0 112.865 -174.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 109.011 170.586 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.273 39.8 Cg_exo -66.7 35.39 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 1 C-N-CA 125.799 4.332 . . . . 0.0 116.976 -176.347 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -98.11 153.75 37.99 Favored Pre-proline 0 N--CA 1.437 -1.121 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 166.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.07 52.12 3.35 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.59 2.193 . . . . 0.0 110.817 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.65 102.26 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 CA-C-O 122.697 1.237 . . . . 0.0 110.69 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -124.67 175.61 7.1 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.745 -2.025 . . . . 0.0 109.596 -160.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 p -178.97 157.71 0.88 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 126.32 1.848 . . . . 0.0 110.663 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -76.16 -61.89 1.79 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 162.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.9 p -140.81 -178.16 5.41 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.105 1.762 . . . . 0.0 109.283 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -51.4 -48.23 62.68 Favored 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 126.285 1.834 . . . . 0.0 113.354 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.722 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -50.81 -33.42 23.48 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.485 176.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -68.72 -10.55 57.11 Favored 'General case' 0 N--CA 1.44 -0.94 0 O-C-N 121.079 -1.013 . . . . 0.0 110.981 -173.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.1 m -136.67 13.23 3.18 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.4 p -31.82 -48.92 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 115.386 1.625 . . . . 0.0 115.386 157.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.583 ' N ' HG13 ' A' ' 14' ' ' VAL . 25.5 ptp -58.97 -21.85 59.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 127.207 2.203 . . . . 0.0 112.665 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.7 m -66.67 -25.3 66.5 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.302 0.641 . . . . 0.0 110.429 178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.74 -78.85 0.05 OUTLIER Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 171.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tp -140.61 -91.36 0.16 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.545 1.138 . . . . 0.0 109.199 -173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -109.18 49.08 0.88 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 -177.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -65.51 78.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.1 p -68.85 153.17 44.27 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.535 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.2 m -116.28 114.04 23.82 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.527 0.68 . . . . 0.0 109.297 -163.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -160.22 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -47.98 75.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.755 2.422 . . . . 0.0 114.183 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 53.21 28.15 33.56 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 127.8 2.619 . . . . 0.0 113.247 -169.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.23 121.35 26.02 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.127 0.971 . . . . 0.0 112.438 -166.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.17 63.27 4.3 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 127.163 2.185 . . . . 0.0 109.197 -172.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -56.77 119.92 6.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 113.84 -1.527 . . . . 0.0 111.158 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.52 6.6 67.96 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.135 -1.369 . . . . 0.0 114.678 165.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 t -10.76 -76.26 0.0 OUTLIER 'General case' 0 C--N 1.343 0.323 0 C-N-CA 127.997 2.519 . . . . 0.0 115.242 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.636 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.244 0.545 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.78 87.24 0.06 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.638 1 C-N-CA 125.341 4.028 . . . . 0.0 112.726 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -39.54 111.29 0.68 Allowed Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.802 2.041 . . . . 0.0 110.773 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.1 57.57 5.28 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.906 2.404 . . . . 0.0 108.208 177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.294 3.0 t -117.77 107.67 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 101.245 -3.613 . . . . 0.0 101.245 -169.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -143.73 170.83 15.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.349 1.071 . . . . 0.0 110.103 -144.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 26.3 p -166.85 144.56 4.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 112.662 -2.063 . . . . 0.0 113.823 -157.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -88.12 -39.36 14.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.412 1.485 . . . . 0.0 108.534 159.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.9 t -154.93 -179.05 7.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 168.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -44.64 -42.03 7.14 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 129.631 3.172 . . . . 0.0 113.43 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.68 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -49.56 -41.44 41.53 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.663 177.301 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.46 -7.32 49.25 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.062 -169.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 75.7 m -134.27 10.64 3.82 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.412 1.085 . . . . 0.0 113.264 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.4 p -39.58 -41.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 122.534 1.159 . . . . 0.0 113.655 161.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.512 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptm -55.93 -24.43 37.87 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.778 1.631 . . . . 0.0 111.834 -178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.9 m -66.18 -22.61 66.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.527 0.731 . . . . 0.0 111.88 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.51 -87.4 0.1 OUTLIER Glycine 0 C--N 1.34 0.766 0 CA-C-N 119.028 0.831 . . . . 0.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.729 HD23 ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -96.97 -146.03 0.3 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.291 1.436 . . . . 0.0 107.159 178.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.729 ' H ' HD23 ' A' ' 18' ' ' LEU . . . -81.38 49.57 4.04 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 127.167 2.317 . . . . 0.0 108.829 172.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 mm -46.85 127.52 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.13 1.372 . . . . 0.0 110.846 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.2 p -68.69 125.76 27.57 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.87 1.268 . . . . 0.0 112.186 -172.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -87.08 113.67 23.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 165.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -90.1 -170.96 2.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.112 1.365 . . . . 0.0 108.105 167.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -44.57 74.57 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.559 2.744 . . . . 0.0 114.314 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.91 -5.39 32.35 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 127.903 2.668 . . . . 0.0 114.166 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -133.11 132.93 42.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.093 1.757 . . . . 0.0 107.785 -162.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 21.3 p -114.66 82.29 1.7 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 120.996 1.725 . . . . 0.0 113.427 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -49.22 142.13 7.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.406 166.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 116.25 -32.1 5.74 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.5 m -58.87 -40.06 83.21 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--O 1.238 0.455 0 C-N-CA 126.032 1.733 . . . . 0.0 107.223 165.436 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.256 29.9 Cg_exo -69.32 38.49 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 125.141 3.894 . . . . 0.0 116.667 -170.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -71.1 117.39 56.0 Favored Pre-proline 0 N--CA 1.435 -1.195 0 C-N-CA 124.623 1.169 . . . . 0.0 108.589 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.23 61.97 8.34 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.17 1.913 . . . . 0.0 109.608 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -71.37 104.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 122.561 1.172 . . . . 0.0 110.858 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -132.3 175.32 9.37 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 112.976 -1.92 . . . . 0.0 110.866 -158.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.0 p -172.61 146.31 1.67 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.019 -1.9 . . . . 0.0 110.767 -161.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.44 -55.96 4.82 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 158.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.7 p -136.48 176.1 9.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.507 1.923 . . . . 0.0 108.036 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -48.8 -44.66 39.27 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 125.688 1.595 . . . . 0.0 112.405 174.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.666 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -48.11 -38.85 18.72 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.214 174.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.25 -10.93 58.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 O-C-N 121.016 -1.052 . . . . 0.0 112.527 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -129.53 7.09 5.27 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 11' ' ' ARG . 12.2 p -40.17 -41.02 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 163.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.513 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.7 ptm -57.75 -24.72 58.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.311 1.845 . . . . 0.0 112.347 -177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 32.3 m -68.82 -26.87 65.4 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.959 0.904 . . . . 0.0 110.516 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.2 -82.16 0.06 OUTLIER Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 tp -142.97 -97.02 0.12 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 124.695 1.198 . . . . 0.0 109.501 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.43 40.92 2.64 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.319 1.438 . . . . 0.0 110.24 -173.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.8 mm -69.11 76.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.423 1.089 . . . . 0.0 108.595 176.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 t -71.8 152.82 42.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.668 1.187 . . . . 0.0 111.855 -166.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.6 t -114.78 136.68 52.81 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 125.379 1.472 . . . . 0.0 111.58 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -137.06 129.69 30.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m120 39.38 53.22 2.29 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.548 1.539 . . . . 0.0 113.373 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.57 -19.19 52.39 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 124.557 1.075 . . . . 0.0 113.644 171.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -115.69 131.54 56.9 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.026 1.331 . . . . 0.0 111.696 -169.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.51 131.81 55.92 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.151 1.38 . . . . 0.0 111.927 -167.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -100.19 115.92 30.99 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.481 -153.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.06 20.25 53.61 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.584 -0.564 . . . . 0.0 114.382 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t -41.54 -53.17 3.54 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.581 1.552 . . . . 0.0 114.04 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 120.994 0.426 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.0 101.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.836 0 C-N-CA 125.033 3.822 . . . . 0.0 112.666 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -52.01 119.74 14.96 Favored Pre-proline 0 N--CA 1.437 -1.091 0 C-N-CA 124.706 1.203 . . . . 0.0 109.038 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.41 61.88 6.84 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.436 2.091 . . . . 0.0 108.447 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.256 3.8 t -125.07 115.12 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -163.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -130.35 174.58 9.71 Favored 'General case' 0 N--CA 1.408 -2.529 0 C-N-CA 125.514 1.525 . . . . 0.0 108.432 -164.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -176.45 138.88 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.171 -164.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -27.11 33.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.401 0.281 . . . . 0.0 111.272 161.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -158.42 168.44 26.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 126.263 1.825 . . . . 0.0 106.943 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -54.98 -39.06 68.59 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 126.352 1.861 . . . . 0.0 110.93 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.702 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -45.36 -41.61 9.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.627 168.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -74.04 -2.55 24.77 Favored 'General case' 0 N--CA 1.434 -1.246 0 O-C-N 121.068 -1.02 . . . . 0.0 111.085 -169.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -137.11 7.43 2.9 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 125.492 1.517 . . . . 0.0 113.97 176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.702 HG12 ' O ' ' A' ' 11' ' ' ARG . 10.9 p -38.17 -41.98 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 162.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.512 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.2 ptt? -54.18 -27.3 33.03 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.646 1.578 . . . . 0.0 111.826 -178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.5 m -65.61 -26.47 67.85 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.271 1.029 . . . . 0.0 111.797 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.58 -90.22 0.1 Allowed Glycine 0 C--N 1.339 0.724 0 CA-C-N 119.302 0.955 . . . . 0.0 111.697 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.576 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -91.94 -139.6 0.18 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -58.76 -51.68 57.58 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.598 1.094 . . . . 0.0 111.009 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.8 mm 49.79 71.21 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.279 1.432 . . . . 0.0 110.316 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -49.84 146.96 4.09 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.786 2.035 . . . . 0.0 114.001 -172.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -111.59 118.2 35.05 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.715 1.206 . . . . 0.0 110.661 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -89.39 -175.45 4.74 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 165.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -40.44 79.25 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.932 2.493 . . . . 0.0 114.133 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.49 1.34 76.01 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 127.614 2.53 . . . . 0.0 114.551 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.9 129.93 40.95 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.868 1.334 . . . . 0.0 110.576 -163.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 145.99 33.37 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-N 119.102 0.864 . . . . 0.0 111.044 -163.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -131.97 126.69 34.63 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.152 -0.343 . . . . 0.0 110.194 -154.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.75 -29.1 10.79 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.313 0.958 . . . . 0.0 111.889 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.5 t -41.68 -56.89 2.48 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 125.243 1.417 . . . . 0.0 113.312 -169.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.1 p . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 171.094 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -54.29 161.95 4.85 Favored 'Trans proline' 0 N--CA 1.44 -1.632 0 C-N-CA 125.079 3.852 . . . . 0.0 113.142 170.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -49.83 117.58 7.54 Favored Pre-proline 0 N--CA 1.439 -0.976 0 C-N-CA 124.708 1.203 . . . . 0.0 109.43 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.58 64.82 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.583 2.188 . . . . 0.0 108.359 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.265 5.4 t -124.42 114.25 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -162.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -143.13 169.25 17.96 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.004 -155.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.8 p -154.52 156.38 36.55 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.543 -1.662 . . . . 0.0 109.206 -167.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.93 -53.66 5.68 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 155.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.4 p -140.35 168.96 18.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.592 1.957 . . . . 0.0 107.269 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -42.1 -48.21 4.67 Favored 'General case' 0 CA--C 1.502 -0.897 0 C-N-CA 127.195 2.198 . . . . 0.0 114.964 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.697 ' O ' HG12 ' A' ' 14' ' ' VAL 0.252 0.0 OUTLIER -60.11 -24.73 64.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.655 -176.887 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -63.37 -23.77 67.55 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.954 -1.091 . . . . 0.0 111.313 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.07 11.57 10.96 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.532 1.133 . . . . 0.0 113.19 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.697 HG12 ' O ' ' A' ' 11' ' ' ARG . 9.3 p -42.48 -39.94 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.719 1.247 . . . . 0.0 113.413 163.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.508 ' N ' HG13 ' A' ' 14' ' ' VAL . 23.0 ptp -54.25 -25.16 21.73 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.066 1.346 . . . . 0.0 111.718 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m -60.2 -29.46 68.73 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.961 0.904 . . . . 0.0 112.377 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 175.42 -91.73 0.09 OUTLIER Glycine 0 C--N 1.338 0.648 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.554 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -95.61 -138.73 0.24 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 172.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.554 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -54.36 -48.33 64.91 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.28 0.943 . . . . 0.0 111.565 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.3 mm 41.44 66.2 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.361 1.464 . . . . 0.0 109.634 -170.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.52 100.17 0.13 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.547 1.139 . . . . 0.0 111.008 -174.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.4 142.22 58.5 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.017 -168.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.01 -158.97 0.59 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.74 1.216 . . . . 0.0 108.254 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -53.35 73.88 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 128.001 2.52 . . . . 0.0 113.767 -176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.99 66.57 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 127.342 2.401 . . . . 0.0 112.949 -175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.65 119.3 13.17 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.859 -162.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . 0.291 27.4 p -107.46 66.24 0.66 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 121.236 1.835 . . . . 0.0 111.314 -164.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -16.32 111.19 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.914 2.885 . . . . 0.0 115.592 165.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.87 28.66 73.42 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.321 159.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.4 m -22.7 -58.64 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 127.9 2.48 . . . . 0.0 113.98 174.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 122.541 0.336 . . . . 0.0 110.934 169.336 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 46.8 p . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.34 0.2 OUTLIER -27.98 -66.4 0.06 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.905 1 C-N-CA 127.644 5.562 . . . . 0.0 118.134 -167.81 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -63.31 116.45 25.46 Favored Pre-proline 0 N--CA 1.44 -0.947 0 CA-C-O 117.747 -1.12 . . . . 0.0 108.531 -177.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.32 48.86 2.84 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.667 1.631 . . . . 0.0 109.012 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 t -110.87 107.2 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -160.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -132.73 170.08 15.77 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 113.833 -1.531 . . . . 0.0 108.843 -154.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -160.2 147.7 16.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.739 -164.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.91 -33.97 57.73 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.775 -0.578 . . . . 0.0 110.009 155.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.4 t -170.7 -168.57 0.7 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 126.586 1.954 . . . . 0.0 106.122 174.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.84 -46.44 87.88 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 127.856 2.463 . . . . 0.0 113.221 -168.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.712 ' O ' HG12 ' A' ' 14' ' ' VAL . 23.0 ptt180 -39.68 -41.28 1.05 Allowed 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.827 -1.079 . . . . 0.0 110.332 167.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' N ' ' CG ' ' A' ' 11' ' ' ARG . 0.4 OUTLIER -79.68 -0.26 33.28 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -159.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.3 m -139.94 8.38 2.31 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 11' ' ' ARG . 13.6 p -36.89 -44.3 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 161.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.552 ' N ' HG13 ' A' ' 14' ' ' VAL . 26.8 ptt? -58.35 -22.34 53.12 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 126.727 2.011 . . . . 0.0 111.812 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.3 m -60.45 -28.77 68.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.492 -0.29 . . . . 0.0 110.801 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -173.42 -89.02 0.07 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 173.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.0 tp -102.61 -90.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.898 0.879 . . . . 0.0 109.872 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.69 57.64 0.7 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mm -64.36 92.15 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.777 0.831 . . . . 0.0 109.469 -177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -60.81 150.38 32.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.212 1.005 . . . . 0.0 110.894 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 38.2 t -119.53 136.95 54.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.875 0.87 . . . . 0.0 112.528 -170.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.2 mttt -85.37 -154.15 0.19 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.112 0.965 . . . . 0.0 110.473 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -58.53 76.82 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.835 2.054 . . . . 0.0 112.87 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.03 16.35 66.35 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 127.427 2.441 . . . . 0.0 112.961 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -141.94 124.4 15.75 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.257 1.029 . . . . 0.0 111.789 -162.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.6 p -118.57 86.82 2.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 120.622 1.556 . . . . 0.0 112.669 -160.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -48.83 155.73 0.56 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.25 1.42 . . . . 0.0 112.925 175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.59 69.12 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 119.245 -0.753 . . . . 0.0 114.914 159.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 56.7 m -52.38 -38.83 59.86 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.317 1.058 . . . . 0.0 111.118 173.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 168.763 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 118.257 -0.877 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . 0.267 85.9 Cg_exo -44.56 -50.91 7.69 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 124.811 3.674 . . . . 0.0 114.479 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -85.43 110.62 30.73 Favored Pre-proline 0 N--CA 1.431 -1.387 0 C-N-CA 125.478 1.511 . . . . 0.0 108.312 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.07 64.38 6.1 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.365 2.043 . . . . 0.0 108.133 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG12 ' SG ' ' A' ' 27' ' ' CYS 0.271 6.6 t -124.47 109.05 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.154 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 -165.28 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -135.46 166.14 23.86 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.623 -150.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 p -166.57 155.84 11.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.771 -1.559 . . . . 0.0 111.966 -162.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.07 -50.43 4.17 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.813 1.645 . . . . 0.0 107.447 161.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -132.59 170.67 14.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.698 1.999 . . . . 0.0 107.673 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -57.61 -40.03 78.2 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 125.569 1.548 . . . . 0.0 111.425 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.685 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -60.3 -22.45 63.17 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.037 -1.438 . . . . 0.0 111.624 177.819 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -65.11 -23.26 67.09 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.742 1.155 . . . . 0.0 109.797 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.0 m -120.23 13.82 12.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 125.824 1.65 . . . . 0.0 113.372 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.685 HG12 ' O ' ' A' ' 11' ' ' ARG . 7.5 p -36.36 -43.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 159.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.537 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.0 ptp -54.39 -26.28 29.46 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.479 1.511 . . . . 0.0 111.656 -178.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.96 -32.45 72.89 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.168 0.587 . . . . 0.0 111.31 176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.47 -80.83 0.08 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.681 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 0.8 OUTLIER -104.9 -142.53 0.37 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.768 1.627 . . . . 0.0 108.412 -175.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.681 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -81.6 52.79 4.62 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 128.11 2.767 . . . . 0.0 108.276 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.4 mm -58.68 87.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.092 1.357 . . . . 0.0 110.624 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 t -36.52 136.54 0.34 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.388 2.275 . . . . 0.0 113.389 174.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.6 t -102.25 122.5 44.33 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.425 1.49 . . . . 0.0 109.847 174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -96.65 -172.13 2.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.943 1.297 . . . . 0.0 108.2 168.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -50.37 77.47 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.73 2.412 . . . . 0.0 113.156 -173.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 78.26 -2.28 66.81 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 127.998 2.713 . . . . 0.0 114.26 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -133.12 135.07 45.0 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.651 1.58 . . . . 0.0 107.771 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 5' ' ' VAL . 30.2 p -111.82 138.47 48.37 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 121.113 1.778 . . . . 0.0 111.709 -169.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -102.85 125.36 49.57 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.235 -156.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.54 31.67 56.15 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.645 168.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.1 m -45.01 -44.87 10.32 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.178 0.991 . . . . 0.0 111.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 123.026 0.53 . . . . 0.0 109.585 164.045 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -59.95 172.89 2.02 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 124.308 3.339 . . . . 0.0 113.253 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -56.22 126.74 68.89 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-O 118.196 -0.907 . . . . 0.0 108.71 168.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -76.07 55.88 4.67 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.654 2.236 . . . . 0.0 108.566 173.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.255 2.1 t -119.82 114.93 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 -175.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -119.75 164.17 16.35 Favored 'General case' 0 N--CA 1.422 -1.827 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.335 -144.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 p -156.81 156.81 33.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.636 -172.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -88.28 -28.87 20.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 152.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -170.7 -178.33 2.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.358 1.863 . . . . 0.0 107.391 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -48.26 -49.29 34.06 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 126.753 2.021 . . . . 0.0 113.931 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.687 ' O ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -46.93 -38.58 10.78 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.06 174.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -72.28 -6.61 44.29 Favored 'General case' 0 N--CA 1.429 -1.516 0 O-C-N 121.43 -0.794 . . . . 0.0 110.578 -170.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 57.0 m -131.25 6.44 4.52 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.696 1.198 . . . . 0.0 114.113 177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 11' ' ' ARG . 13.2 p -41.2 -38.26 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-O 122.394 1.093 . . . . 0.0 113.838 163.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.473 ' N ' HG13 ' A' ' 14' ' ' VAL . 24.2 ptp -54.18 -27.12 31.85 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.435 1.494 . . . . 0.0 111.812 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.0 m -62.14 -27.6 69.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.217 0.607 . . . . 0.0 112.075 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.38 -86.85 0.1 OUTLIER Glycine 0 C--N 1.338 0.682 0 CA-C-N 119.21 0.913 . . . . 0.0 111.549 174.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.57 ' CD2' ' H ' ' A' ' 19' ' ' GLY . 1.1 tt -92.88 -138.88 0.19 Allowed 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.57 ' H ' ' CD2' ' A' ' 18' ' ' LEU . . . -59.83 -52.16 54.61 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.432 1.015 . . . . 0.0 110.998 178.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.9 mm 46.79 69.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.633 1.573 . . . . 0.0 110.546 -176.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -58.98 153.69 17.0 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 114.459 -1.246 . . . . 0.0 112.072 -172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.3 t -120.84 136.79 54.83 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -95.0 -173.29 2.92 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.145 1.378 . . . . 0.0 108.16 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -57.57 69.8 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.605 2.362 . . . . 0.0 113.464 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.6 -35.81 2.7 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.864 3.126 . . . . 0.0 113.31 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -141.59 133.5 27.43 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -141.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.1 p -109.24 128.46 55.08 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.968 1.258 . . . . 0.0 113.456 -164.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.43 86.35 2.56 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.988 -148.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 160.31 -25.91 0.3 Allowed Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.576 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 32.3 t -40.53 -49.16 2.92 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 125.893 1.677 . . . . 0.0 113.413 -173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 124.574 1.15 . . . . 0.0 108.318 169.016 . . . . . . . . 0 0 . 1 stop_ save_